data_2mmm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mmm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.397 -0.281 . . . . 74.15 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 -21.93 50.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.41 112.599 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -47.67 -61.5 1.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.019 0.438 . . . . 63.52 110.748 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -61.21 -23.67 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.64 . . . . 72.25 110.42 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -68.86 -40.63 79.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 61.04 110.866 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.62 -39.91 30.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 74.23 111.015 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.35 -22.01 76.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.808 -0.71 . . . . 75.21 112.756 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -96.02 -26.8 15.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.68 0.276 . . . . 61.41 111.202 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.16 -63.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 74.55 111.023 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -41.03 78.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 73.11 111.099 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -37.98 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.54 111.21 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.23 -38.02 66.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 75.51 112.769 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -70.88 -49.33 47.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 52.42 111.073 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.22 -21.88 27.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.651 -0.785 . . . . 55.43 112.911 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.633 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.69 -39.33 24.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.772 0.286 . . . . 75.21 111.116 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.67 -37.17 27.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.173 0.511 . . . . 65.05 110.625 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' ALA . 31.7 t -72.56 -22.67 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.604 -0.725 . . . . 71.42 111.839 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.87 -26.8 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 74.52 110.76 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.504 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.3 mttp -76.36 -34.29 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.101 0.477 . . . . 62.03 109.819 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -72.03 -35.12 69.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.604 -0.725 . . . . 74.54 110.405 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -50.86 6.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.616 . . . . 74.52 111.265 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 pp20? -50.56 -34.55 26.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.827 0.346 . . . . 53.33 111.049 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.78 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.13 111.011 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.1 11.81 38.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.358 . . . . 64.33 111.926 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.658 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.52 -43.35 99.1 Favored Pre-proline 0 C--O 1.223 -0.339 0 C-N-CA 120.213 -0.595 . . . . 64.11 110.052 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.8 Cg_exo -66.11 -22.73 54.08 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.866 2.377 . . . . 74.01 110.007 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.478 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 77.2 t -96.27 -16.97 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.814 -1.085 . . . . 74.54 111.266 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 49' ' ' ALA . 1.9 p -99.34 -27.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.898 -0.778 . . . . 74.21 108.898 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.3 m -82.23 -42.43 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.047 -0.978 . . . . 62.52 110.548 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.458 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.92 -29.55 2.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.627 -0.797 . . . . 72.32 112.032 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.478 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.93 -39.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 74.11 109.789 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -76.93 -22.01 53.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 72.43 109.475 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.31 -27.55 25.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.807 -0.633 . . . . 45.23 110.407 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.459 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -90.5 -45.28 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.975 -0.557 . . . . 61.43 110.392 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.66 -2.82 81.48 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.637 -0.792 . . . . 61.53 111.198 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 63.44 110.929 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.472 -0.251 . . . . 45.03 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.55 -21.97 77.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 74.3 112.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -47.52 -61.38 1.95 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.032 0.444 . . . . 74.33 110.748 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -23.77 64.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 73.13 110.309 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -68.22 -42.84 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 75.34 110.744 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.02 -34.6 29.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 72.32 110.913 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.62 -21.93 71.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 38.41 112.89 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -105.45 -24.43 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 72.35 111.404 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.6 -60.62 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 75.34 110.919 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.76 -52.83 61.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.009 -0.541 . . . . 74.33 110.983 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -34.14 46.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 74.35 111.254 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.23 -36.49 68.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.673 -0.775 . . . . 42.24 112.424 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.66 -45.3 59.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 72.12 110.858 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -21.93 30.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 38.41 112.762 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 4.1 mttt -79.26 -40.57 30.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.66 0.23 . . . . 70.32 111.058 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.69 -39.28 24.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 70.15 110.732 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 45' ' ' ALA . 38.7 t -70.0 -22.34 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 74.02 111.696 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.91 -27.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.598 -0.274 . . . . 70.42 110.979 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -75.42 -34.75 61.05 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.174 0.511 . . . . 64.0 109.983 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -73.01 -34.39 66.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 75.21 110.416 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.1 p -85.19 -49.58 8.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.776 -0.647 . . . . 75.3 111.181 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -51.15 -34.75 32.54 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.942 0.401 . . . . 71.43 111.12 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -38.27 83.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 73.2 111.071 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -96.67 13.16 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 54.22 111.808 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.665 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.7 tt -56.15 -43.35 99.22 Favored Pre-proline 0 C--O 1.223 -0.333 0 C-N-CA 120.158 -0.617 . . . . 74.24 110.102 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.7 Cg_exo -66.53 -21.83 52.33 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.908 2.406 . . . . 72.23 110.125 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 68.3 t -97.42 -17.08 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.861 -1.063 . . . . 71.25 111.211 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 49' ' ' ALA . 1.9 p -99.18 -27.79 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.969 -0.752 . . . . 73.45 108.969 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.7 m -82.3 -42.34 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-N 115.099 -0.955 . . . . 75.02 110.588 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.92 -29.68 2.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.667 -0.778 . . . . 74.22 112.056 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.7 -40.36 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.171 0.51 . . . . 65.42 109.841 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -21.8 56.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.728 -0.669 . . . . 60.34 109.479 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.56 -26.91 25.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.78 -0.645 . . . . 74.42 110.384 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.459 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -92.3 -44.75 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.034 -0.53 . . . . 74.55 110.389 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -88.55 -1.45 80.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.655 -0.783 . . . . 72.43 111.277 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 63.53 110.869 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 45.03 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -21.91 78.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 63.53 112.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -47.51 -61.07 2.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.894 0.378 . . . . 75.43 110.821 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -61.1 -23.83 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.085 -0.507 . . . . 62.1 110.4 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.99 -42.71 80.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 73.45 110.714 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.09 -39.95 22.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 72.32 110.811 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.61 -22.48 61.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.778 -0.725 . . . . 75.45 112.731 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -101.56 -36.7 8.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.772 0.32 . . . . 75.54 110.935 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -64.38 -57.83 8.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 75.02 110.729 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -44.13 94.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 63.41 110.875 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.69 -44.92 81.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.074 -0.512 . . . . 74.53 111.04 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.93 -47.07 89.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 38.27 112.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -74.3 -45.34 48.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 44.1 110.908 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.24 -23.35 47.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.968 -0.634 . . . . 65.15 112.356 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 1.9 mmtt -64.89 -57.88 7.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 65.53 110.332 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.8 -20.08 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 74.53 110.043 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.45 HG23 ' HD2' ' A' ' 41' ' ' ARG . 95.1 t -81.13 -48.87 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 116.054 -0.521 . . . . 73.32 110.463 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.79 -46.2 41.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 72.3 109.606 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -70.42 -30.55 67.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.786 -0.643 . . . . 71.01 109.612 178.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.06 92.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.896 -0.593 . . . . 64.4 110.377 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -85.11 -35.08 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.524 . . . . 61.34 110.549 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.75 -31.23 64.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 75.32 110.59 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -71.74 -31.28 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.31 110.528 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -101.94 13.36 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 73.21 111.513 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.1 tt -56.03 -42.95 98.8 Favored Pre-proline 0 C--O 1.223 -0.321 0 C-N-CA 120.173 -0.611 . . . . 72.34 109.934 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -24.78 55.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.88 2.387 . . . . 74.21 109.848 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 47.3 t -96.63 -9.8 9.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.828 -1.078 . . . . 75.05 111.169 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' ALA . 62.0 t -105.42 -28.13 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.717 -0.846 . . . . 73.23 108.717 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ALA . 19.2 m -82.39 -42.05 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.079 -0.964 . . . . 64.25 110.456 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.21 -28.76 3.28 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.531 -0.842 . . . . 53.35 112.097 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.41 -35.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.568 -0.53 . . . . 70.12 109.568 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.84 -21.82 47.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.61 -0.723 . . . . 75.51 109.498 178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.5 -21.45 25.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.937 -0.574 . . . . 54.22 110.858 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.49 -44.04 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 75.42 111.991 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.442 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -126.42 2.55 7.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.89 -0.671 . . . . 63.31 111.803 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 2.8 tttm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 51.52 111.045 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.493 -0.243 . . . . 45.03 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.95 78.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 62.32 112.658 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -47.0 -61.18 1.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.977 0.418 . . . . 45.31 110.826 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -23.82 66.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 64.45 110.387 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -69.12 -43.86 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.581 . . . . 72.3 110.703 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.7 tp -82.07 -39.1 23.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.861 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.3 66.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 75.14 112.655 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -26.08 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.701 0.286 . . . . 75.04 111.0 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -67.36 -64.5 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.258 0.552 . . . . 74.13 110.523 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 36' ' ' GLU . 3.9 pp -53.98 -47.76 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.85 . . . . 63.33 110.833 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -51.73 -37.74 52.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.41 -0.814 . . . . 63.12 111.049 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.41 -44.53 64.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 60.32 112.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -73.87 -34.55 64.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 73.23 110.907 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.04 -21.82 66.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.992 -0.623 . . . . 41.54 112.529 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.4 tttt -65.02 -58.22 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.955 0.407 . . . . 74.31 110.521 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -63.14 -19.87 64.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.973 0.416 . . . . 75.34 110.245 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 40.3 t -84.32 -44.48 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.937 -0.574 . . . . 73.41 111.05 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.15 -39.65 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.24 109.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 3.2 mttm -75.1 -30.93 61.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 63.25 109.777 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.63 99.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.751 -0.659 . . . . 74.12 110.565 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 t -85.08 -35.69 21.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.921 -0.581 . . . . 71.24 110.542 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.85 -34.0 67.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 54.31 110.499 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -69.27 -32.55 71.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 64.13 110.731 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.6 11.24 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.565 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.0 -43.58 99.12 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 120.243 -0.583 . . . . 72.13 110.106 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.5 Cg_exo -66.02 -22.06 55.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.857 2.371 . . . . 72.14 110.003 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 75.0 t -97.31 -16.9 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.902 -1.044 . . . . 65.34 111.322 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.0 p -99.43 -27.61 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.985 -0.746 . . . . 73.34 108.985 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.6 m -82.23 -42.33 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 115.071 -0.968 . . . . 75.31 110.445 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.13 -29.65 2.36 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 74.33 112.003 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.73 -38.47 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.164 0.506 . . . . 74.24 109.654 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 4.5 mtmt -76.31 -21.7 55.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 70.11 109.458 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.6 -21.49 25.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.94 -0.573 . . . . 74.34 110.939 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -99.73 -43.61 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 73.25 111.905 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -125.03 1.46 8.4 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.586 -0.734 . . . . 73.22 111.828 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.197 -0.906 . . . . 64.12 110.945 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.494 -0.242 . . . . 54.33 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.03 -26.55 44.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 75.24 112.585 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -48.15 -62.2 1.6 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.225 0.536 . . . . 75.24 110.924 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -64.45 -23.95 67.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.382 -0.827 . . . . 75.04 109.885 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -35.81 77.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.886 -0.597 . . . . 72.31 110.639 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.95 -35.73 28.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.911 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -57.5 7.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 42.4 112.612 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.98 -26.49 62.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.689 0.281 . . . . 63.13 111.016 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.95 -56.41 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.964 0.411 . . . . 73.02 110.644 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -51.99 15.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.951 -0.568 . . . . 72.34 110.752 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -32.5 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 72.3 110.977 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.16 -38.15 88.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.776 . . . . 63.31 112.456 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.75 73.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 73.33 110.983 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.33 -21.84 35.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 71.1 112.574 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -81.07 -40.72 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 0.175 . . . . 72.1 110.977 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' C ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.33 -40.63 23.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 73.35 110.671 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' ALA . 43.7 t -65.76 -22.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.677 -0.692 . . . . 70.13 111.415 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.83 -28.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 74.41 110.833 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -72.21 -43.4 64.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.659 0.742 . . . . 65.22 109.75 179.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -66.69 -34.61 78.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.58 -1.191 . . . . 53.12 110.588 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 p -85.16 -45.92 11.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.544 . . . . 72.05 111.031 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.598 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 pp20? -58.63 -20.4 47.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 54.42 110.873 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -33.11 64.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.742 -0.466 . . . . 64.43 109.742 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.575 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -110.24 18.43 19.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.721 -0.672 . . . . 51.53 110.515 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.774 ' HG ' ' HD3' ' A' ' 51' ' ' PRO . 4.2 pp -62.52 -36.37 26.67 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 119.917 -0.713 . . . . 72.42 110.44 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.774 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 50.1 Cg_endo -77.82 -11.36 16.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.794 2.329 . . . . 44.42 110.052 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.47 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 53.2 t -107.46 -10.77 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.697 -1.138 . . . . 75.43 110.333 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 49' ' ' ALA . 83.0 t -105.05 -30.77 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.682 -0.858 . . . . 71.21 108.682 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 58' ' ' ALA . 20.3 m -82.35 -40.22 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.422 -0.808 . . . . 63.3 110.404 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.98 -29.37 3.29 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.533 -0.842 . . . . 74.25 112.072 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -85.12 -38.17 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.687 -0.486 . . . . 65.23 109.687 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -77.69 -21.79 51.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.717 -0.674 . . . . 62.3 109.483 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.77 -26.94 25.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.898 -0.592 . . . . 51.54 110.383 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -91.52 -45.01 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.936 -0.575 . . . . 64.52 110.498 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -89.0 -1.45 79.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 74.43 111.317 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.5 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.245 -0.883 . . . . 72.22 110.89 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.505 -0.238 . . . . 64.43 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.52 -25.24 65.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 73.02 112.571 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.68 -62.15 1.59 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.187 0.518 . . . . 62.22 111.018 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.443 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 20.6 pttt -63.72 -23.94 67.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 64.42 109.868 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -40.37 82.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 73.45 110.648 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.11 -35.74 28.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 74.54 110.898 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.2 -21.94 72.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 72.32 112.801 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -29.63 12.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 74.44 111.026 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -64.29 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 75.21 110.82 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -41.24 67.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.876 -0.602 . . . . 64.53 111.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -44.41 83.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 75.25 111.017 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.16 -47.02 76.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 73.2 112.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.9 -47.07 61.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 73.1 110.716 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.22 -28.53 26.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.933 -0.576 . . . . 63.13 112.389 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 5.2 mmtm -64.99 -59.62 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 75.43 109.991 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -23.32 52.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.089 -0.505 . . . . 74.42 110.252 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.63 -40.28 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 72.13 111.754 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.65 -39.0 34.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.761 -0.459 . . . . 71.33 109.761 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 mttm -72.74 -31.81 65.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 75.12 110.001 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.015 -0.539 . . . . 39.17 110.395 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 t -85.19 -31.76 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.816 -0.629 . . . . 74.43 110.608 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.94 -36.46 79.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 71.4 110.636 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -75.43 -29.45 59.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.23 110.744 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.33 12.53 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 71.04 111.592 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.9 tt -55.84 -43.42 99.19 Favored Pre-proline 0 C--O 1.223 -0.3 0 C-N-CA 120.308 -0.557 . . . . 72.14 110.032 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.2 Cg_exo -66.03 -20.39 57.21 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.818 2.345 . . . . 75.11 110.001 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 66.0 t -98.55 -19.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.843 -1.071 . . . . 71.15 111.217 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.0 p -97.27 -27.58 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.066 -0.716 . . . . 71.22 109.066 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.4 m -82.26 -42.26 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.076 -0.966 . . . . 72.22 110.587 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.89 -29.72 2.15 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.696 -0.764 . . . . 72.14 111.992 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -82.68 -41.63 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.733 -0.469 . . . . 71.24 109.733 178.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -22.38 57.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 75.11 109.39 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.68 -26.72 27.56 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.746 -0.661 . . . . 62.23 110.396 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -93.27 -44.4 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.965 -0.561 . . . . 75.4 110.372 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -85.88 -3.02 86.0 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.696 -0.764 . . . . 64.0 111.246 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.192 -0.909 . . . . 74.24 110.924 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.521 -0.232 . . . . 64.22 112.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.1 -22.57 77.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 36.55 112.579 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.98 -62.22 1.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.202 0.525 . . . . 74.33 110.985 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -63.72 -23.81 67.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 74.55 109.961 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -70.79 -44.77 65.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.824 -0.625 . . . . 74.12 110.647 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -82.1 -37.78 25.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 64.33 110.816 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -22.03 57.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.825 -0.702 . . . . 73.12 112.696 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -94.38 -31.41 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 73.24 110.998 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -62.56 -57.79 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 63.53 110.551 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 -52.95 63.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 61.14 110.722 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.28 -40.98 62.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 65.01 110.964 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.49 88.41 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 70.13 112.286 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.39 -53.29 14.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 64.53 110.708 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.26 -29.4 22.19 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.091 -0.576 . . . . 61.15 112.461 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 mttt -65.14 -59.31 4.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.101 0.477 . . . . 62.32 110.025 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -29.92 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 64.21 109.911 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -75.99 -47.55 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.534 -0.757 . . . . 72.23 111.24 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.46 -40.42 50.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.721 -0.474 . . . . 74.31 109.721 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 14.1 mttt -75.25 -30.0 60.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 65.22 109.655 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.55 99.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.801 -0.636 . . . . 74.01 110.556 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 t -85.12 -37.65 20.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.022 -0.535 . . . . 72.1 110.748 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.18 -33.5 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 74.53 110.57 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -70.16 -33.15 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 73.22 110.664 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.71 11.18 34.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 63.42 111.493 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.662 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.6 tt -55.23 -43.32 99.03 Favored Pre-proline 0 C--O 1.223 -0.32 0 C-N-CA 120.188 -0.605 . . . . 54.32 110.02 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.9 Cg_exo -66.44 -22.19 52.45 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.875 2.384 . . . . 60.44 110.045 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 71.5 t -97.51 -14.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.93 -1.032 . . . . 63.54 111.374 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.0 p -101.54 -27.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.804 -0.814 . . . . 74.44 108.804 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 58' ' ' ALA . 17.1 m -82.27 -41.97 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.076 -0.965 . . . . 55.25 110.41 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.69 -29.25 2.89 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.604 -0.808 . . . . 52.33 112.032 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -86.88 -35.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.605 -0.517 . . . . 74.32 109.605 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.43 -21.75 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.545 -0.752 . . . . 64.11 109.661 178.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.71 -21.45 25.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.878 -0.601 . . . . 73.24 110.96 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.04 -44.09 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 65.24 111.981 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -124.3 -0.12 8.78 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.768 -0.729 . . . . 65.44 111.762 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 12.8 tttm . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.204 -0.903 . . . . 64.04 111.35 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.521 -0.232 . . . . 51.22 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.56 -21.99 76.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.739 . . . . 75.15 112.584 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.62 -61.2 2.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.953 0.406 . . . . 71.13 110.118 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -63.16 -23.44 67.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 55.13 109.685 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -44.25 77.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.879 -0.6 . . . . 62.44 110.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.79 -46.07 69.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.54 110.859 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.95 -36.94 93.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.738 -0.744 . . . . 44.25 112.465 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -70.45 -29.17 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 64.44 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -63.49 -57.07 11.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 70.42 110.827 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -42.64 81.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.977 -0.556 . . . . 74.22 110.916 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -53.61 -40.24 65.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.12 111.071 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.64 -41.43 82.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 70.11 112.651 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 74.12 110.941 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.09 34.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 40.33 112.706 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.09 -40.58 23.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.664 0.232 . . . . 72.4 110.967 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -37.16 27.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.038 0.447 . . . . 71.12 110.663 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ALA . 21.8 t -71.88 -22.69 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 74.54 111.717 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -47.92 -27.64 2.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.517 -0.31 . . . . 72.11 110.838 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 5.6 mtpt -77.03 -33.74 57.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.171 0.51 . . . . 74.34 109.806 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -76.6 -32.69 58.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.476 -0.784 . . . . 54.52 110.302 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 p -85.22 -45.75 11.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 71.14 111.046 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -53.61 -35.55 61.01 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.998 0.428 . . . . 75.41 110.916 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -37.2 85.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 75.3 110.974 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -97.84 13.86 29.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 70.21 111.851 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.4 tt -56.96 -42.64 97.41 Favored Pre-proline 0 C--O 1.223 -0.317 0 C-N-CA 120.148 -0.621 . . . . 72.34 109.99 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.7 Cg_exo -66.27 -23.81 51.59 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.87 2.38 . . . . 74.54 109.915 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 50.9 t -96.8 -10.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.878 -1.056 . . . . 73.31 111.215 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ALA . 71.4 t -104.58 -28.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.783 -0.821 . . . . 72.52 108.783 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.614 ' O ' ' N ' ' A' ' 58' ' ' ALA . 17.3 m -82.44 -41.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.932 -1.031 . . . . 75.11 110.517 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.61 -28.45 3.57 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.596 -0.812 . . . . 73.11 112.157 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.0 -33.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 71.1 109.798 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -82.19 -22.18 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 45.45 109.495 178.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.69 -21.51 25.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.948 -0.569 . . . . 45.11 111.2 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.25 -47.3 14.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 62.1 112.073 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -130.36 4.5 5.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.69 -0.686 . . . . 36.71 111.433 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 1.3 tttp . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.236 -0.887 . . . . 74.14 111.146 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.465 -0.254 . . . . 71.23 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 -21.75 52.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 63.42 112.717 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -46.02 -61.35 1.79 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.991 0.424 . . . . 65.52 110.84 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.94 -23.8 55.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.58 . . . . 75.24 110.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 -35.35 65.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.77 -0.65 . . . . 74.32 110.923 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -31.26 31.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 73.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.2 -21.99 78.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 64.11 112.812 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -29.98 13.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 72.1 110.959 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -65.77 -57.79 7.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 75.13 111.012 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -48.52 81.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 54.33 111.134 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -37.96 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 63.43 111.082 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.9 -39.78 63.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.778 -0.725 . . . . 52.34 112.584 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.9 -48.77 65.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 62.45 110.837 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.92 -36.48 60.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.904 -0.665 . . . . 44.23 112.667 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 8.1 mttt -62.34 -36.87 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.688 0.28 . . . . 72.42 110.323 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.28 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.301 0.572 . . . . 74.0 110.195 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' ALA . 16.1 t -55.89 -23.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 63.2 111.839 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.621 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.68 -28.19 5.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.818 0.342 . . . . 74.31 110.449 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -77.65 -34.24 53.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 71.43 109.729 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -75.52 -32.86 60.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.528 -0.76 . . . . 72.25 110.252 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.15 -47.16 10.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 74.51 111.154 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -53.51 -37.39 62.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.926 0.393 . . . . 75.35 111.009 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -68.27 -33.48 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 61.41 111.094 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -99.72 13.11 34.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 74.34 111.872 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.684 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.8 tt -57.29 -42.62 96.98 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.016 -0.674 . . . . 64.43 109.734 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.9 Cg_exo -65.35 -25.43 56.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.774 2.316 . . . . 74.22 109.842 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 53.2 t -94.17 -12.67 8.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.751 -1.113 . . . . 60.51 111.243 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' ALA . 67.1 t -102.9 -28.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.793 -0.818 . . . . 64.32 108.793 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.7 m -82.36 -41.85 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.04 -0.982 . . . . 73.43 110.419 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.66 -29.11 2.79 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.515 -0.85 . . . . 42.41 112.113 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.93 -37.12 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.158 0.504 . . . . 75.44 109.697 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 5.0 mtmt -78.37 -21.47 49.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.664 -0.698 . . . . 74.31 109.456 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.57 -21.55 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.883 -0.598 . . . . 73.31 110.982 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.13 -43.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 74.03 111.933 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -124.08 -0.38 8.92 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.757 -0.735 . . . . 71.42 111.755 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.18 -0.914 . . . . 71.14 111.314 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.541 -0.223 . . . . 50.21 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.88 -21.89 78.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 54.31 112.661 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -46.54 -61.41 1.83 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.009 0.433 . . . . 73.23 110.93 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -61.02 -23.85 65.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 74.32 110.356 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -69.65 -37.44 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 73.34 110.87 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -81.88 -43.59 17.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 53.01 111.079 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.8 52.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.678 -0.772 . . . . 75.12 112.617 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -30.49 66.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.22 110.956 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -63.11 -57.0 12.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 72.03 110.742 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.65 -55.54 16.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.525 . . . . 72.5 110.834 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -37.03 52.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 73.21 111.197 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.06 80.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 52.24 112.586 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -80.59 -37.64 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.868 0.366 . . . . 75.14 110.917 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.73 -27.28 69.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 54.43 113.122 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.639 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 17.8 pttt -63.39 -38.63 91.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.149 0.474 . . . . 62.13 110.957 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -32.07 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 54.42 110.453 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 45' ' ' ALA . 43.4 t -80.85 -22.93 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.528 -0.76 . . . . 65.31 112.212 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.62 -26.89 3.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.759 0.314 . . . . 74.41 110.803 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.5 tttt -77.66 -31.61 52.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.183 0.516 . . . . 75.53 109.671 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -77.87 -33.55 52.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.386 -0.825 . . . . 53.45 110.305 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -45.3 12.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.779 -0.646 . . . . 64.34 111.026 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -52.43 -36.87 55.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.939 0.4 . . . . 71.45 110.789 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -64.17 -33.16 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.44 110.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -101.51 12.89 36.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 73.13 111.671 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.2 tt -55.87 -43.11 99.05 Favored Pre-proline 0 C--O 1.223 -0.331 0 C-N-CA 120.155 -0.618 . . . . 62.44 109.949 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 7.0 Cg_exo -65.27 -24.4 58.24 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.89 2.393 . . . . 74.21 109.945 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.474 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 54.6 t -95.39 -15.14 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.765 -1.107 . . . . 64.51 111.216 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' ALA . 61.1 t -100.08 -28.8 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 74.34 108.94 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.611 ' O ' ' N ' ' A' ' 58' ' ' ALA . 17.4 m -82.27 -42.29 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 114.995 -1.002 . . . . 44.51 110.589 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.98 -29.53 2.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.601 -0.809 . . . . 65.23 111.976 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.59 -40.72 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 73.25 109.758 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -21.75 56.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.654 . . . . 74.24 109.432 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.42 -27.21 25.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.742 -0.663 . . . . 44.32 110.411 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.79 -44.81 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.357 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.7 -2.28 81.99 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.65 -0.786 . . . . 54.31 111.245 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 74.14 110.932 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.484 -0.246 . . . . 72.41 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.82 71.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.694 -0.765 . . . . 74.31 112.679 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -47.37 -61.38 1.94 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.022 0.439 . . . . 73.02 110.799 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -60.62 -23.72 64.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 75.51 110.332 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -40.66 78.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.932 -0.576 . . . . 65.03 110.922 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.3 tp -74.39 -40.35 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 74.3 110.958 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.64 -54.72 24.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 60.11 112.589 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -26.98 62.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 75.11 111.113 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.42 -57.83 8.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 73.42 110.913 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -46.59 72.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 64.45 111.003 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.13 82.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 73.11 111.019 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.53 -47.9 67.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.819 -0.705 . . . . 35.52 112.549 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.62 88.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.392 . . . . 72.43 110.842 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.9 -37.74 63.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.034 -0.603 . . . . 65.31 112.58 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mttt -62.13 -36.59 82.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.699 0.285 . . . . 62.43 110.43 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.53 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.577 . . . . 74.14 110.286 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 t -55.44 -23.9 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 73.44 111.834 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.83 -27.96 5.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 72.43 110.444 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 mtmm -77.86 -33.94 51.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.171 0.51 . . . . 71.32 109.814 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.84 64.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.609 -0.723 . . . . 73.03 110.274 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -85.39 -50.33 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.756 -0.656 . . . . 73.3 111.16 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.7 pp20? -51.15 -34.41 31.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.911 0.386 . . . . 72.33 111.089 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -36.76 82.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 60.31 111.087 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -99.68 14.14 31.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 60.33 111.916 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.683 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.1 tt -57.88 -42.57 96.02 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.084 -0.646 . . . . 61.12 109.861 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.6 Cg_exo -66.04 -24.06 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.884 2.389 . . . . 70.01 109.877 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 64.6 t -95.09 -15.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.766 -1.107 . . . . 73.15 111.161 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ALA . 78.9 t -100.15 -28.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 73.4 108.874 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.5 m -82.29 -41.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 115.082 -0.963 . . . . 73.4 110.534 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.96 -29.48 2.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.657 -0.783 . . . . 60.32 112.072 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.33 -40.74 16.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.493 . . . . 65.41 109.808 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -76.48 -21.96 55.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.75 -0.659 . . . . 71.3 109.465 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.633 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.93 -27.88 26.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.785 -0.643 . . . . 63.1 110.398 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.1 -44.99 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.92 -0.582 . . . . 51.32 110.349 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -86.68 -3.1 84.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.175 -0.77 . . . . 44.33 111.175 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.292 -0.861 . . . . 75.31 111.009 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.508 -0.237 . . . . 70.02 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -66.5 -21.99 71.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.772 . . . . 51.53 112.642 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -56.69 -61.29 2.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 74.41 110.105 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -23.46 67.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 72.33 109.756 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -66.89 -39.81 87.57 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.762 -0.653 . . . . 61.35 110.921 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 tp -79.2 -38.47 35.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 61.15 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.34 -22.34 78.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.779 -0.724 . . . . 73.11 112.643 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.06 -26.31 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 61.15 111.066 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -66.14 -60.5 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 64.12 110.783 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.5 -51.71 68.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 74.41 110.871 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.99 -34.39 59.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.556 . . . . 71.33 111.04 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.2 -37.2 71.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.771 -0.728 . . . . 72.32 112.464 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -72.43 -45.86 57.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.02 110.864 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.0 -21.78 32.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.829 -0.701 . . . . 72.25 112.747 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -73.12 -42.62 62.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.582 0.191 . . . . 55.5 111.25 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -81.56 -39.3 24.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 74.53 110.699 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 45' ' ' ALA . 41.6 t -67.94 -22.53 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 72.33 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.8 -26.95 1.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.226 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 1.1 mttt -78.61 -35.25 45.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.026 0.441 . . . . 71.44 110.111 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -58.9 -40.78 85.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 72.05 110.293 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -85.14 -33.04 22.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.891 -0.595 . . . . 62.14 110.211 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -57.19 -39.82 76.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 70.55 110.431 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -66.75 -29.14 69.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 65.3 110.999 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.72 11.48 32.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.419 -0.355 . . . . 54.41 111.833 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.79 -43.1 99.03 Favored Pre-proline 0 C--O 1.223 -0.312 0 C-N-CA 120.164 -0.614 . . . . 71.24 109.981 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.3 Cg_exo -67.13 -21.87 48.07 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.768 2.312 . . . . 72.41 110.02 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.6 t -97.77 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.008 -0.996 . . . . 74.43 111.415 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.1 p -102.25 -27.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 62.13 108.881 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.566 ' CG1' ' O ' ' A' ' 50' ' ' LEU . 15.5 m -82.5 -42.06 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 114.992 -1.004 . . . . 75.33 110.637 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -47.16 -28.34 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.493 -0.861 . . . . 55.21 112.277 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.549 ' HA ' HG12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -86.53 -29.32 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.483 . . . . 65.23 109.963 179.116 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 2.1 mtmt -86.45 -24.08 25.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 71.51 109.524 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.92 -21.21 25.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.581 . . . . 71.14 112.25 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 56' ' ' ILE . 1.1 pp -62.05 -61.47 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.147 0.499 . . . . 72.21 112.17 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.08 8.25 4.44 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.911 -0.876 . . . . 52.32 110.911 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.5 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 72.02 111.197 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.529 -0.228 . . . . 52.12 112.529 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.32 -24.27 75.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 52.22 112.56 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.51 -62.2 1.55 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.278 0.561 . . . . 73.42 110.841 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.419 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -65.35 -23.92 67.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 71.32 110.008 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.78 71.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.876 -0.602 . . . . 74.02 110.701 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.0 tp -81.91 -34.2 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 62.12 110.837 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.9 -21.97 77.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 73.34 112.822 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -95.03 -46.66 6.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.31 . . . . 71.41 111.154 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 3.3 pttt -57.41 -50.52 72.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.98 0.419 . . . . 72.1 110.856 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -64.71 -42.85 94.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.76 -0.655 . . . . 63.45 110.842 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -39.42 76.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 61.33 111.034 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.91 -41.99 68.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 74.43 112.647 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.64 -46.21 73.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 54.03 110.848 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.82 -34.03 56.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.973 -0.632 . . . . 63.32 112.692 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -64.39 -37.69 88.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.695 0.283 . . . . 72.44 110.436 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -51.2 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 72.12 110.252 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.97 -23.65 18.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 74.44 111.739 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.82 -27.05 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.338 . . . . 74.31 110.708 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 tttp -82.07 -35.04 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.083 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.98 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 73.11 110.05 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.99 -33.33 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 72.55 110.174 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mm-40 -58.66 -36.77 74.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 73.15 110.373 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -66.07 -31.02 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.91 -0.587 . . . . 74.43 110.794 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.18 13.54 30.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.44 111.638 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.678 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.7 tt -57.56 -42.65 96.82 Favored Pre-proline 0 C--O 1.223 -0.335 0 C-N-CA 120.09 -0.644 . . . . 74.14 109.756 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.47 -24.67 56.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.845 2.364 . . . . 73.13 109.826 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.5 t -94.36 -15.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 114.718 -1.128 . . . . 73.54 111.262 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 49' ' ' ALA . 86.4 t -100.58 -29.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.932 -0.766 . . . . 63.23 108.932 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.4 m -82.21 -42.0 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 114.986 -1.006 . . . . 70.45 110.511 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.46 ' O ' ' CG1' ' A' ' 59' ' ' ILE . . . -44.92 -29.62 2.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.688 -0.767 . . . . 55.23 111.974 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.477 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -82.8 -41.47 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.49 . . . . 74.24 109.808 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -22.29 56.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 64.13 109.341 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.6 -27.2 27.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.788 -0.642 . . . . 53.4 110.391 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -92.62 -44.45 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.911 -0.586 . . . . 75.35 110.341 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.443 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -86.67 -2.62 84.46 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.206 -0.758 . . . . 44.52 111.206 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.226 -0.893 . . . . 70.41 110.895 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.43 -0.268 . . . . 62.14 112.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.99 -27.49 31.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.767 -0.73 . . . . 74.31 112.6 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -50.5 -62.18 1.74 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.168 0.508 . . . . 73.44 110.647 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 14.0 mtpp -64.89 -23.91 67.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 73.22 109.734 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.85 -40.29 79.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.776 -0.647 . . . . 74.44 110.755 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -81.94 -35.87 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 73.25 110.875 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.04 -22.4 78.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 71.0 112.843 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -97.64 -27.19 14.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.312 . . . . 74.45 111.126 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -62.22 -56.4 19.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 74.51 110.724 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -64.09 -54.18 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.879 -0.6 . . . . 70.22 110.846 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -45.09 78.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 74.55 111.084 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.82 44.93 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.797 -0.716 . . . . 64.23 112.708 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.43 -48.72 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 63.22 110.863 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.05 50.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.015 -0.612 . . . . 73.43 112.66 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -59.78 -37.65 79.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.697 0.284 . . . . 71.03 110.464 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -52.25 7.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.202 0.525 . . . . 74.53 110.221 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.51 -25.27 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 73.11 111.742 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.72 -26.78 2.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 74.45 110.753 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.1 tttt -81.99 -35.13 29.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.106 0.479 . . . . 53.31 110.102 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.14 90.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 72.42 110.19 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.18 -34.76 22.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 65.42 110.342 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -57.85 -38.52 75.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.494 . . . . 73.31 110.524 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -66.71 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 71.42 111.118 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.11 11.97 32.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 63.32 111.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.9 tt -56.64 -42.73 97.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 C-N-CA 120.025 -0.67 . . . . 73.23 109.852 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -25.39 55.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.817 2.345 . . . . 73.22 109.811 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.473 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.0 t -93.98 -13.64 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 114.865 -1.061 . . . . 55.31 111.237 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' ALA . 58.4 t -101.81 -29.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.882 -0.785 . . . . 73.44 108.882 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.5 m -82.23 -42.09 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.042 -0.981 . . . . 73.34 110.398 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.27 -29.33 2.42 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 51.32 111.96 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -85.14 -39.74 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.625 -0.509 . . . . 62.21 109.625 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 1.1 mtmm -76.1 -21.02 57.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 63.12 109.602 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.53 -21.46 25.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 72.1 111.286 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 23.7 pt -91.26 -47.12 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.079 0.466 . . . . 73.35 112.17 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 59' ' ' ILE . . . -133.27 4.06 4.84 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.251 -0.739 . . . . 72.12 111.251 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.25 -0.881 . . . . 72.43 110.831 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.487 -0.245 . . . . 45.03 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 -21.8 74.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.624 -0.798 . . . . 55.24 112.68 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -46.53 -61.45 1.81 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 74.41 110.883 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -23.79 64.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 63.04 110.405 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -41.14 76.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 72.41 111.0 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -79.87 -35.35 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.034 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.41 -22.01 76.23 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 70.01 112.838 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -93.79 -43.3 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 73.15 111.158 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -58.79 -50.82 72.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.411 . . . . 36.79 111.021 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.438 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.12 -48.93 79.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 71.42 111.074 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -45.29 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 54.23 111.19 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.13 -44.27 51.18 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.837 -0.697 . . . . 60.41 112.732 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.96 -48.59 70.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.936 0.398 . . . . 51.15 110.907 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.14 -35.95 55.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.986 -0.626 . . . . 63.23 112.641 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mtpt -62.73 -37.49 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 73.44 110.421 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.7 -53.01 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 74.51 110.315 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.8 -23.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.316 -0.856 . . . . 75.02 111.679 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.14 -27.85 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.348 . . . . 71.55 110.456 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 mttm -78.47 -32.79 48.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 61.02 109.798 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.32 -32.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.621 -0.718 . . . . 74.11 110.302 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.37 -47.98 9.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 63.35 111.044 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 2.9 pp20? -51.9 -33.96 39.18 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 64.41 110.916 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -66.17 -38.32 87.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 65.21 111.053 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.37 12.94 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 36.79 111.82 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.0 tt -56.79 -42.81 98.21 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.068 -0.653 . . . . 75.11 109.837 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 5.1 Cg_exo -65.82 -25.07 53.4 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.747 2.298 . . . . 74.04 109.944 176.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.484 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 56.0 t -95.43 -11.02 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.909 -1.042 . . . . 75.25 111.229 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' ALA . 73.2 t -104.35 -28.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.798 -0.815 . . . . 63.05 108.798 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' A' ' 58' ' ' ALA . 18.1 m -82.28 -41.82 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.002 -0.999 . . . . 63.44 110.443 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.28 -28.72 3.34 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.596 -0.811 . . . . 73.45 112.089 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.484 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.14 -35.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.593 -0.521 . . . . 73.02 109.593 178.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.05 -22.04 45.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.68 -0.691 . . . . 64.31 109.491 178.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.73 -21.42 25.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.911 -0.586 . . . . 73.21 111.059 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -96.67 -44.52 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.22 112.105 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -129.84 4.42 6.1 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.809 -0.71 . . . . 42.43 111.607 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 48.1 tttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.832 . . . . 72.12 110.952 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.534 -0.226 . . . . 65.3 112.534 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.28 -21.9 79.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 62.42 112.657 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.13 -61.1 2.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 75.43 110.222 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -23.39 67.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 74.52 109.719 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -38.28 81.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.794 -0.639 . . . . 74.14 110.937 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -79.25 -36.65 39.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.8 -57.24 9.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 42.0 112.558 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -25.43 63.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 62.44 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -65.27 -59.09 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.1 110.833 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -46.35 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 72.35 111.003 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -54.9 -38.75 67.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 74.5 111.019 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.67 95.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 54.32 112.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 84.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 73.12 110.843 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.51 -36.03 57.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.002 -0.618 . . . . 75.21 112.617 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -62.15 -36.61 82.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.724 0.297 . . . . 71.42 110.269 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -52.96 6.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.259 0.552 . . . . 62.41 110.152 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.62 -23.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.217 -0.901 . . . . 70.31 111.867 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.78 -27.77 5.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 75.23 110.553 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 23.2 mttt -77.79 -33.75 52.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.115 0.483 . . . . 65.32 109.787 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 -33.02 60.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.562 -0.744 . . . . 72.44 110.254 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.32 -47.87 9.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 72.52 111.121 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -52.36 -39.03 60.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.964 0.412 . . . . 63.5 111.025 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -30.07 71.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 75.2 111.115 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.83 11.44 35.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 51.31 111.901 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.658 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.34 -43.34 99.06 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 120.238 -0.585 . . . . 63.4 110.123 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.0 Cg_exo -66.34 -22.43 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.819 2.346 . . . . 64.54 110.017 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 79.6 t -96.2 -17.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.797 -1.092 . . . . 75.43 111.26 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ALA . 1.8 p -98.76 -27.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.939 -0.763 . . . . 73.13 108.939 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.0 m -82.38 -42.19 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.099 -0.955 . . . . 75.53 110.511 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' CG1' ' A' ' 59' ' ' ILE . . . -44.95 -29.46 2.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.731 -0.747 . . . . 72.33 112.011 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.57 -40.29 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 63.42 109.784 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -21.97 54.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.756 -0.656 . . . . 74.11 109.393 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.12 -24.1 28.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.792 -0.64 . . . . 52.32 110.439 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -96.63 -43.97 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 115.935 -0.575 . . . . 73.2 110.495 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.437 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -83.45 -4.97 89.03 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.628 -0.796 . . . . 55.31 111.291 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.248 -0.882 . . . . 72.04 110.996 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.487 -0.245 . . . . 55.42 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.55 -24.76 41.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.747 . . . . 71.23 112.608 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.36 -62.25 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.18 0.515 . . . . 74.33 110.925 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 15.4 mttt -65.54 -23.89 66.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.387 -0.824 . . . . 73.0 109.916 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -70.54 -34.7 72.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 71.32 110.728 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -81.98 -34.96 29.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 73.05 110.988 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.07 -58.77 5.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 51.4 112.605 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -37.32 65.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 64.32 111.114 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -65.03 -57.45 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 74.2 110.844 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.39 90.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 73.44 111.067 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -47.81 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.53 110.938 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.71 -48.92 59.93 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.807 -0.711 . . . . 52.54 112.383 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.6 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 72.33 110.654 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.57 24.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.056 -0.592 . . . . 62.3 112.529 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 6.3 mmtp -65.12 -59.14 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.125 0.488 . . . . 64.33 110.031 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -28.77 63.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 65.03 110.139 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 t -78.88 -43.68 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.575 -0.739 . . . . 72.2 111.638 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -50.07 -37.21 32.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.448 . . . . 75.42 109.789 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -30.75 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 51.35 109.896 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.09 99.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.784 -0.644 . . . . 51.42 110.493 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 t -84.97 -35.78 21.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 74.41 110.47 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.5 -34.06 66.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.423 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -69.18 -31.57 70.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 64.23 110.757 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -106.11 12.8 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 54.42 111.636 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.686 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.8 tt -57.42 -42.56 96.5 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.18 -0.608 . . . . 71.5 109.697 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.1 Cg_exo -65.58 -23.98 56.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.832 2.354 . . . . 72.11 109.875 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.0 t -94.93 -15.65 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.71 -1.132 . . . . 51.01 111.21 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ALA . 77.7 t -100.14 -28.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.998 -0.742 . . . . 71.42 108.998 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.8 m -82.36 -42.05 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.994 -1.003 . . . . 75.43 110.475 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.9 -29.59 2.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.652 -0.785 . . . . 75.05 111.956 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.67 -39.95 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.093 0.473 . . . . 74.15 109.81 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -77.13 -21.59 53.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 71.43 109.514 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.26 -28.41 25.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.817 -0.629 . . . . 62.34 110.313 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -89.86 -45.12 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.965 -0.561 . . . . 73.02 110.444 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.4 -2.88 82.21 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.679 -0.772 . . . . 36.85 111.229 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.238 -0.887 . . . . 65.12 110.966 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.475 -0.25 . . . . 73.31 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.28 -21.99 59.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 54.02 112.672 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -48.02 -61.28 2.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.956 0.408 . . . . 63.05 110.721 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -60.41 -23.69 64.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.84 -0.618 . . . . 72.54 110.291 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.2 -42.32 80.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.944 -0.571 . . . . 70.54 110.74 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.31 -41.64 33.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 74.21 110.84 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.61 -22.98 66.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 64.01 112.643 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -94.1 -28.97 15.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 51.42 111.028 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -64.44 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.254 0.55 . . . . 64.25 110.907 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 -40.81 54.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 75.02 110.961 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.55 -37.85 73.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 70.25 110.917 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.91 91.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 38.35 112.448 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -74.39 -41.12 61.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 75.14 110.937 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.67 69.61 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.067 -0.587 . . . . 72.35 112.531 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.2 -58.13 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.933 0.396 . . . . 73.34 110.549 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.49 -19.88 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 73.4 110.15 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 42.8 t -83.17 -48.14 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.848 -0.615 . . . . 71.32 110.714 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.44 -39.88 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 74.25 109.765 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -76.23 -28.97 57.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.726 -0.67 . . . . 74.1 109.558 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.3 -46.0 85.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.584 -0.734 . . . . 65.31 110.32 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -79.24 -35.07 42.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.84 -0.618 . . . . 73.54 110.072 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.645 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.29 -21.81 50.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 54.04 110.394 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.83 66.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.717 -0.475 . . . . 64.45 109.717 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -112.72 18.11 18.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.897 -0.592 . . . . 52.13 110.602 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HG ' ' HD3' ' A' ' 51' ' ' PRO . 4.2 pp -62.82 -36.27 24.64 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.788 -0.765 . . . . 70.2 110.444 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 49.7 Cg_endo -77.96 -12.18 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.772 2.314 . . . . 53.14 109.929 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.47 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 65.0 t -105.86 -10.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.856 -1.065 . . . . 71.33 110.366 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ALA . 78.4 t -105.75 -31.14 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.676 -0.861 . . . . 65.23 108.676 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 58' ' ' ALA . 20.5 m -82.38 -39.92 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.41 -0.814 . . . . 74.1 110.393 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.18 -29.28 3.48 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.602 -0.809 . . . . 70.04 112.05 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.47 -37.73 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 74.5 109.724 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -78.01 -21.71 50.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 65.33 109.545 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.84 -27.15 25.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.887 -0.597 . . . . 45.14 110.367 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -91.15 -45.08 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.879 -0.601 . . . . 72.31 110.473 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -89.14 -1.42 79.17 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.773 . . . . 65.43 111.302 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.3 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 71.04 110.85 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.386 -0.286 . . . . 54.11 112.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.8 -22.86 65.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 72.51 112.6 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.25 -62.12 1.57 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.171 0.51 . . . . 72.24 111.008 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.4 ptmt -65.34 -23.89 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.471 -0.786 . . . . 74.41 110.038 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.32 -36.03 71.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 75.33 110.741 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.04 -42.59 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 70.14 110.873 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -22.02 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.13 112.799 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -97.07 -23.85 16.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.642 0.258 . . . . 54.25 111.24 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -67.32 -60.82 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 74.45 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -45.91 91.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 72.02 110.935 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.31 -40.44 71.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 73.13 111.125 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.97 -41.26 59.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.747 -0.739 . . . . 53.22 112.592 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.14 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.13 110.814 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.82 69.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.927 -0.654 . . . . 45.13 112.596 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -63.02 -36.47 83.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.667 0.27 . . . . 72.31 110.426 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.224 0.535 . . . . 74.11 110.28 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.0 -24.05 19.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.346 -0.843 . . . . 45.25 111.858 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.42 -27.24 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.483 -0.326 . . . . 73.52 110.81 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -81.0 -36.83 30.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 72.13 109.941 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 71.12 109.928 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -85.29 -36.94 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 62.31 110.349 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.23 -36.48 73.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 62.04 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -67.02 -31.81 72.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 71.52 110.949 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -102.03 11.56 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.01 111.819 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.663 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.9 tt -55.01 -43.62 99.16 Favored Pre-proline 0 C--O 1.224 -0.268 0 C-N-CA 120.263 -0.575 . . . . 71.01 110.064 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.2 Cg_exo -66.25 -21.52 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.885 2.39 . . . . 61.31 110.107 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.0 t -97.92 -17.24 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.944 -1.025 . . . . 70.43 111.289 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.1 p -98.85 -27.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.003 -0.74 . . . . 75.54 109.003 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 58' ' ' ALA . 15.9 m -82.21 -42.4 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.14 -0.936 . . . . 61.33 110.583 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.87 -29.63 2.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.658 -0.782 . . . . 74.15 111.961 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.82 -40.84 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.707 -0.479 . . . . 73.32 109.707 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 -21.56 57.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 75.23 109.425 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.87 -26.86 25.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.871 -0.604 . . . . 64.02 110.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.456 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -92.7 -44.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.954 -0.566 . . . . 72.14 110.484 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -89.93 0.01 78.64 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.217 -0.753 . . . . 41.44 111.217 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.207 -0.902 . . . . 71.15 110.83 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.394 -0.282 . . . . 52.03 112.394 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -67.5 -29.12 73.76 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.682 -0.771 . . . . 63.31 112.417 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.95 -62.21 1.58 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.224 0.535 . . . . 62.54 110.799 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 1.2 mttt -64.61 -23.89 67.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.358 -0.837 . . . . 73.14 109.792 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.97 -41.9 77.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.806 -0.634 . . . . 74.22 110.581 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 tp -82.06 -36.52 27.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.498 . . . . 55.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -21.95 72.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.712 . . . . 64.54 112.654 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -101.42 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 75.52 111.173 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -64.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.966 0.412 . . . . 65.44 110.88 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -44.1 75.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 71.25 111.067 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -39.24 76.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.021 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.22 93.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.753 . . . . 65.33 112.333 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.73 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 72.42 110.592 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 43' ' ' PHE . . . -52.37 -31.42 35.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.955 -0.641 . . . . 37.78 112.519 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 8.3 tttm -66.69 -35.85 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.184 0.516 . . . . 63.3 110.21 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -24.25 37.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 73.33 109.74 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 t -85.28 -40.36 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 74.24 111.397 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -51.12 -33.16 25.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.062 0.458 . . . . 74.43 109.788 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -79.63 -30.32 41.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 75.32 109.762 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.84 -44.74 84.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.774 -0.648 . . . . 54.14 110.167 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -77.56 -34.67 53.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 61.4 109.914 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.614 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.74 -21.72 61.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 73.51 110.436 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -73.14 -32.15 64.72 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.735 -0.468 . . . . 73.23 109.735 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.567 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.29 18.33 19.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.753 -0.658 . . . . 74.34 110.559 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.78 ' HG ' ' HD3' ' A' ' 51' ' ' PRO . 4.3 pp -62.92 -36.38 24.99 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.948 -0.701 . . . . 54.53 110.352 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.78 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 46.5 Cg_endo -77.52 -12.31 16.92 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.745 2.296 . . . . 73.44 110.033 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.467 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 70.0 t -104.85 -12.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.718 -1.128 . . . . 75.05 110.225 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' ALA . 85.9 t -104.2 -31.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.631 -0.877 . . . . 72.24 108.631 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 58' ' ' ALA . 20.3 m -82.32 -39.74 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.379 -0.828 . . . . 64.53 110.398 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.83 -29.53 3.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.55 -0.834 . . . . 71.24 112.053 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -84.05 -39.74 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.114 0.483 . . . . 73.2 109.839 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -21.84 54.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 63.12 109.422 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.22 -28.13 25.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.78 -0.645 . . . . 72.01 110.363 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -90.53 -45.12 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 115.967 -0.56 . . . . 73.23 110.396 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.51 -2.53 82.24 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.233 -0.747 . . . . 73.24 111.233 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.265 -0.874 . . . . 65.32 110.867 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.397 -0.281 . . . . 74.15 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 -21.93 50.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.41 112.599 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -47.67 -61.5 1.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.019 0.438 . . . . 63.52 110.748 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.0 tttp -61.21 -23.67 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.64 . . . . 72.25 110.42 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -68.86 -40.63 79.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 61.04 110.866 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.62 -39.91 30.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 74.23 111.015 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.35 -22.01 76.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.808 -0.71 . . . . 75.21 112.756 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -96.02 -26.8 15.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.68 0.276 . . . . 61.41 111.202 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.16 -63.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 74.55 111.023 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -41.03 78.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 73.11 111.099 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -37.98 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.54 111.21 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.23 -38.02 66.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 75.51 112.769 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -70.88 -49.33 47.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 52.42 111.073 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.22 -21.88 27.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.651 -0.785 . . . . 55.43 112.911 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.633 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.69 -39.33 24.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.772 0.286 . . . . 75.21 111.116 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.412 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.67 -37.17 27.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.173 0.511 . . . . 65.05 110.625 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' O ' ' N ' ' A' ' 45' ' ' ALA . 31.7 t -72.56 -22.67 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.604 -0.725 . . . . 71.42 111.839 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.87 -26.8 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 74.52 110.76 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.3 mttp -76.36 -34.29 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.101 0.477 . . . . 62.03 109.819 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -72.03 -35.12 69.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.604 -0.725 . . . . 74.54 110.405 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -50.86 6.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.616 . . . . 74.52 111.265 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 pp20? -50.56 -34.55 26.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.827 0.346 . . . . 53.33 111.049 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.78 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.13 111.011 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.1 11.81 38.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.358 . . . . 64.33 111.926 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.658 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.52 -43.35 99.1 Favored Pre-proline 0 C--O 1.223 -0.339 0 C-N-CA 120.213 -0.595 . . . . 64.11 110.052 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.8 Cg_exo -66.11 -22.73 54.08 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.866 2.377 . . . . 74.01 110.007 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.478 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 77.2 t -96.27 -16.97 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.814 -1.085 . . . . 74.54 111.266 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 49' ' ' ALA . 1.9 p -99.34 -27.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.898 -0.778 . . . . 74.21 108.898 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.3 m -82.23 -42.43 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.047 -0.978 . . . . 62.52 110.548 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.458 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.92 -29.55 2.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.627 -0.797 . . . . 72.32 112.032 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.478 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.93 -39.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 74.11 109.789 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -76.93 -22.01 53.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 72.43 109.475 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.31 -27.55 25.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.807 -0.633 . . . . 45.23 110.407 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -90.5 -45.28 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.975 -0.557 . . . . 61.43 110.392 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.66 -2.82 81.48 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.637 -0.792 . . . . 61.53 111.198 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 63.44 110.929 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.472 -0.251 . . . . 45.03 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.55 -21.97 77.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 74.3 112.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -47.52 -61.38 1.95 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.032 0.444 . . . . 74.33 110.748 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.5 -23.77 64.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 73.13 110.309 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -68.22 -42.84 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 75.34 110.744 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.02 -34.6 29.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 72.32 110.913 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.62 -21.93 71.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 38.41 112.89 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -105.45 -24.43 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 72.35 111.404 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.6 -60.62 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 75.34 110.919 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.76 -52.83 61.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.009 -0.541 . . . . 74.33 110.983 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -34.14 46.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 74.35 111.254 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.23 -36.49 68.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.673 -0.775 . . . . 42.24 112.424 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.66 -45.3 59.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 72.12 110.858 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -21.93 30.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 38.41 112.762 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 4.1 mttt -79.26 -40.57 30.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.66 0.23 . . . . 70.32 111.058 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' C ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.69 -39.28 24.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 70.15 110.732 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 45' ' ' ALA . 38.7 t -70.0 -22.34 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 74.02 111.696 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.91 -27.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.598 -0.274 . . . . 70.42 110.979 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -75.42 -34.75 61.05 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.174 0.511 . . . . 64.0 109.983 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -73.01 -34.39 66.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 75.21 110.416 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.1 p -85.19 -49.58 8.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.776 -0.647 . . . . 75.3 111.181 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -51.15 -34.75 32.54 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.942 0.401 . . . . 71.43 111.12 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -38.27 83.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 73.2 111.071 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -96.67 13.16 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 54.22 111.808 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.665 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.7 tt -56.15 -43.35 99.22 Favored Pre-proline 0 C--O 1.223 -0.333 0 C-N-CA 120.158 -0.617 . . . . 74.24 110.102 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.7 Cg_exo -66.53 -21.83 52.33 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.908 2.406 . . . . 72.23 110.125 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 68.3 t -97.42 -17.08 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.861 -1.063 . . . . 71.25 111.211 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 49' ' ' ALA . 1.9 p -99.18 -27.79 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.969 -0.752 . . . . 73.45 108.969 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.619 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.7 m -82.3 -42.34 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-N 115.099 -0.955 . . . . 75.02 110.588 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.92 -29.68 2.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.667 -0.778 . . . . 74.22 112.056 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.7 -40.36 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.171 0.51 . . . . 65.42 109.841 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -21.8 56.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.728 -0.669 . . . . 60.34 109.479 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.619 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.56 -26.91 25.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.78 -0.645 . . . . 74.42 110.384 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.459 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -92.3 -44.75 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.034 -0.53 . . . . 74.55 110.389 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.436 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -88.55 -1.45 80.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.655 -0.783 . . . . 72.43 111.277 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 63.53 110.869 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 45.03 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -21.91 78.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 63.53 112.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -47.51 -61.07 2.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.894 0.378 . . . . 75.43 110.821 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -61.1 -23.83 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.085 -0.507 . . . . 62.1 110.4 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.99 -42.71 80.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 73.45 110.714 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -82.09 -39.95 22.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 72.32 110.811 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.61 -22.48 61.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.778 -0.725 . . . . 75.45 112.731 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -101.56 -36.7 8.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.772 0.32 . . . . 75.54 110.935 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -64.38 -57.83 8.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 75.02 110.729 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -44.13 94.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 63.41 110.875 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.69 -44.92 81.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.074 -0.512 . . . . 74.53 111.04 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.93 -47.07 89.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 38.27 112.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.469 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -74.3 -45.34 48.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 44.1 110.908 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.24 -23.35 47.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.968 -0.634 . . . . 65.15 112.356 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.509 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 1.9 mmtt -64.89 -57.88 7.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 65.53 110.332 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.8 -20.08 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 74.53 110.043 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.45 HG23 ' HD2' ' A' ' 41' ' ' ARG . 95.1 t -81.13 -48.87 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 116.054 -0.521 . . . . 73.32 110.463 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.79 -46.2 41.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 72.3 109.606 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -70.42 -30.55 67.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.786 -0.643 . . . . 71.01 109.612 178.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.06 92.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.896 -0.593 . . . . 64.4 110.377 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -85.11 -35.08 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.524 . . . . 61.34 110.549 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.75 -31.23 64.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 75.32 110.59 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -71.74 -31.28 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.31 110.528 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.561 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -101.94 13.36 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 73.21 111.513 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.1 tt -56.03 -42.95 98.8 Favored Pre-proline 0 C--O 1.223 -0.321 0 C-N-CA 120.173 -0.611 . . . . 72.34 109.934 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -24.78 55.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.88 2.387 . . . . 74.21 109.848 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 47.3 t -96.63 -9.8 9.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.828 -1.078 . . . . 75.05 111.169 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.561 ' N ' ' O ' ' A' ' 49' ' ' ALA . 62.0 t -105.42 -28.13 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.717 -0.846 . . . . 73.23 108.717 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ALA . 19.2 m -82.39 -42.05 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.079 -0.964 . . . . 64.25 110.456 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.21 -28.76 3.28 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.531 -0.842 . . . . 53.35 112.097 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.41 -35.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.568 -0.53 . . . . 70.12 109.568 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.614 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.84 -21.82 47.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.61 -0.723 . . . . 75.51 109.498 178.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.5 -21.45 25.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.937 -0.574 . . . . 54.22 110.858 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.49 -44.04 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 75.42 111.991 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.442 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -126.42 2.55 7.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.89 -0.671 . . . . 63.31 111.803 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.614 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 2.8 tttm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 51.52 111.045 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.493 -0.243 . . . . 45.03 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.95 78.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 62.32 112.658 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -47.0 -61.18 1.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.977 0.418 . . . . 45.31 110.826 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -23.82 66.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 64.45 110.387 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -69.12 -43.86 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.581 . . . . 72.3 110.703 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.7 tp -82.07 -39.1 23.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.21 110.861 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.3 66.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 75.14 112.655 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -26.08 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.701 0.286 . . . . 75.04 111.0 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -67.36 -64.5 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.258 0.552 . . . . 74.13 110.523 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.44 ' CD1' ' N ' ' A' ' 36' ' ' GLU . 3.9 pp -53.98 -47.76 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.85 . . . . 63.33 110.833 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.44 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -51.73 -37.74 52.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.41 -0.814 . . . . 63.12 111.049 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.41 -44.53 64.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 60.32 112.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -73.87 -34.55 64.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 73.23 110.907 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.04 -21.82 66.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.992 -0.623 . . . . 41.54 112.529 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.4 tttt -65.02 -58.22 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.955 0.407 . . . . 74.31 110.521 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -63.14 -19.87 64.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.973 0.416 . . . . 75.34 110.245 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 40.3 t -84.32 -44.48 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.937 -0.574 . . . . 73.41 111.05 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.15 -39.65 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 75.24 109.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 3.2 mttm -75.1 -30.93 61.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 63.25 109.777 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.59 -41.63 99.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.751 -0.659 . . . . 74.12 110.565 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 t -85.08 -35.69 21.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.921 -0.581 . . . . 71.24 110.542 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.85 -34.0 67.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 54.31 110.499 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -69.27 -32.55 71.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 64.13 110.731 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.6 11.24 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 74.42 111.565 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.0 -43.58 99.12 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 120.243 -0.583 . . . . 72.13 110.106 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.5 Cg_exo -66.02 -22.06 55.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.857 2.371 . . . . 72.14 110.003 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 75.0 t -97.31 -16.9 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.902 -1.044 . . . . 65.34 111.322 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.0 p -99.43 -27.61 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.985 -0.746 . . . . 73.34 108.985 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.6 m -82.23 -42.33 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 115.071 -0.968 . . . . 75.31 110.445 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.13 -29.65 2.36 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 74.33 112.003 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.73 -38.47 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.164 0.506 . . . . 74.24 109.654 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 4.5 mtmt -76.31 -21.7 55.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 70.11 109.458 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.6 -21.49 25.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.94 -0.573 . . . . 74.34 110.939 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -99.73 -43.61 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 73.25 111.905 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -125.03 1.46 8.4 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.586 -0.734 . . . . 73.22 111.828 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.197 -0.906 . . . . 64.12 110.945 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.494 -0.242 . . . . 54.33 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.03 -26.55 44.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 75.24 112.585 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.425 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -48.15 -62.2 1.6 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.225 0.536 . . . . 75.24 110.924 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -64.45 -23.95 67.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.382 -0.827 . . . . 75.04 109.885 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -35.81 77.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.886 -0.597 . . . . 72.31 110.639 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.95 -35.73 28.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 72.41 110.911 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -57.5 7.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 42.4 112.612 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.98 -26.49 62.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.689 0.281 . . . . 63.13 111.016 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.95 -56.41 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.964 0.411 . . . . 73.02 110.644 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -51.99 15.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.951 -0.568 . . . . 72.34 110.752 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -32.5 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 72.3 110.977 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.16 -38.15 88.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.776 . . . . 63.31 112.456 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.26 -41.75 73.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 73.33 110.983 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.33 -21.84 35.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 71.1 112.574 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -81.07 -40.72 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 0.175 . . . . 72.1 110.977 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' C ' ' HD3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.33 -40.63 23.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 73.35 110.671 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.421 ' O ' ' N ' ' A' ' 45' ' ' ALA . 43.7 t -65.76 -22.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.677 -0.692 . . . . 70.13 111.415 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.83 -28.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 74.41 110.833 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -72.21 -43.4 64.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.659 0.742 . . . . 65.22 109.75 179.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -66.69 -34.61 78.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.58 -1.191 . . . . 53.12 110.588 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 p -85.16 -45.92 11.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.544 . . . . 72.05 111.031 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.598 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 pp20? -58.63 -20.4 47.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 54.42 110.873 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -33.11 64.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.742 -0.466 . . . . 64.43 109.742 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.575 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -110.24 18.43 19.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.721 -0.672 . . . . 51.53 110.515 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.774 ' HG ' ' HD3' ' A' ' 51' ' ' PRO . 4.2 pp -62.52 -36.37 26.67 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 119.917 -0.713 . . . . 72.42 110.44 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.774 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 50.1 Cg_endo -77.82 -11.36 16.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.794 2.329 . . . . 44.42 110.052 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.47 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 53.2 t -107.46 -10.77 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.697 -1.138 . . . . 75.43 110.333 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' A' ' 49' ' ' ALA . 83.0 t -105.05 -30.77 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.682 -0.858 . . . . 71.21 108.682 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.621 ' O ' ' N ' ' A' ' 58' ' ' ALA . 20.3 m -82.35 -40.22 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.422 -0.808 . . . . 63.3 110.404 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.449 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.98 -29.37 3.29 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.533 -0.842 . . . . 74.25 112.072 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -85.12 -38.17 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.687 -0.486 . . . . 65.23 109.687 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -77.69 -21.79 51.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.717 -0.674 . . . . 62.3 109.483 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.77 -26.94 25.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.898 -0.592 . . . . 51.54 110.383 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -91.52 -45.01 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.936 -0.575 . . . . 64.52 110.498 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -89.0 -1.45 79.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 74.43 111.317 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.5 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.245 -0.883 . . . . 72.22 110.89 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.505 -0.238 . . . . 64.43 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.52 -25.24 65.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 73.02 112.571 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.68 -62.15 1.59 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.187 0.518 . . . . 62.22 111.018 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.443 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 20.6 pttt -63.72 -23.94 67.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 64.42 109.868 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -40.37 82.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 73.45 110.648 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.11 -35.74 28.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 74.54 110.898 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.2 -21.94 72.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 72.32 112.801 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -29.63 12.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 74.44 111.026 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -64.29 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 75.21 110.82 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -41.24 67.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.876 -0.602 . . . . 64.53 111.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -44.41 83.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 75.25 111.017 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.16 -47.02 76.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 73.2 112.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.9 -47.07 61.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 73.1 110.716 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.22 -28.53 26.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.933 -0.576 . . . . 63.13 112.389 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 5.2 mmtm -64.99 -59.62 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 75.43 109.991 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -23.32 52.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.089 -0.505 . . . . 74.42 110.252 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 t -85.63 -40.28 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 72.13 111.754 -179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.516 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.65 -39.0 34.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.761 -0.459 . . . . 71.33 109.761 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 mttm -72.74 -31.81 65.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 75.12 110.001 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.015 -0.539 . . . . 39.17 110.395 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 t -85.19 -31.76 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.816 -0.629 . . . . 74.43 110.608 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -60.94 -36.46 79.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 71.4 110.636 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -75.43 -29.45 59.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.23 110.744 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.33 12.53 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 71.04 111.592 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.669 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.9 tt -55.84 -43.42 99.19 Favored Pre-proline 0 C--O 1.223 -0.3 0 C-N-CA 120.308 -0.557 . . . . 72.14 110.032 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.2 Cg_exo -66.03 -20.39 57.21 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.818 2.345 . . . . 75.11 110.001 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 66.0 t -98.55 -19.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.843 -1.071 . . . . 71.15 111.217 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.0 p -97.27 -27.58 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.066 -0.716 . . . . 71.22 109.066 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.617 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.4 m -82.26 -42.26 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.076 -0.966 . . . . 72.22 110.587 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.455 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.89 -29.72 2.15 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.696 -0.764 . . . . 72.14 111.992 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -82.68 -41.63 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.733 -0.469 . . . . 71.24 109.733 178.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -22.38 57.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 75.11 109.39 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.68 -26.72 27.56 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.746 -0.661 . . . . 62.23 110.396 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.455 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -93.27 -44.4 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.965 -0.561 . . . . 75.4 110.372 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -85.88 -3.02 86.0 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.696 -0.764 . . . . 64.0 111.246 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.192 -0.909 . . . . 74.24 110.924 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.521 -0.232 . . . . 64.22 112.521 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.1 -22.57 77.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 36.55 112.579 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.441 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.98 -62.22 1.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.202 0.525 . . . . 74.33 110.985 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -63.72 -23.81 67.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 74.55 109.961 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -70.79 -44.77 65.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.824 -0.625 . . . . 74.12 110.647 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -82.1 -37.78 25.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 64.33 110.816 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -22.03 57.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.825 -0.702 . . . . 73.12 112.696 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -94.38 -31.41 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 73.24 110.998 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -62.56 -57.79 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 63.53 110.551 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 -52.95 63.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 61.14 110.722 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.28 -40.98 62.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 65.01 110.964 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.49 88.41 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 70.13 112.286 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.39 -53.29 14.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 64.53 110.708 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.26 -29.4 22.19 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.091 -0.576 . . . . 61.15 112.461 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 mttt -65.14 -59.31 4.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.101 0.477 . . . . 62.32 110.025 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -29.92 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 64.21 109.911 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.4 t -75.99 -47.55 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.534 -0.757 . . . . 72.23 111.24 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.46 -40.42 50.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.721 -0.474 . . . . 74.31 109.721 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 14.1 mttt -75.25 -30.0 60.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 65.22 109.655 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.55 99.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.801 -0.636 . . . . 74.01 110.556 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 t -85.12 -37.65 20.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.022 -0.535 . . . . 72.1 110.748 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.18 -33.5 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 74.53 110.57 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -70.16 -33.15 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 73.22 110.664 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.71 11.18 34.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 63.42 111.493 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.662 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.6 tt -55.23 -43.32 99.03 Favored Pre-proline 0 C--O 1.223 -0.32 0 C-N-CA 120.188 -0.605 . . . . 54.32 110.02 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.9 Cg_exo -66.44 -22.19 52.45 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.875 2.384 . . . . 60.44 110.045 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 71.5 t -97.51 -14.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.93 -1.032 . . . . 63.54 111.374 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.0 p -101.54 -27.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.804 -0.814 . . . . 74.44 108.804 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.616 ' O ' ' N ' ' A' ' 58' ' ' ALA . 17.1 m -82.27 -41.97 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.076 -0.965 . . . . 55.25 110.41 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.69 -29.25 2.89 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.604 -0.808 . . . . 52.33 112.032 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -86.88 -35.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.605 -0.517 . . . . 74.32 109.605 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.43 -21.75 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.545 -0.752 . . . . 64.11 109.661 178.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.71 -21.45 25.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.878 -0.601 . . . . 73.24 110.96 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.04 -44.09 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 65.24 111.981 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -124.3 -0.12 8.78 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.768 -0.729 . . . . 65.44 111.762 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 12.8 tttm . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.204 -0.903 . . . . 64.04 111.35 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.521 -0.232 . . . . 51.22 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.56 -21.99 76.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.739 . . . . 75.15 112.584 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.62 -61.2 2.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.953 0.406 . . . . 71.13 110.118 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -63.16 -23.44 67.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 55.13 109.685 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -44.25 77.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.879 -0.6 . . . . 62.44 110.79 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.79 -46.07 69.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.54 110.859 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.95 -36.94 93.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.738 -0.744 . . . . 44.25 112.465 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -70.45 -29.17 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 64.44 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -63.49 -57.07 11.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 70.42 110.827 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -42.64 81.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.977 -0.556 . . . . 74.22 110.916 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -53.61 -40.24 65.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.12 111.071 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.64 -41.43 82.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 70.11 112.651 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.68 -43.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 74.12 110.941 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.09 34.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 40.33 112.706 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.09 -40.58 23.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.664 0.232 . . . . 72.4 110.967 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.66 -37.16 27.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.038 0.447 . . . . 71.12 110.663 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 45' ' ' ALA . 21.8 t -71.88 -22.69 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 74.54 111.717 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -47.92 -27.64 2.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.517 -0.31 . . . . 72.11 110.838 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 5.6 mtpt -77.03 -33.74 57.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.171 0.51 . . . . 74.34 109.806 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -76.6 -32.69 58.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.476 -0.784 . . . . 54.52 110.302 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 p -85.22 -45.75 11.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 71.14 111.046 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.414 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -53.61 -35.55 61.01 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.998 0.428 . . . . 75.41 110.916 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -37.2 85.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 75.3 110.974 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.552 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -97.84 13.86 29.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 70.21 111.851 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.675 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.4 tt -56.96 -42.64 97.41 Favored Pre-proline 0 C--O 1.223 -0.317 0 C-N-CA 120.148 -0.621 . . . . 72.34 109.99 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.7 Cg_exo -66.27 -23.81 51.59 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.87 2.38 . . . . 74.54 109.915 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 50.9 t -96.8 -10.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.878 -1.056 . . . . 73.31 111.215 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 49' ' ' ALA . 71.4 t -104.58 -28.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.783 -0.821 . . . . 72.52 108.783 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.614 ' O ' ' N ' ' A' ' 58' ' ' ALA . 17.3 m -82.44 -41.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.932 -1.031 . . . . 75.11 110.517 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.61 -28.45 3.57 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.596 -0.812 . . . . 73.11 112.157 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.489 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.0 -33.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 71.1 109.798 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -82.19 -22.18 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 45.45 109.495 178.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.69 -21.51 25.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.948 -0.569 . . . . 45.11 111.2 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.53 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.25 -47.3 14.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 62.1 112.073 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -130.36 4.5 5.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.69 -0.686 . . . . 36.71 111.433 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.599 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 1.3 tttp . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.236 -0.887 . . . . 74.14 111.146 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.465 -0.254 . . . . 71.23 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 -21.75 52.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 63.42 112.717 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -46.02 -61.35 1.79 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.991 0.424 . . . . 65.52 110.84 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -57.94 -23.8 55.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.58 . . . . 75.24 110.235 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 -35.35 65.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.77 -0.65 . . . . 74.32 110.923 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.99 -31.26 31.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 73.0 110.952 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.2 -21.99 78.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 64.11 112.812 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -29.98 13.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 72.1 110.959 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -65.77 -57.79 7.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 75.13 111.012 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -48.52 81.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 54.33 111.134 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -37.96 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 63.43 111.082 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.9 -39.78 63.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.778 -0.725 . . . . 52.34 112.584 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.9 -48.77 65.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 62.45 110.837 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.92 -36.48 60.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.904 -0.665 . . . . 44.23 112.667 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 8.1 mttt -62.34 -36.87 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.688 0.28 . . . . 72.42 110.323 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.28 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.301 0.572 . . . . 74.0 110.195 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.401 ' O ' ' N ' ' A' ' 45' ' ' ALA . 16.1 t -55.89 -23.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 63.2 111.839 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.621 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.68 -28.19 5.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.818 0.342 . . . . 74.31 110.449 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -77.65 -34.24 53.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 71.43 109.729 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -75.52 -32.86 60.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.528 -0.76 . . . . 72.25 110.252 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.15 -47.16 10.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 74.51 111.154 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -53.51 -37.39 62.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.926 0.393 . . . . 75.35 111.009 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -68.27 -33.48 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 61.41 111.094 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -99.72 13.11 34.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 74.34 111.872 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.684 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.8 tt -57.29 -42.62 96.98 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.016 -0.674 . . . . 64.43 109.734 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.9 Cg_exo -65.35 -25.43 56.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.774 2.316 . . . . 74.22 109.842 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 53.2 t -94.17 -12.67 8.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.751 -1.113 . . . . 60.51 111.243 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 49' ' ' ALA . 67.1 t -102.9 -28.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.793 -0.818 . . . . 64.32 108.793 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.63 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.7 m -82.36 -41.85 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.04 -0.982 . . . . 73.43 110.419 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.66 -29.11 2.79 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.515 -0.85 . . . . 42.41 112.113 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.93 -37.12 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.158 0.504 . . . . 75.44 109.697 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.574 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 5.0 mtmt -78.37 -21.47 49.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.664 -0.698 . . . . 74.31 109.456 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.57 -21.55 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.883 -0.598 . . . . 73.31 110.982 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.525 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.13 -43.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 74.03 111.933 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -124.08 -0.38 8.92 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.757 -0.735 . . . . 71.42 111.755 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.18 -0.914 . . . . 71.14 111.314 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.541 -0.223 . . . . 50.21 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.88 -21.89 78.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 54.31 112.661 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -46.54 -61.41 1.83 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.009 0.433 . . . . 73.23 110.93 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -61.02 -23.85 65.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 74.32 110.356 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -69.65 -37.44 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 73.34 110.87 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -81.88 -43.59 17.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 53.01 111.079 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.8 52.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.678 -0.772 . . . . 75.12 112.617 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -30.49 66.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.22 110.956 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -63.11 -57.0 12.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 72.03 110.742 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.65 -55.54 16.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.525 . . . . 72.5 110.834 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -37.03 52.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 73.21 111.197 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.06 80.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 52.24 112.586 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.422 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -80.59 -37.64 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.868 0.366 . . . . 75.14 110.917 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.73 -27.28 69.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 54.43 113.122 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.639 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 17.8 pttt -63.39 -38.63 91.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.149 0.474 . . . . 62.13 110.957 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -32.07 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 54.42 110.453 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 45' ' ' ALA . 43.4 t -80.85 -22.93 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.528 -0.76 . . . . 65.31 112.212 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.62 -26.89 3.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.759 0.314 . . . . 74.41 110.803 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.5 tttt -77.66 -31.61 52.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.183 0.516 . . . . 75.53 109.671 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -77.87 -33.55 52.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.386 -0.825 . . . . 53.45 110.305 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -45.3 12.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.779 -0.646 . . . . 64.34 111.026 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -52.43 -36.87 55.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.939 0.4 . . . . 71.45 110.789 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -64.17 -33.16 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.44 110.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -101.51 12.89 36.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 73.13 111.671 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.2 tt -55.87 -43.11 99.05 Favored Pre-proline 0 C--O 1.223 -0.331 0 C-N-CA 120.155 -0.618 . . . . 62.44 109.949 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 7.0 Cg_exo -65.27 -24.4 58.24 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.89 2.393 . . . . 74.21 109.945 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.474 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 54.6 t -95.39 -15.14 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.765 -1.107 . . . . 64.51 111.216 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' ALA . 61.1 t -100.08 -28.8 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 74.34 108.94 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.611 ' O ' ' N ' ' A' ' 58' ' ' ALA . 17.4 m -82.27 -42.29 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 114.995 -1.002 . . . . 44.51 110.589 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.98 -29.53 2.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.601 -0.809 . . . . 65.23 111.976 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.59 -40.72 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 73.25 109.758 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -21.75 56.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.654 . . . . 74.24 109.432 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.42 -27.21 25.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.742 -0.663 . . . . 44.32 110.411 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.454 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.79 -44.81 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.357 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.7 -2.28 81.99 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.65 -0.786 . . . . 54.31 111.245 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 74.14 110.932 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.484 -0.246 . . . . 72.41 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.82 71.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.694 -0.765 . . . . 74.31 112.679 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -47.37 -61.38 1.94 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.022 0.439 . . . . 73.02 110.799 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -60.62 -23.72 64.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 75.51 110.332 179.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -40.66 78.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.932 -0.576 . . . . 65.03 110.922 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.3 tp -74.39 -40.35 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 74.3 110.958 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.64 -54.72 24.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 60.11 112.589 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -26.98 62.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 75.11 111.113 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.42 -57.83 8.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 73.42 110.913 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -46.59 72.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 64.45 111.003 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.13 82.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 73.11 111.019 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.53 -47.9 67.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.819 -0.705 . . . . 35.52 112.549 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.01 -44.62 88.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.392 . . . . 72.43 110.842 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.9 -37.74 63.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.034 -0.603 . . . . 65.31 112.58 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mttt -62.13 -36.59 82.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.699 0.285 . . . . 62.43 110.43 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.53 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.577 . . . . 74.14 110.286 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.2 t -55.44 -23.9 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 73.44 111.834 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.83 -27.96 5.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 72.43 110.444 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 mtmm -77.86 -33.94 51.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.171 0.51 . . . . 71.32 109.814 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.84 64.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.609 -0.723 . . . . 73.03 110.274 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -85.39 -50.33 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.756 -0.656 . . . . 73.3 111.16 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.7 pp20? -51.15 -34.41 31.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.911 0.386 . . . . 72.33 111.089 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -36.76 82.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 60.31 111.087 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -99.68 14.14 31.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 60.33 111.916 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.683 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.1 tt -57.88 -42.57 96.02 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.084 -0.646 . . . . 61.12 109.861 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.6 Cg_exo -66.04 -24.06 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.884 2.389 . . . . 70.01 109.877 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 64.6 t -95.09 -15.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.766 -1.107 . . . . 73.15 111.161 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 49' ' ' ALA . 78.9 t -100.15 -28.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 73.4 108.874 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.5 m -82.29 -41.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 115.082 -0.963 . . . . 73.4 110.534 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.464 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.96 -29.48 2.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.657 -0.783 . . . . 60.32 112.072 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.33 -40.74 16.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.493 . . . . 65.41 109.808 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -76.48 -21.96 55.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.75 -0.659 . . . . 71.3 109.465 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.633 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.93 -27.88 26.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.785 -0.643 . . . . 63.1 110.398 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.1 -44.99 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.92 -0.582 . . . . 51.32 110.349 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.44 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -86.68 -3.1 84.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.175 -0.77 . . . . 44.33 111.175 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.292 -0.861 . . . . 75.31 111.009 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.508 -0.237 . . . . 70.02 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.409 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -66.5 -21.99 71.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.772 . . . . 51.53 112.642 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -56.69 -61.29 2.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 74.41 110.105 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -23.46 67.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 72.33 109.756 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.409 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -66.89 -39.81 87.57 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.762 -0.653 . . . . 61.35 110.921 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 tp -79.2 -38.47 35.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 61.15 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.34 -22.34 78.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.779 -0.724 . . . . 73.11 112.643 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.06 -26.31 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 61.15 111.066 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -66.14 -60.5 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 64.12 110.783 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.5 -51.71 68.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 74.41 110.871 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.99 -34.39 59.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.556 . . . . 71.33 111.04 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.2 -37.2 71.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.771 -0.728 . . . . 72.32 112.464 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -72.43 -45.86 57.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.02 110.864 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.0 -21.78 32.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.829 -0.701 . . . . 72.25 112.747 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -73.12 -42.62 62.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.582 0.191 . . . . 55.5 111.25 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -81.56 -39.3 24.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 74.53 110.699 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 45' ' ' ALA . 41.6 t -67.94 -22.53 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 72.33 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.8 -26.95 1.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 73.14 111.226 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 1.1 mttt -78.61 -35.25 45.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.026 0.441 . . . . 71.44 110.111 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -58.9 -40.78 85.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 72.05 110.293 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -85.14 -33.04 22.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.891 -0.595 . . . . 62.14 110.211 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -57.19 -39.82 76.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 70.55 110.431 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -66.75 -29.14 69.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 65.3 110.999 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.72 11.48 32.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.419 -0.355 . . . . 54.41 111.833 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.67 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.79 -43.1 99.03 Favored Pre-proline 0 C--O 1.223 -0.312 0 C-N-CA 120.164 -0.614 . . . . 71.24 109.981 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.3 Cg_exo -67.13 -21.87 48.07 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.768 2.312 . . . . 72.41 110.02 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.6 t -97.77 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.008 -0.996 . . . . 74.43 111.415 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.1 p -102.25 -27.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 62.13 108.881 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.566 ' CG1' ' O ' ' A' ' 50' ' ' LEU . 15.5 m -82.5 -42.06 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 114.992 -1.004 . . . . 75.33 110.637 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -47.16 -28.34 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.493 -0.861 . . . . 55.21 112.277 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.549 ' HA ' HG12 ' A' ' 59' ' ' ILE . 0.4 OUTLIER -86.53 -29.32 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.483 . . . . 65.23 109.963 179.116 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.427 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 2.1 mtmt -86.45 -24.08 25.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 71.51 109.524 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.92 -21.21 25.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.581 . . . . 71.14 112.25 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.549 HG12 ' HA ' ' A' ' 56' ' ' ILE . 1.1 pp -62.05 -61.47 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.147 0.499 . . . . 72.21 112.17 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -135.08 8.25 4.44 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.911 -0.876 . . . . 52.32 110.911 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.427 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.5 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 72.02 111.197 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.529 -0.228 . . . . 52.12 112.529 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.32 -24.27 75.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 52.22 112.56 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.51 -62.2 1.55 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.278 0.561 . . . . 73.42 110.841 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.419 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -65.35 -23.92 67.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 71.32 110.008 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.78 71.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.876 -0.602 . . . . 74.02 110.701 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.0 tp -81.91 -34.2 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 62.12 110.837 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.9 -21.97 77.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 73.34 112.822 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -95.03 -46.66 6.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.31 . . . . 71.41 111.154 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 3.3 pttt -57.41 -50.52 72.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.98 0.419 . . . . 72.1 110.856 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -64.71 -42.85 94.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.76 -0.655 . . . . 63.45 110.842 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -39.42 76.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 61.33 111.034 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.91 -41.99 68.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 74.43 112.647 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.64 -46.21 73.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 54.03 110.848 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.82 -34.03 56.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.973 -0.632 . . . . 63.32 112.692 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -64.39 -37.69 88.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.695 0.283 . . . . 72.44 110.436 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -51.2 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 72.12 110.252 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.8 t -56.97 -23.65 18.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 74.44 111.739 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.82 -27.05 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.338 . . . . 74.31 110.708 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 tttp -82.07 -35.04 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 73.43 110.083 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.98 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 73.11 110.05 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.99 -33.33 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 72.55 110.174 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mm-40 -58.66 -36.77 74.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 73.15 110.373 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -66.07 -31.02 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.91 -0.587 . . . . 74.43 110.794 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.555 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.18 13.54 30.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.44 111.638 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.678 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.7 tt -57.56 -42.65 96.82 Favored Pre-proline 0 C--O 1.223 -0.335 0 C-N-CA 120.09 -0.644 . . . . 74.14 109.756 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.47 -24.67 56.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.845 2.364 . . . . 73.13 109.826 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.5 t -94.36 -15.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 114.718 -1.128 . . . . 73.54 111.262 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.555 ' N ' ' O ' ' A' ' 49' ' ' ALA . 86.4 t -100.58 -29.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.932 -0.766 . . . . 63.23 108.932 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.4 m -82.21 -42.0 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 114.986 -1.006 . . . . 70.45 110.511 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.46 ' O ' ' CG1' ' A' ' 59' ' ' ILE . . . -44.92 -29.62 2.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.688 -0.767 . . . . 55.23 111.974 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.477 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -82.8 -41.47 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.49 . . . . 74.24 109.808 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -22.29 56.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 64.13 109.341 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.6 -27.2 27.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.788 -0.642 . . . . 53.4 110.391 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' CG1' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -92.62 -44.45 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.911 -0.586 . . . . 75.35 110.341 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.443 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -86.67 -2.62 84.46 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.206 -0.758 . . . . 44.52 111.206 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.226 -0.893 . . . . 70.41 110.895 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.43 -0.268 . . . . 62.14 112.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.99 -27.49 31.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.767 -0.73 . . . . 74.31 112.6 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -50.5 -62.18 1.74 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.168 0.508 . . . . 73.44 110.647 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 14.0 mtpp -64.89 -23.91 67.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 73.22 109.734 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.411 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.85 -40.29 79.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.776 -0.647 . . . . 74.44 110.755 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -81.94 -35.87 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 73.25 110.875 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.04 -22.4 78.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 71.0 112.843 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -97.64 -27.19 14.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.312 . . . . 74.45 111.126 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -62.22 -56.4 19.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 74.51 110.724 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -64.09 -54.18 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.879 -0.6 . . . . 70.22 110.846 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -45.09 78.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 74.55 111.084 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.82 44.93 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.797 -0.716 . . . . 64.23 112.708 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.43 -48.72 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 63.22 110.863 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.05 50.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.015 -0.612 . . . . 73.43 112.66 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -59.78 -37.65 79.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.697 0.284 . . . . 71.03 110.464 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -52.25 7.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.202 0.525 . . . . 74.53 110.221 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.3 t -55.51 -25.27 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 73.11 111.742 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.72 -26.78 2.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 74.45 110.753 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.1 tttt -81.99 -35.13 29.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.106 0.479 . . . . 53.31 110.102 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.14 90.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 72.42 110.19 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.18 -34.76 22.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 65.42 110.342 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -57.85 -38.52 75.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.494 . . . . 73.31 110.524 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -66.71 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 71.42 111.118 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.11 11.97 32.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 63.32 111.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.676 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.9 tt -56.64 -42.73 97.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 C-N-CA 120.025 -0.67 . . . . 73.23 109.852 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -25.39 55.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.817 2.345 . . . . 73.22 109.811 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.473 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.0 t -93.98 -13.64 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 114.865 -1.061 . . . . 55.31 111.237 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.554 ' N ' ' O ' ' A' ' 49' ' ' ALA . 58.4 t -101.81 -29.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.882 -0.785 . . . . 73.44 108.882 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.631 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.5 m -82.23 -42.09 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.042 -0.981 . . . . 73.34 110.398 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.27 -29.33 2.42 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 51.32 111.96 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.491 ' HA ' HG12 ' A' ' 59' ' ' ILE . 0.7 OUTLIER -85.14 -39.74 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.625 -0.509 . . . . 62.21 109.625 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 1.1 mtmm -76.1 -21.02 57.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 63.12 109.602 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.53 -21.46 25.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 72.1 111.286 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 23.7 pt -91.26 -47.12 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.079 0.466 . . . . 73.35 112.17 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.496 ' N ' HG13 ' A' ' 59' ' ' ILE . . . -133.27 4.06 4.84 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.251 -0.739 . . . . 72.12 111.251 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.25 -0.881 . . . . 72.43 110.831 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.487 -0.245 . . . . 45.03 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 -21.8 74.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.624 -0.798 . . . . 55.24 112.68 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -46.53 -61.45 1.81 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 74.41 110.883 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.27 -23.79 64.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 63.04 110.405 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -41.14 76.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 72.41 111.0 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.3 tp -79.87 -35.35 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.34 111.034 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.41 -22.01 76.23 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 70.01 112.838 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -93.79 -43.3 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 73.15 111.158 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -58.79 -50.82 72.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.411 . . . . 36.79 111.021 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.438 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.12 -48.93 79.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 71.42 111.074 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -45.29 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 54.23 111.19 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.13 -44.27 51.18 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.837 -0.697 . . . . 60.41 112.732 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.96 -48.59 70.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.936 0.398 . . . . 51.15 110.907 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.14 -35.95 55.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.986 -0.626 . . . . 63.23 112.641 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mtpt -62.73 -37.49 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 73.44 110.421 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.7 -53.01 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 74.51 110.315 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 t -55.8 -23.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.316 -0.856 . . . . 75.02 111.679 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.14 -27.85 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.348 . . . . 71.55 110.456 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 mttm -78.47 -32.79 48.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 61.02 109.798 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.32 -32.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.621 -0.718 . . . . 74.11 110.302 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.37 -47.98 9.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 63.35 111.044 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 2.9 pp20? -51.9 -33.96 39.18 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 64.41 110.916 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -66.17 -38.32 87.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 65.21 111.053 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.556 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.37 12.94 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 36.79 111.82 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.673 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.0 tt -56.79 -42.81 98.21 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.068 -0.653 . . . . 75.11 109.837 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 5.1 Cg_exo -65.82 -25.07 53.4 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.747 2.298 . . . . 74.04 109.944 176.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.484 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 56.0 t -95.43 -11.02 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.909 -1.042 . . . . 75.25 111.229 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' ALA . 73.2 t -104.35 -28.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.798 -0.815 . . . . 63.05 108.798 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.626 ' O ' ' N ' ' A' ' 58' ' ' ALA . 18.1 m -82.28 -41.82 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.002 -0.999 . . . . 63.44 110.443 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.28 -28.72 3.34 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.596 -0.811 . . . . 73.45 112.089 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.484 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.14 -35.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.593 -0.521 . . . . 73.02 109.593 178.912 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.05 -22.04 45.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.68 -0.691 . . . . 64.31 109.491 178.446 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.73 -21.42 25.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.911 -0.586 . . . . 73.21 111.059 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -96.67 -44.52 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.22 112.105 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.441 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -129.84 4.42 6.1 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.809 -0.71 . . . . 42.43 111.607 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 48.1 tttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.832 . . . . 72.12 110.952 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.534 -0.226 . . . . 65.3 112.534 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -72.28 -21.9 79.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 62.42 112.657 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.13 -61.1 2.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 75.43 110.222 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -23.39 67.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 74.52 109.719 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -38.28 81.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.794 -0.639 . . . . 74.14 110.937 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -79.25 -36.65 39.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.8 -57.24 9.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 42.0 112.558 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -25.43 63.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 62.44 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -65.27 -59.09 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.1 110.833 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -46.35 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 72.35 111.003 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -54.9 -38.75 67.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 74.5 111.019 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.67 95.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 54.32 112.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.45 -43.65 84.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 73.12 110.843 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.51 -36.03 57.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.002 -0.618 . . . . 75.21 112.617 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -62.15 -36.61 82.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.724 0.297 . . . . 71.42 110.269 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -52.96 6.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.259 0.552 . . . . 62.41 110.152 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.7 t -56.62 -23.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.217 -0.901 . . . . 70.31 111.867 -179.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.78 -27.77 5.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 75.23 110.553 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 23.2 mttt -77.79 -33.75 52.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.115 0.483 . . . . 65.32 109.787 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 -33.02 60.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.562 -0.744 . . . . 72.44 110.254 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.32 -47.87 9.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 72.52 111.121 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -52.36 -39.03 60.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.964 0.412 . . . . 63.5 111.025 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -30.07 71.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 75.2 111.115 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.83 11.44 35.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 51.31 111.901 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.658 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.8 tt -55.34 -43.34 99.06 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 120.238 -0.585 . . . . 63.4 110.123 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.0 Cg_exo -66.34 -22.43 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.819 2.346 . . . . 64.54 110.017 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 79.6 t -96.2 -17.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.797 -1.092 . . . . 75.43 111.26 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' A' ' 49' ' ' ALA . 1.8 p -98.76 -27.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.939 -0.763 . . . . 73.13 108.939 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.0 m -82.38 -42.19 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.099 -0.955 . . . . 75.53 110.511 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.444 ' O ' ' CG1' ' A' ' 59' ' ' ILE . . . -44.95 -29.46 2.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.731 -0.747 . . . . 72.33 112.011 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.483 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.57 -40.29 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 63.42 109.784 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -21.97 54.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.756 -0.656 . . . . 74.11 109.393 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.12 -24.1 28.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.792 -0.64 . . . . 52.32 110.439 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.457 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -96.63 -43.97 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 115.935 -0.575 . . . . 73.2 110.495 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -83.45 -4.97 89.03 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.628 -0.796 . . . . 55.31 111.291 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.248 -0.882 . . . . 72.04 110.996 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.487 -0.245 . . . . 55.42 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.55 -24.76 41.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.747 . . . . 71.23 112.608 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.415 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.36 -62.25 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.18 0.515 . . . . 74.33 110.925 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 15.4 mttt -65.54 -23.89 66.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.387 -0.824 . . . . 73.0 109.916 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -70.54 -34.7 72.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 71.32 110.728 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -81.98 -34.96 29.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 73.05 110.988 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.07 -58.77 5.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 51.4 112.605 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -37.32 65.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 64.32 111.114 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -65.03 -57.45 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 74.2 110.844 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.39 90.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 73.44 111.067 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -47.81 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.53 110.938 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.71 -48.92 59.93 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.807 -0.711 . . . . 52.54 112.383 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.28 -47.6 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 72.33 110.654 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.57 24.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.056 -0.592 . . . . 62.3 112.529 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 6.3 mmtp -65.12 -59.14 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.125 0.488 . . . . 64.33 110.031 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -28.77 63.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 65.03 110.139 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.1 t -78.88 -43.68 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.575 -0.739 . . . . 72.2 111.638 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -50.07 -37.21 32.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.448 . . . . 75.42 109.789 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -76.28 -30.75 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 51.35 109.896 178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.09 99.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.784 -0.644 . . . . 51.42 110.493 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 t -84.97 -35.78 21.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 74.41 110.47 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -56.5 -34.06 66.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.14 110.423 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -69.18 -31.57 70.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 64.23 110.757 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -106.11 12.8 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 54.42 111.636 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.686 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 4.8 tt -57.42 -42.56 96.5 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.18 -0.608 . . . . 71.5 109.697 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.1 Cg_exo -65.58 -23.98 56.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.832 2.354 . . . . 72.11 109.875 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.0 t -94.93 -15.65 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.71 -1.132 . . . . 51.01 111.21 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' N ' ' O ' ' A' ' 49' ' ' ALA . 77.7 t -100.14 -28.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.998 -0.742 . . . . 71.42 108.998 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.627 ' O ' ' N ' ' A' ' 58' ' ' ALA . 16.8 m -82.36 -42.05 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.994 -1.003 . . . . 75.43 110.475 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.9 -29.59 2.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.652 -0.785 . . . . 75.05 111.956 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.67 -39.95 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.093 0.473 . . . . 74.15 109.81 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -77.13 -21.59 53.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 71.43 109.514 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.26 -28.41 25.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.817 -0.629 . . . . 62.34 110.313 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' CG2' ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -89.86 -45.12 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.965 -0.561 . . . . 73.02 110.444 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.4 -2.88 82.21 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.679 -0.772 . . . . 36.85 111.229 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.238 -0.887 . . . . 65.12 110.966 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.475 -0.25 . . . . 73.31 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.28 -21.99 59.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 54.02 112.672 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -48.02 -61.28 2.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.956 0.408 . . . . 63.05 110.721 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -60.41 -23.69 64.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.84 -0.618 . . . . 72.54 110.291 179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.2 -42.32 80.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.944 -0.571 . . . . 70.54 110.74 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -78.31 -41.64 33.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 74.21 110.84 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.61 -22.98 66.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 64.01 112.643 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -94.1 -28.97 15.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 51.42 111.028 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -64.44 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.254 0.55 . . . . 64.25 110.907 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 -40.81 54.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 75.02 110.961 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.55 -37.85 73.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 70.25 110.917 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.91 91.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 38.35 112.448 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 41' ' ' ARG . . . -74.39 -41.12 61.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 75.14 110.937 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.67 69.61 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.067 -0.587 . . . . 72.35 112.531 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.2 -58.13 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.933 0.396 . . . . 73.34 110.549 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.49 -19.88 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 73.4 110.15 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.422 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 42.8 t -83.17 -48.14 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.848 -0.615 . . . . 71.32 110.714 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.44 -39.88 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 74.25 109.765 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -76.23 -28.97 57.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.726 -0.67 . . . . 74.1 109.558 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.3 -46.0 85.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.584 -0.734 . . . . 65.31 110.32 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -79.24 -35.07 42.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.84 -0.618 . . . . 73.54 110.072 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.645 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.29 -21.81 50.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 54.04 110.394 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.83 66.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.717 -0.475 . . . . 64.45 109.717 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -112.72 18.11 18.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.897 -0.592 . . . . 52.13 110.602 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.814 ' HG ' ' HD3' ' A' ' 51' ' ' PRO . 4.2 pp -62.82 -36.27 24.64 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.788 -0.765 . . . . 70.2 110.444 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 49.7 Cg_endo -77.96 -12.18 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.772 2.314 . . . . 53.14 109.929 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.47 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 65.0 t -105.86 -10.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.856 -1.065 . . . . 71.33 110.366 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' N ' ' O ' ' A' ' 49' ' ' ALA . 78.4 t -105.75 -31.14 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.676 -0.861 . . . . 65.23 108.676 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.637 ' O ' ' N ' ' A' ' 58' ' ' ALA . 20.5 m -82.38 -39.92 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.41 -0.814 . . . . 74.1 110.393 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -46.18 -29.28 3.48 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.602 -0.809 . . . . 70.04 112.05 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.47 -37.73 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 74.5 109.724 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -78.01 -21.71 50.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 65.33 109.545 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.84 -27.15 25.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.887 -0.597 . . . . 45.14 110.367 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.452 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -91.15 -45.08 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.879 -0.601 . . . . 72.31 110.473 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.43 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -89.14 -1.42 79.17 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.773 . . . . 65.43 111.302 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.3 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 71.04 110.85 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.386 -0.286 . . . . 54.11 112.386 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -78.8 -22.86 65.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 72.51 112.6 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.437 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.25 -62.12 1.57 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.171 0.51 . . . . 72.24 111.008 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.437 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.4 ptmt -65.34 -23.89 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.471 -0.786 . . . . 74.41 110.038 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.32 -36.03 71.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 75.33 110.741 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -82.04 -42.59 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 70.14 110.873 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -22.02 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.13 112.799 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -97.07 -23.85 16.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.642 0.258 . . . . 54.25 111.24 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -67.32 -60.82 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 74.45 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -45.91 91.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 72.02 110.935 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.31 -40.44 71.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 73.13 111.125 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.97 -41.26 59.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.747 -0.739 . . . . 53.22 112.592 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -67.94 -47.14 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.13 110.814 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.82 69.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.927 -0.654 . . . . 45.13 112.596 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -63.02 -36.47 83.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.667 0.27 . . . . 72.31 110.426 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.224 0.535 . . . . 74.11 110.28 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.3 t -57.0 -24.05 19.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.346 -0.843 . . . . 45.25 111.858 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.42 -27.24 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.483 -0.326 . . . . 73.52 110.81 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -81.0 -36.83 30.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 72.13 109.941 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 71.12 109.928 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -85.29 -36.94 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 62.31 110.349 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.23 -36.48 73.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 62.04 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -67.02 -31.81 72.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 71.52 110.949 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -102.03 11.56 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.01 111.819 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.663 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 5.9 tt -55.01 -43.62 99.16 Favored Pre-proline 0 C--O 1.224 -0.268 0 C-N-CA 120.263 -0.575 . . . . 71.01 110.064 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.2 Cg_exo -66.25 -21.52 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.885 2.39 . . . . 61.31 110.107 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 69.0 t -97.92 -17.24 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.944 -1.025 . . . . 70.43 111.289 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 49' ' ' ALA . 2.1 p -98.85 -27.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.003 -0.74 . . . . 75.54 109.003 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.632 ' O ' ' N ' ' A' ' 58' ' ' ALA . 15.9 m -82.21 -42.4 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.14 -0.936 . . . . 61.33 110.583 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -44.87 -29.63 2.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.658 -0.782 . . . . 74.15 111.961 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.82 -40.84 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.707 -0.479 . . . . 73.32 109.707 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 -21.56 57.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 75.23 109.425 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.87 -26.86 25.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.871 -0.604 . . . . 64.02 110.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.456 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -92.7 -44.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.954 -0.566 . . . . 72.14 110.484 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -89.93 0.01 78.64 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.217 -0.753 . . . . 41.44 111.217 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.207 -0.902 . . . . 71.15 110.83 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.394 -0.282 . . . . 52.03 112.394 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.408 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -67.5 -29.12 73.76 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.682 -0.771 . . . . 63.31 112.417 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HG ' ' H ' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -47.95 -62.21 1.58 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.224 0.535 . . . . 62.54 110.799 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 1.2 mttt -64.61 -23.89 67.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.358 -0.837 . . . . 73.14 109.792 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.408 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.97 -41.9 77.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.806 -0.634 . . . . 74.22 110.581 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 tp -82.06 -36.52 27.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.498 . . . . 55.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -21.95 72.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.712 . . . . 64.54 112.654 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -101.42 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 75.52 111.173 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -64.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.966 0.412 . . . . 65.44 110.88 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -44.1 75.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 71.25 111.067 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -39.24 76.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.021 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.22 93.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.753 . . . . 65.33 112.333 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.94 -50.73 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 72.42 110.592 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 43' ' ' PHE . . . -52.37 -31.42 35.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.955 -0.641 . . . . 37.78 112.519 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 8.3 tttm -66.69 -35.85 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.184 0.516 . . . . 63.3 110.21 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -24.25 37.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 73.33 109.74 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.8 t -85.28 -40.36 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 74.24 111.397 -179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -51.12 -33.16 25.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.062 0.458 . . . . 74.43 109.788 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -79.63 -30.32 41.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 75.32 109.762 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.84 -44.74 84.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.774 -0.648 . . . . 54.14 110.167 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -77.56 -34.67 53.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 61.4 109.914 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.614 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.74 -21.72 61.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 73.51 110.436 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -73.14 -32.15 64.72 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.735 -0.468 . . . . 73.23 109.735 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.567 ' C ' ' HD2' ' A' ' 51' ' ' PRO . . . -111.29 18.33 19.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.753 -0.658 . . . . 74.34 110.559 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.78 ' HG ' ' HD3' ' A' ' 51' ' ' PRO . 4.3 pp -62.92 -36.38 24.99 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.948 -0.701 . . . . 54.53 110.352 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.78 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 46.5 Cg_endo -77.52 -12.31 16.92 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.745 2.296 . . . . 73.44 110.033 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.467 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 70.0 t -104.85 -12.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.718 -1.128 . . . . 75.05 110.225 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 49' ' ' ALA . 85.9 t -104.2 -31.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.631 -0.877 . . . . 72.24 108.631 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.623 ' O ' ' N ' ' A' ' 58' ' ' ALA . 20.3 m -82.32 -39.74 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.379 -0.828 . . . . 64.53 110.398 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' O ' ' CG2' ' A' ' 59' ' ' ILE . . . -45.83 -29.53 3.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.55 -0.834 . . . . 71.24 112.053 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -84.05 -39.74 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.114 0.483 . . . . 73.2 109.839 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -21.84 54.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 63.12 109.422 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.22 -28.13 25.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.78 -0.645 . . . . 72.01 110.363 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.453 ' CG1' ' HA ' ' A' ' 56' ' ' ILE . 2.7 pp -90.53 -45.12 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 115.967 -0.56 . . . . 73.23 110.396 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.435 ' N ' ' CD1' ' A' ' 59' ' ' ILE . . . -87.51 -2.53 82.24 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.233 -0.747 . . . . 73.24 111.233 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.265 -0.874 . . . . 65.32 110.867 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.397 -0.281 . . . . 74.150000000000006 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 -21.93 50.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.409999999999997 112.599 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -47.67 -61.5 1.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.019 0.438 . . . . 63.520000000000003 110.748 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' HD13 ' A' ' 28' ' ' LEU . 8.0 tttp -61.21 -23.67 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.64 . . . . 71.5 110.42 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -68.86 -40.63 79.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 61.039999999999999 110.866 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -79.62 -39.91 30.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 62.240000000000002 111.015 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.35 -22.01 76.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.808 -0.71 . . . . 75.209999999999994 112.756 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -96.02 -26.8 15.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.202 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.16 -63.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 74.549999999999997 111.023 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -41.03 78.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 71.120000000000005 111.099 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -37.98 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.21 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.23 -38.02 66.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 75.510000000000005 112.769 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.88 -49.33 47.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 52.420000000000002 111.073 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.22 -21.88 27.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.651 -0.785 . . . . 55.43 112.911 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.633 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.69 -39.33 24.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.772 0.286 . . . . 75.209999999999994 111.116 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.67 -37.17 27.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.173 0.511 . . . . 65.049999999999997 110.625 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 38' ' ' ALA . 31.7 t -72.56 -22.67 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.604 -0.725 . . . . 71.420000000000002 111.839 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.87 -26.8 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 74.519999999999996 110.76 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.504 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.3 mttp -76.36 -34.29 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.101 0.477 . . . . 62.030000000000001 109.819 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -72.03 -35.12 69.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.604 -0.725 . . . . 65.040000000000006 110.405 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -50.86 6.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.616 . . . . 74.519999999999996 111.265 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 pp20? -50.56 -34.55 26.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.827 0.346 . . . . 53.329999999999998 111.049 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.78 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 111.011 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.1 11.81 38.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.358 . . . . 64.329999999999998 111.926 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.52 -43.35 99.1 Favored Pre-proline 0 C--O 1.223 -0.339 0 C-N-CA 120.213 -0.595 . . . . 64.109999999999999 110.052 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.8 Cg_exo -66.11 -22.73 54.08 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.866 2.377 . . . . 70.099999999999994 110.007 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 77.2 t -96.27 -16.97 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.814 -1.085 . . . . 74.540000000000006 111.266 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.34 -27.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.898 -0.778 . . . . 74.209999999999994 108.898 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.3 m -82.23 -42.43 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.047 -0.978 . . . . 62.520000000000003 110.548 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.55 2.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.627 -0.797 . . . . 72.319999999999993 112.032 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.93 -39.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 74.109999999999999 109.789 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -76.93 -22.01 53.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 72.430000000000007 109.475 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.31 -27.55 25.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.807 -0.633 . . . . 45.229999999999997 110.407 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.5 -45.28 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.975 -0.557 . . . . 61.43 110.392 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.748 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.66 -2.82 81.48 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.637 -0.792 . . . . 61.530000000000001 111.198 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 63.439999999999998 110.929 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.472 -0.251 . . . . 45.030000000000001 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.55 -21.97 77.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.52 -61.38 1.95 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.032 0.444 . . . . 74.329999999999998 110.748 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -60.5 -23.77 64.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 73.129999999999995 110.309 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -68.22 -42.84 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 75.340000000000003 110.744 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.02 -34.6 29.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 110.913 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.62 -21.93 71.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 33.140000000000001 112.89 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -105.45 -24.43 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 72.349999999999994 111.404 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.6 -60.62 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 75.340000000000003 110.919 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.514 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.1 tm? -62.76 -52.83 61.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.009 -0.541 . . . . 74.329999999999998 110.983 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -34.14 46.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 74.349999999999994 111.254 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.23 -36.49 68.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.673 -0.775 . . . . 42.240000000000002 112.424 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.66 -45.3 59.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 51.119999999999997 110.858 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -21.93 30.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 33.439999999999998 112.762 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 4.1 mttt -79.26 -40.57 30.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.66 0.23 . . . . 63.130000000000003 111.058 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.69 -39.28 24.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 70.150000000000006 110.732 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' ALA . 38.7 t -70.0 -22.34 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 74.019999999999996 111.696 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.91 -27.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.598 -0.274 . . . . 70.420000000000002 110.979 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -75.42 -34.75 61.05 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.174 0.511 . . . . 64.0 109.983 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -73.01 -34.39 66.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 75.209999999999994 110.416 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.1 p -85.19 -49.58 8.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 111.181 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -51.15 -34.75 32.54 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.942 0.401 . . . . 71.310000000000002 111.12 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -38.27 83.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.071 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -96.67 13.16 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 54.219999999999999 111.808 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 tt -56.15 -43.35 99.22 Favored Pre-proline 0 C--O 1.223 -0.333 0 C-N-CA 120.158 -0.617 . . . . 74.239999999999995 110.102 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.7 Cg_exo -66.53 -21.83 52.33 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.908 2.406 . . . . 72.230000000000004 110.125 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.875 ' O ' HD11 ' A' ' 56' ' ' ILE . 68.3 t -97.42 -17.08 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.861 -1.063 . . . . 71.25 111.211 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.18 -27.79 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.969 -0.752 . . . . 73.450000000000003 108.969 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.3 -42.34 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-N 115.099 -0.955 . . . . 75.019999999999996 110.588 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.68 2.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.056 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.7 -40.36 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.171 0.51 . . . . 65.420000000000002 109.841 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -21.8 56.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 109.479 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.56 -26.91 25.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 110.384 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.3 -44.75 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.034 -0.53 . . . . 74.549999999999997 110.389 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -88.55 -1.45 80.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.655 -0.783 . . . . 72.430000000000007 111.277 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 63.530000000000001 110.869 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 45.030000000000001 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -21.91 78.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 63.530000000000001 112.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -47.51 -61.07 2.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.894 0.378 . . . . 75.430000000000007 110.821 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -61.1 -23.83 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.085 -0.507 . . . . 62.100000000000001 110.4 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.99 -42.71 80.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 73.450000000000003 110.714 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.639 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -82.09 -39.95 22.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 72.319999999999993 110.811 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.61 -22.48 61.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.778 -0.725 . . . . 75.450000000000003 112.731 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -101.56 -36.7 8.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.772 0.32 . . . . 75.540000000000006 110.935 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -64.38 -57.83 8.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 110.729 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -44.13 94.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 63.409999999999997 110.875 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.69 -44.92 81.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.074 -0.512 . . . . 74.530000000000001 111.04 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.93 -47.07 89.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 35.409999999999997 112.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.3 -45.34 48.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 33.340000000000003 110.908 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.24 -23.35 47.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.968 -0.634 . . . . 65.150000000000006 112.356 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 1.9 mmtt -64.89 -57.88 7.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 41.5 110.332 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.632 ' HD2' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.8 -20.08 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 110.043 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' HD2' ' A' ' 41' ' ' ARG . 95.1 t -81.13 -48.87 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 116.054 -0.521 . . . . 65.129999999999995 110.463 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.79 -46.2 41.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 71.209999999999994 109.606 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -70.42 -30.55 67.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 109.612 178.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -59.34 -45.06 92.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.896 -0.593 . . . . 64.400000000000006 110.377 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -85.11 -35.08 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.524 . . . . 61.340000000000003 110.549 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.75 -31.23 64.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 75.319999999999993 110.59 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -71.74 -31.28 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.528 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.94 13.36 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.513 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.902 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -56.03 -42.95 98.8 Favored Pre-proline 0 C--O 1.223 -0.321 0 C-N-CA 120.173 -0.611 . . . . 72.340000000000003 109.934 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -24.78 55.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.88 2.387 . . . . 74.209999999999994 109.848 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.926 ' O ' HD11 ' A' ' 56' ' ' ILE . 47.3 t -96.63 -9.8 9.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.828 -1.078 . . . . 75.049999999999997 111.169 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 62.0 t -105.42 -28.13 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.717 -0.846 . . . . 73.230000000000004 108.717 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 50' ' ' LEU . 19.2 m -82.39 -42.05 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.079 -0.964 . . . . 64.25 110.456 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.21 -28.76 3.28 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.531 -0.842 . . . . 53.350000000000001 112.097 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.41 -35.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.568 -0.53 . . . . 52.329999999999998 109.568 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.84 -21.82 47.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.61 -0.723 . . . . 75.510000000000005 109.498 178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.5 -21.45 25.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.937 -0.574 . . . . 54.219999999999999 110.858 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.49 -44.04 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 75.420000000000002 111.991 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -126.42 2.55 7.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.89 -0.671 . . . . 63.310000000000002 111.803 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 2.8 tttm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 51.520000000000003 111.045 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.493 -0.243 . . . . 45.030000000000001 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.95 78.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 62.32 112.658 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -47.0 -61.18 1.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.977 0.418 . . . . 45.310000000000002 110.826 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -23.82 66.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 64.450000000000003 110.387 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -69.12 -43.86 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.581 . . . . 72.299999999999997 110.703 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.7 tp -82.07 -39.1 23.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.209999999999994 110.861 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.3 66.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 75.140000000000001 112.655 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -26.08 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.701 0.286 . . . . 75.040000000000006 111.0 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -67.36 -64.5 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.258 0.552 . . . . 73.299999999999997 110.523 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 36' ' ' GLU . 3.9 pp -53.98 -47.76 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.85 . . . . 63.329999999999998 110.833 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -51.73 -37.74 52.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.41 -0.814 . . . . 63.119999999999997 111.049 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.41 -44.53 64.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 60.32 112.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -73.87 -34.55 64.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 73.230000000000004 110.907 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.04 -21.82 66.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.992 -0.623 . . . . 41.539999999999999 112.529 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.4 tttt -65.02 -58.22 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.955 0.407 . . . . 74.310000000000002 110.521 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -63.14 -19.87 64.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.973 0.416 . . . . 75.340000000000003 110.245 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 38' ' ' ALA . 40.3 t -84.32 -44.48 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.937 -0.574 . . . . 73.409999999999997 111.05 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.15 -39.65 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 109.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 3.2 mttm -75.1 -30.93 61.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 63.25 109.777 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.59 -41.63 99.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.751 -0.659 . . . . 74.120000000000005 110.565 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 t -85.08 -35.69 21.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.921 -0.581 . . . . 71.239999999999995 110.542 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.85 -34.0 67.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 54.310000000000002 110.499 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -69.27 -32.55 71.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 64.129999999999995 110.731 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.6 11.24 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.565 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.0 -43.58 99.12 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 120.243 -0.583 . . . . 72.129999999999995 110.106 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.5 Cg_exo -66.02 -22.06 55.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.857 2.371 . . . . 72.140000000000001 110.003 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.88 ' O ' HD11 ' A' ' 56' ' ' ILE . 75.0 t -97.31 -16.9 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.902 -1.044 . . . . 61.5 111.322 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -99.43 -27.61 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.985 -0.746 . . . . 73.340000000000003 108.985 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.6 m -82.23 -42.33 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 115.071 -0.968 . . . . 62.100000000000001 110.445 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.13 -29.65 2.36 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 74.329999999999998 112.003 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.88 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.73 -38.47 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.164 0.506 . . . . 74.239999999999995 109.654 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 4.5 mtmt -76.31 -21.7 55.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 70.109999999999999 109.458 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.6 -21.49 25.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.94 -0.573 . . . . 74.340000000000003 110.939 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -99.73 -43.61 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 73.209999999999994 111.905 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.732 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -125.03 1.46 8.4 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.586 -0.734 . . . . 73.219999999999999 111.828 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.197 -0.906 . . . . 62.130000000000003 110.945 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.494 -0.242 . . . . 54.329999999999998 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -83.03 -26.55 44.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 75.239999999999995 112.585 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -48.15 -62.2 1.6 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.225 0.536 . . . . 75.239999999999995 110.924 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -64.45 -23.95 67.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.382 -0.827 . . . . 75.040000000000006 109.885 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.74 -35.81 77.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.886 -0.597 . . . . 72.310000000000002 110.639 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.95 -35.73 28.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 72.409999999999997 110.911 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -57.5 7.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 42.399999999999999 112.612 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.98 -26.49 62.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.689 0.281 . . . . 63.130000000000003 111.016 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.95 -56.41 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.964 0.411 . . . . 65.219999999999999 110.644 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -51.99 15.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.951 -0.568 . . . . 62.409999999999997 110.752 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -32.5 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 72.299999999999997 110.977 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.16 -38.15 88.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.776 . . . . 63.310000000000002 112.456 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.26 -41.75 73.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 73.329999999999998 110.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.33 -21.84 35.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 71.099999999999994 112.574 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -81.07 -40.72 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 0.175 . . . . 72.099999999999994 110.977 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.33 -40.63 23.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 110.671 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.7 t -65.76 -22.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.677 -0.692 . . . . 70.129999999999995 111.415 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.83 -28.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 53.439999999999998 110.833 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -72.21 -43.4 64.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.659 0.742 . . . . 65.219999999999999 109.75 179.008 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 44' ' ' LYS . . . -66.69 -34.61 78.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.58 -1.191 . . . . 53.119999999999997 110.588 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 p -85.16 -45.92 11.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.544 . . . . 65.209999999999994 111.031 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.861 ' HA ' HD23 ' A' ' 50' ' ' LEU . 2.6 pp20? -58.63 -20.4 47.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 54.420000000000002 110.873 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -33.11 64.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.742 -0.466 . . . . 64.430000000000007 109.742 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -110.24 18.43 19.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.721 -0.672 . . . . 51.530000000000001 110.515 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.861 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.52 -36.37 26.67 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 119.917 -0.713 . . . . 72.420000000000002 110.44 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.805 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 50.1 Cg_endo -77.82 -11.36 16.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.794 2.329 . . . . 44.420000000000002 110.052 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.901 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -107.46 -10.77 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.697 -1.138 . . . . 75.430000000000007 110.333 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 49' ' ' ALA . 83.0 t -105.05 -30.77 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.682 -0.858 . . . . 71.209999999999994 108.682 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.35 -40.22 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.422 -0.808 . . . . 63.299999999999997 110.404 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.709 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.98 -29.37 3.29 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.533 -0.842 . . . . 74.25 112.072 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.901 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -85.12 -38.17 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.687 -0.486 . . . . 65.230000000000004 109.687 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -77.69 -21.79 51.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.717 -0.674 . . . . 62.299999999999997 109.483 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.77 -26.94 25.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.898 -0.592 . . . . 51.539999999999999 110.383 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.52 -45.01 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.936 -0.575 . . . . 64.200000000000003 110.498 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.0 -1.45 79.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 74.430000000000007 111.317 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.5 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.245 -0.883 . . . . 72.219999999999999 110.89 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.505 -0.238 . . . . 64.430000000000007 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.52 -25.24 65.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.571 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.68 -62.15 1.59 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.187 0.518 . . . . 62.219999999999999 111.018 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 20.6 pttt -63.72 -23.94 67.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 64.420000000000002 109.868 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -40.37 82.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 72.439999999999998 110.648 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.11 -35.74 28.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 110.898 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.2 -21.94 72.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 72.319999999999993 112.801 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -29.63 12.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 74.439999999999998 111.026 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -64.29 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 75.209999999999994 110.82 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -41.24 67.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.876 -0.602 . . . . 64.530000000000001 111.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -44.41 83.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 75.25 111.017 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.16 -47.02 76.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 73.200000000000003 112.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.878 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.9 -47.07 61.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 73.099999999999994 110.716 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.22 -28.53 26.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.933 -0.576 . . . . 63.130000000000003 112.389 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 5.2 mmtm -64.99 -59.62 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 75.430000000000007 109.991 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -23.32 52.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.089 -0.505 . . . . 74.420000000000002 110.252 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.8 t -85.63 -40.28 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 72.129999999999995 111.754 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.65 -39.0 34.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.761 -0.459 . . . . 71.200000000000003 109.761 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 mttm -72.74 -31.81 65.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 75.120000000000005 110.001 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.015 -0.539 . . . . 33.399999999999999 110.395 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 t -85.19 -31.76 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 110.608 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 7.7 tp10 -60.94 -36.46 79.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 65.310000000000002 110.636 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -75.43 -29.45 59.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 110.744 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.33 12.53 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 71.040000000000006 111.592 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.904 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.84 -43.42 99.19 Favored Pre-proline 0 C--O 1.223 -0.3 0 C-N-CA 120.308 -0.557 . . . . 72.140000000000001 110.032 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.2 Cg_exo -66.03 -20.39 57.21 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.818 2.345 . . . . 75.109999999999999 110.001 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.84 ' O ' HD11 ' A' ' 56' ' ' ILE . 66.0 t -98.55 -19.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.843 -1.071 . . . . 71.150000000000006 111.217 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -97.27 -27.58 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.066 -0.716 . . . . 42.229999999999997 109.066 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.26 -42.26 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.076 -0.966 . . . . 72.219999999999999 110.587 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.89 -29.72 2.15 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.696 -0.764 . . . . 72.140000000000001 111.992 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -82.68 -41.63 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.733 -0.469 . . . . 71.239999999999995 109.733 178.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -22.38 57.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 75.109999999999999 109.39 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.68 -26.72 27.56 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.746 -0.661 . . . . 62.229999999999997 110.396 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -93.27 -44.4 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.965 -0.561 . . . . 75.400000000000006 110.372 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.731 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -85.88 -3.02 86.0 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.696 -0.764 . . . . 64.0 111.246 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.192 -0.909 . . . . 74.239999999999995 110.924 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.521 -0.232 . . . . 64.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.1 -22.57 77.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 24.420000000000002 112.579 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.98 -62.22 1.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.202 0.525 . . . . 74.329999999999998 110.985 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -63.72 -23.81 67.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 74.549999999999997 109.961 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -70.79 -44.77 65.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.824 -0.625 . . . . 74.120000000000005 110.647 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -82.1 -37.78 25.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.816 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -22.03 57.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.825 -0.702 . . . . 73.120000000000005 112.696 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -94.38 -31.41 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 73.239999999999995 110.998 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -62.56 -57.79 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 63.210000000000001 110.551 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 -52.95 63.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 61.140000000000001 110.722 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.28 -40.98 62.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 65.0 110.964 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.49 88.41 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 70.129999999999995 112.286 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.915 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.39 -53.29 14.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 64.519999999999996 110.708 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.26 -29.4 22.19 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.091 -0.576 . . . . 61.149999999999999 112.461 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 mttt -65.14 -59.31 4.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.101 0.477 . . . . 62.32 110.025 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -29.92 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 64.209999999999994 109.911 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.4 t -75.99 -47.55 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.534 -0.757 . . . . 72.230000000000004 111.24 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.52 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.46 -40.42 50.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.721 -0.474 . . . . 74.239999999999995 109.721 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 14.1 mttt -75.25 -30.0 60.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 61.229999999999997 109.655 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.61 -42.55 99.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.801 -0.636 . . . . 74.010000000000005 110.556 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 t -85.12 -37.65 20.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.022 -0.535 . . . . 72.099999999999994 110.748 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.18 -33.5 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.57 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -70.16 -33.15 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 73.219999999999999 110.664 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.71 11.18 34.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 111.493 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.6 tt -55.23 -43.32 99.03 Favored Pre-proline 0 C--O 1.223 -0.32 0 C-N-CA 120.188 -0.605 . . . . 54.25 110.02 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.9 Cg_exo -66.44 -22.19 52.45 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.875 2.384 . . . . 60.439999999999998 110.045 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.896 ' O ' HD11 ' A' ' 56' ' ' ILE . 71.5 t -97.51 -14.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.93 -1.032 . . . . 63.539999999999999 111.374 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.731 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -101.54 -27.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.804 -0.814 . . . . 72.400000000000006 108.804 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.1 m -82.27 -41.97 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.076 -0.965 . . . . 55.25 110.41 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.69 -29.25 2.89 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.604 -0.808 . . . . 52.329999999999998 112.032 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -86.88 -35.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.605 -0.517 . . . . 74.319999999999993 109.605 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.43 -21.75 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.545 -0.752 . . . . 64.109999999999999 109.661 178.447 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.71 -21.45 25.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.878 -0.601 . . . . 73.219999999999999 110.96 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.745 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.04 -44.09 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 65.239999999999995 111.981 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.3 -0.12 8.78 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.768 -0.729 . . . . 65.439999999999998 111.762 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 12.8 tttm . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.204 -0.903 . . . . 64.040000000000006 111.35 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.521 -0.232 . . . . 51.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -69.56 -21.99 76.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.739 . . . . 75.150000000000006 112.584 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.62 -61.2 2.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.953 0.406 . . . . 62.520000000000003 110.118 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -63.16 -23.44 67.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 55.130000000000003 109.685 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -67.78 -44.25 77.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.879 -0.6 . . . . 62.439999999999998 110.79 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.79 -46.07 69.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.539999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.95 -36.94 93.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.738 -0.744 . . . . 44.25 112.465 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -70.45 -29.17 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 64.439999999999998 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -63.49 -57.07 11.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 55.140000000000001 110.827 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -67.65 -42.64 81.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 110.916 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -53.61 -40.24 65.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.120000000000005 111.071 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.64 -41.43 82.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 70.109999999999999 112.651 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.68 -43.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 74.120000000000005 110.941 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.09 34.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 40.329999999999998 112.706 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.09 -40.58 23.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.664 0.232 . . . . 72.400000000000006 110.967 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.66 -37.16 27.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.038 0.447 . . . . 71.120000000000005 110.663 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.8 t -71.88 -22.69 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 64.409999999999997 111.717 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -47.92 -27.64 2.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.517 -0.31 . . . . 72.109999999999999 110.838 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 5.6 mtpt -77.03 -33.74 57.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.171 0.51 . . . . 74.340000000000003 109.806 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -76.6 -32.69 58.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.476 -0.784 . . . . 54.520000000000003 110.302 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 p -85.22 -45.75 11.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 71.140000000000001 111.046 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -53.61 -35.55 61.01 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.998 0.428 . . . . 75.409999999999997 110.916 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -37.2 85.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 75.299999999999997 110.974 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.807 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -97.84 13.86 29.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 70.209999999999994 111.851 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.918 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.4 tt -56.96 -42.64 97.41 Favored Pre-proline 0 C--O 1.223 -0.317 0 C-N-CA 120.148 -0.621 . . . . 72.340000000000003 109.99 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.7 Cg_exo -66.27 -23.81 51.59 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.87 2.38 . . . . 74.540000000000006 109.915 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.937 ' O ' HD11 ' A' ' 56' ' ' ILE . 50.9 t -96.8 -10.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.878 -1.056 . . . . 73.310000000000002 111.215 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 t -104.58 -28.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.783 -0.821 . . . . 72.519999999999996 108.783 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.918 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.3 m -82.44 -41.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.932 -1.031 . . . . 75.109999999999999 110.517 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.61 -28.45 3.57 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.596 -0.812 . . . . 73.109999999999999 112.157 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.937 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.0 -33.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 64.340000000000003 109.798 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -82.19 -22.18 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 45.450000000000003 109.495 178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.69 -21.51 25.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.948 -0.569 . . . . 44.149999999999999 111.2 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.25 -47.3 14.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 62.100000000000001 112.073 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.747 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -130.36 4.5 5.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.69 -0.686 . . . . 34.109999999999999 111.433 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 1.3 tttp . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.236 -0.887 . . . . 74.140000000000001 111.146 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.465 -0.254 . . . . 71.230000000000004 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 -21.75 52.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 63.420000000000002 112.717 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HA ' HD23 ' A' ' 31' ' ' LEU . 2.3 tm? -46.02 -61.35 1.79 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.84 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 28' ' ' LEU . 1.1 pttt -57.94 -23.8 55.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.58 . . . . 54.409999999999997 110.235 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 -35.35 65.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.923 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -81.99 -31.26 31.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 73.0 110.952 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.2 -21.99 78.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 64.109999999999999 112.812 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -29.98 13.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 72.099999999999994 110.959 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -65.77 -57.79 7.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 75.129999999999995 111.012 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -48.52 81.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.134 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -37.96 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 63.43 111.082 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.9 -39.78 63.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.778 -0.725 . . . . 52.340000000000003 112.584 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.9 -48.77 65.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 62.450000000000003 110.837 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.92 -36.48 60.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.904 -0.665 . . . . 44.229999999999997 112.667 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 8.1 mttt -62.34 -36.87 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.688 0.28 . . . . 64.030000000000001 110.323 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.28 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.195 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.1 t -55.89 -23.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 52.229999999999997 111.839 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.621 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.68 -28.19 5.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.449 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -77.65 -34.24 53.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 71.430000000000007 109.729 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -75.52 -32.86 60.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.528 -0.76 . . . . 72.25 110.252 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.15 -47.16 10.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 74.510000000000005 111.154 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -53.51 -37.39 62.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.926 0.393 . . . . 75.349999999999994 111.009 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -68.27 -33.48 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 61.409999999999997 111.094 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.72 13.11 34.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 74.340000000000003 111.872 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.29 -42.62 96.98 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.016 -0.674 . . . . 53.32 109.734 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.9 Cg_exo -65.35 -25.43 56.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.774 2.316 . . . . 74.219999999999999 109.842 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.904 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -94.17 -12.67 8.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.751 -1.113 . . . . 60.509999999999998 111.243 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 67.1 t -102.9 -28.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.793 -0.818 . . . . 64.319999999999993 108.793 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.36 -41.85 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.04 -0.982 . . . . 72.430000000000007 110.419 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.66 -29.11 2.79 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.515 -0.85 . . . . 42.409999999999997 112.113 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.904 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.93 -37.12 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.158 0.504 . . . . 75.439999999999998 109.697 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 5.0 mtmt -78.37 -21.47 49.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.664 -0.698 . . . . 74.310000000000002 109.456 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.57 -21.55 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.883 -0.598 . . . . 73.310000000000002 110.982 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.13 -43.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 74.030000000000001 111.933 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.08 -0.38 8.92 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.757 -0.735 . . . . 71.420000000000002 111.755 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.18 -0.914 . . . . 71.140000000000001 111.314 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.541 -0.223 . . . . 50.210000000000001 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.88 -21.89 78.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 54.310000000000002 112.661 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -46.54 -61.41 1.83 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.009 0.433 . . . . 72.340000000000003 110.93 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 26.1 mmtt -61.02 -23.85 65.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 74.319999999999993 110.356 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -69.65 -37.44 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 73.340000000000003 110.87 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -81.88 -43.59 17.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 42.200000000000003 111.079 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.8 52.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.678 -0.772 . . . . 75.120000000000005 112.617 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -30.49 66.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 110.956 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -63.11 -57.0 12.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.742 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.65 -55.54 16.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.525 . . . . 72.5 110.834 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -37.03 52.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.197 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.06 80.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 52.240000000000002 112.586 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -80.59 -37.64 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.917 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.73 -27.28 69.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 54.43 113.122 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.639 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 17.8 pttt -63.39 -38.63 91.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.149 0.474 . . . . 62.130000000000003 110.957 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -32.07 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 42.329999999999998 110.453 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.4 t -80.85 -22.93 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.528 -0.76 . . . . 63.420000000000002 112.212 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.62 -26.89 3.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.759 0.314 . . . . 65.420000000000002 110.803 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.5 tttt -77.66 -31.61 52.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.183 0.516 . . . . 75.530000000000001 109.671 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -77.87 -33.55 52.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.386 -0.825 . . . . 43.340000000000003 110.305 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -45.3 12.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.779 -0.646 . . . . 64.340000000000003 111.026 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -52.43 -36.87 55.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 110.789 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -64.17 -33.16 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.439999999999998 110.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.51 12.89 36.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 111.671 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.2 tt -55.87 -43.11 99.05 Favored Pre-proline 0 C--O 1.223 -0.331 0 C-N-CA 120.155 -0.618 . . . . 54.340000000000003 109.949 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 7.0 Cg_exo -65.27 -24.4 58.24 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.89 2.393 . . . . 74.209999999999994 109.945 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.885 ' O ' HD11 ' A' ' 56' ' ' ILE . 54.6 t -95.39 -15.14 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.765 -1.107 . . . . 64.510000000000005 111.216 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 61.1 t -100.08 -28.8 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 54.310000000000002 108.94 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.4 m -82.27 -42.29 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 114.995 -1.002 . . . . 44.509999999999998 110.589 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.98 -29.53 2.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.601 -0.809 . . . . 65.230000000000004 111.976 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.885 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.59 -40.72 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 73.25 109.758 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -21.75 56.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.654 . . . . 74.239999999999995 109.432 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.42 -27.21 25.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.742 -0.663 . . . . 44.32 110.411 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.79 -44.81 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.357 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.739 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.7 -2.28 81.99 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.65 -0.786 . . . . 54.310000000000002 111.245 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 74.140000000000001 110.932 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.484 -0.246 . . . . 72.409999999999997 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.82 71.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.694 -0.765 . . . . 74.310000000000002 112.679 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.37 -61.38 1.94 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.022 0.439 . . . . 73.019999999999996 110.799 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.8 tttt -60.62 -23.72 64.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 75.510000000000005 110.332 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -40.66 78.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.932 -0.576 . . . . 65.030000000000001 110.922 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.3 tp -74.39 -40.35 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 74.299999999999997 110.958 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.64 -54.72 24.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 60.109999999999999 112.589 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -26.98 62.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 75.109999999999999 111.113 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.42 -57.83 8.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 73.420000000000002 110.913 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -46.59 72.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 61.549999999999997 111.003 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.13 82.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 111.019 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.53 -47.9 67.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.819 -0.705 . . . . 35.240000000000002 112.549 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.01 -44.62 88.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.392 . . . . 72.430000000000007 110.842 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.9 -37.74 63.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.034 -0.603 . . . . 65.310000000000002 112.58 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mttt -62.13 -36.59 82.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.699 0.285 . . . . 53.119999999999997 110.43 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.53 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.577 . . . . 74.140000000000001 110.286 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 38' ' ' ALA . 17.2 t -55.44 -23.9 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 73.439999999999998 111.834 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.83 -27.96 5.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 64.230000000000004 110.444 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 mtmm -77.86 -33.94 51.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.171 0.51 . . . . 71.319999999999993 109.814 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.84 64.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.609 -0.723 . . . . 73.030000000000001 110.274 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -85.39 -50.33 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.756 -0.656 . . . . 73.299999999999997 111.16 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.7 pp20? -51.15 -34.41 31.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.911 0.386 . . . . 72.329999999999998 111.089 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -36.76 82.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 52.439999999999998 111.087 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.68 14.14 31.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 60.329999999999998 111.916 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -57.88 -42.57 96.02 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.084 -0.646 . . . . 61.119999999999997 109.861 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.6 Cg_exo -66.04 -24.06 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.884 2.389 . . . . 70.010000000000005 109.877 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 64.6 t -95.09 -15.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.766 -1.107 . . . . 62.32 111.161 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.9 t -100.15 -28.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 71.219999999999999 108.874 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.29 -41.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 115.082 -0.963 . . . . 73.400000000000006 110.534 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.96 -29.48 2.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.657 -0.783 . . . . 60.32 112.072 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.33 -40.74 16.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.493 . . . . 51.25 109.808 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -76.48 -21.96 55.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.75 -0.659 . . . . 71.299999999999997 109.465 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.633 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.93 -27.88 26.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.785 -0.643 . . . . 63.100000000000001 110.398 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.745 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.1 -44.99 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.92 -0.582 . . . . 51.32 110.349 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.68 -3.1 84.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.175 -0.77 . . . . 44.329999999999998 111.175 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.292 -0.861 . . . . 75.310000000000002 111.009 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.508 -0.237 . . . . 70.019999999999996 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -66.5 -21.99 71.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.772 . . . . 51.530000000000001 112.642 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -56.69 -61.29 2.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 74.409999999999997 110.105 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -23.46 67.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 72.329999999999998 109.756 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -66.89 -39.81 87.57 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.762 -0.653 . . . . 60.049999999999997 110.921 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 tp -79.2 -38.47 35.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 61.149999999999999 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.34 -22.34 78.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.779 -0.724 . . . . 73.109999999999999 112.643 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.06 -26.31 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 61.149999999999999 111.066 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -66.14 -60.5 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 64.120000000000005 110.783 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.2 tm? -58.5 -51.71 68.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 74.409999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.99 -34.39 59.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.556 . . . . 71.329999999999998 111.04 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.2 -37.2 71.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.771 -0.728 . . . . 72.319999999999993 112.464 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.43 -45.86 57.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.019999999999996 110.864 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.0 -21.78 32.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.829 -0.701 . . . . 72.25 112.747 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -73.12 -42.62 62.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.582 0.191 . . . . 55.5 111.25 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -81.56 -39.3 24.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 74.530000000000001 110.699 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 38' ' ' ALA . 41.6 t -67.94 -22.53 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 72.329999999999998 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.8 -26.95 1.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 111.226 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 1.1 mttt -78.61 -35.25 45.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.026 0.441 . . . . 71.439999999999998 110.111 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -58.9 -40.78 85.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 72.049999999999997 110.293 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -85.14 -33.04 22.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.891 -0.595 . . . . 62.140000000000001 110.211 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -57.19 -39.82 76.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 70.549999999999997 110.431 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -66.75 -29.14 69.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 65.299999999999997 110.999 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.72 11.48 32.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.419 -0.355 . . . . 54.409999999999997 111.833 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.79 -43.1 99.03 Favored Pre-proline 0 C--O 1.223 -0.312 0 C-N-CA 120.164 -0.614 . . . . 71.239999999999995 109.981 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.3 Cg_exo -67.13 -21.87 48.07 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.768 2.312 . . . . 72.409999999999997 110.02 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.942 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.6 t -97.77 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.008 -0.996 . . . . 74.430000000000007 111.415 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -102.25 -27.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 60.530000000000001 108.881 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.5 m -82.5 -42.06 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 114.992 -1.004 . . . . 75.329999999999998 110.637 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.962 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -47.16 -28.34 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.493 -0.861 . . . . 55.210000000000001 112.277 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.942 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -86.53 -29.32 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.483 . . . . 62.340000000000003 109.963 179.116 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 2.1 mtmt -86.45 -24.08 25.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 71.510000000000005 109.524 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.92 -21.21 25.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.581 . . . . 71.140000000000001 112.25 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.962 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.1 pp -62.05 -61.47 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.147 0.499 . . . . 72.209999999999994 112.17 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -135.08 8.25 4.44 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.911 -0.876 . . . . 52.32 110.911 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.5 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 72.019999999999996 111.197 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.529 -0.228 . . . . 52.119999999999997 112.529 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -73.32 -24.27 75.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 52.219999999999999 112.56 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.51 -62.2 1.55 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.278 0.561 . . . . 73.420000000000002 110.841 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -65.35 -23.92 67.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 71.319999999999993 110.008 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -71.02 -34.78 71.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.876 -0.602 . . . . 74.019999999999996 110.701 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.0 tp -81.91 -34.2 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 62.119999999999997 110.837 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.9 -21.97 77.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 73.340000000000003 112.822 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -95.03 -46.66 6.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.31 . . . . 71.409999999999997 111.154 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 3.3 pttt -57.41 -50.52 72.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.98 0.419 . . . . 72.099999999999994 110.856 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -64.71 -42.85 94.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.76 -0.655 . . . . 51.310000000000002 110.842 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -39.42 76.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 111.034 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.91 -41.99 68.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 74.430000000000007 112.647 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.64 -46.21 73.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 54.030000000000001 110.848 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.82 -34.03 56.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.973 -0.632 . . . . 63.32 112.692 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -64.39 -37.69 88.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.695 0.283 . . . . 72.439999999999998 110.436 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -51.2 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 72.120000000000005 110.252 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 15.8 t -56.97 -23.65 18.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 74.439999999999998 111.739 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.82 -27.05 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.338 . . . . 74.310000000000002 110.708 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 tttp -82.07 -35.04 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.083 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.98 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 73.109999999999999 110.05 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.99 -33.33 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 72.549999999999997 110.174 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mm-40 -58.66 -36.77 74.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 73.150000000000006 110.373 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -66.07 -31.02 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.91 -0.587 . . . . 74.430000000000007 110.794 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.779 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.18 13.54 30.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.519999999999996 111.638 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.7 tt -57.56 -42.65 96.82 Favored Pre-proline 0 C--O 1.223 -0.335 0 C-N-CA 120.09 -0.644 . . . . 63.25 109.756 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.47 -24.67 56.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.845 2.364 . . . . 73.129999999999995 109.826 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.858 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.5 t -94.36 -15.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 114.718 -1.128 . . . . 73.540000000000006 111.262 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 49' ' ' ALA . 86.4 t -100.58 -29.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.932 -0.766 . . . . 62.240000000000002 108.932 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.21 -42.0 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 114.986 -1.006 . . . . 70.340000000000003 110.511 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.62 2.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.688 -0.767 . . . . 55.229999999999997 111.974 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.858 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -82.8 -41.47 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.49 . . . . 74.239999999999995 109.808 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -22.29 56.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 64.129999999999995 109.341 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.6 -27.2 27.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.788 -0.642 . . . . 53.399999999999999 110.391 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.62 -44.45 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.911 -0.586 . . . . 64.200000000000003 110.341 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.67 -2.62 84.46 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.206 -0.758 . . . . 44.520000000000003 111.206 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.226 -0.893 . . . . 70.409999999999997 110.895 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.43 -0.268 . . . . 62.140000000000001 112.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.99 -27.49 31.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.767 -0.73 . . . . 74.310000000000002 112.6 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -50.5 -62.18 1.74 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.168 0.508 . . . . 64.439999999999998 110.647 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 14.0 mtpp -64.89 -23.91 67.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 73.219999999999999 109.734 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.85 -40.29 79.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.776 -0.647 . . . . 63.5 110.755 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -81.94 -35.87 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 73.25 110.875 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.04 -22.4 78.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 71.0 112.843 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -97.64 -27.19 14.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.312 . . . . 73.310000000000002 111.126 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -62.22 -56.4 19.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 74.510000000000005 110.724 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -64.09 -54.18 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.879 -0.6 . . . . 70.219999999999999 110.846 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -45.09 78.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 74.549999999999997 111.084 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.82 44.93 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.797 -0.716 . . . . 64.230000000000004 112.708 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.43 -48.72 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.863 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.05 50.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.015 -0.612 . . . . 73.430000000000007 112.66 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -59.78 -37.65 79.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.697 0.284 . . . . 71.030000000000001 110.464 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -52.25 7.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.202 0.525 . . . . 74.530000000000001 110.221 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.3 t -55.51 -25.27 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 64.200000000000003 111.742 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.72 -26.78 2.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 74.450000000000003 110.753 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.1 tttt -81.99 -35.13 29.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.106 0.479 . . . . 53.310000000000002 110.102 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.14 90.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 72.420000000000002 110.19 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.18 -34.76 22.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 65.420000000000002 110.342 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -57.85 -38.52 75.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.494 . . . . 73.310000000000002 110.524 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -66.71 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 71.420000000000002 111.118 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.11 11.97 32.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 63.32 111.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.916 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.9 tt -56.64 -42.73 97.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 C-N-CA 120.025 -0.67 . . . . 73.109999999999999 109.852 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -25.39 55.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.817 2.345 . . . . 73.219999999999999 109.811 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.898 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -93.98 -13.64 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 114.865 -1.061 . . . . 55.310000000000002 111.237 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' ALA . 58.4 t -101.81 -29.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.882 -0.785 . . . . 73.439999999999998 108.882 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.23 -42.09 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.042 -0.981 . . . . 73.340000000000003 110.398 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.27 -29.33 2.42 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 51.32 111.96 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.898 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.14 -39.74 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.625 -0.509 . . . . 62.210000000000001 109.625 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 1.1 mtmm -76.1 -21.02 57.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 63.119999999999997 109.602 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.53 -21.46 25.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 72.099999999999994 111.286 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 55' ' ' GLY . 23.7 pt -91.26 -47.12 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.079 0.466 . . . . 73.349999999999994 112.17 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' HG13 ' A' ' 59' ' ' ILE . . . -133.27 4.06 4.84 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.251 -0.739 . . . . 72.120000000000005 111.251 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.25 -0.881 . . . . 72.430000000000007 110.831 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.487 -0.245 . . . . 45.030000000000001 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 -21.8 74.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.624 -0.798 . . . . 55.240000000000002 112.68 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -46.53 -61.45 1.81 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 74.409999999999997 110.883 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.27 -23.79 64.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 63.039999999999999 110.405 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -41.14 76.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 72.409999999999997 111.0 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.438 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.3 tp -79.87 -35.35 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 111.034 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.41 -22.01 76.23 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 70.010000000000005 112.838 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -93.79 -43.3 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 73.150000000000006 111.158 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -58.79 -50.82 72.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.411 . . . . 34.340000000000003 111.021 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.438 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.12 -48.93 79.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 71.340000000000003 111.074 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -45.29 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 54.229999999999997 111.19 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.13 -44.27 51.18 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.837 -0.697 . . . . 60.409999999999997 112.732 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.96 -48.59 70.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.936 0.398 . . . . 51.149999999999999 110.907 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.14 -35.95 55.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.986 -0.626 . . . . 63.229999999999997 112.641 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mtpt -62.73 -37.49 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 73.439999999999998 110.421 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.7 -53.01 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 74.510000000000005 110.315 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 38' ' ' ALA . 14.6 t -55.8 -23.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.316 -0.856 . . . . 75.019999999999996 111.679 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.14 -27.85 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.348 . . . . 71.549999999999997 110.456 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 mttm -78.47 -32.79 48.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 61.020000000000003 109.798 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.32 -32.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.621 -0.718 . . . . 74.109999999999999 110.302 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.37 -47.98 9.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 63.350000000000001 111.044 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -51.9 -33.96 39.18 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 64.329999999999998 110.916 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -66.17 -38.32 87.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 65.209999999999994 111.053 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -100.37 12.94 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 34.310000000000002 111.82 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.908 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.0 tt -56.79 -42.81 98.21 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.068 -0.653 . . . . 75.109999999999999 109.837 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 5.1 Cg_exo -65.82 -25.07 53.4 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.747 2.298 . . . . 74.040000000000006 109.944 176.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.923 ' O ' HD11 ' A' ' 56' ' ' ILE . 56.0 t -95.43 -11.02 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.909 -1.042 . . . . 75.25 111.229 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 73.2 t -104.35 -28.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.798 -0.815 . . . . 63.049999999999997 108.798 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.908 HG13 ' O ' ' A' ' 50' ' ' LEU . 18.1 m -82.28 -41.82 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.002 -0.999 . . . . 63.439999999999998 110.443 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.769 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.28 -28.72 3.34 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.596 -0.811 . . . . 73.450000000000003 112.089 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.923 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.14 -35.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.593 -0.521 . . . . 73.019999999999996 109.593 178.912 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.05 -22.04 45.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.68 -0.691 . . . . 64.310000000000002 109.491 178.446 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.73 -21.42 25.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.059 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -96.67 -44.52 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 112.105 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -129.84 4.42 6.1 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.809 -0.71 . . . . 42.43 111.607 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 48.1 tttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.832 . . . . 72.120000000000005 110.952 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.534 -0.226 . . . . 65.299999999999997 112.534 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -72.28 -21.9 79.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 112.657 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.13 -61.1 2.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 75.430000000000007 110.222 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -23.39 67.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 74.519999999999996 109.719 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -68.4 -38.28 81.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.794 -0.639 . . . . 74.140000000000001 110.937 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -79.25 -36.65 39.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.8 -57.24 9.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 42.0 112.558 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -25.43 63.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 62.439999999999998 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -65.27 -59.09 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.100000000000001 110.833 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -46.35 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 72.349999999999994 111.003 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -54.9 -38.75 67.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 74.5 111.019 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.67 95.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 54.32 112.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -66.45 -43.65 84.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 73.120000000000005 110.843 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.51 -36.03 57.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.002 -0.618 . . . . 75.209999999999994 112.617 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -62.15 -36.61 82.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.724 0.297 . . . . 71.420000000000002 110.269 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -52.96 6.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.259 0.552 . . . . 62.409999999999997 110.152 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.7 t -56.62 -23.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.217 -0.901 . . . . 70.310000000000002 111.867 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.78 -27.77 5.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 75.230000000000004 110.553 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 23.2 mttt -77.79 -33.75 52.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.115 0.483 . . . . 65.319999999999993 109.787 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 -33.02 60.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.562 -0.744 . . . . 72.439999999999998 110.254 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.32 -47.87 9.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 72.519999999999996 111.121 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -52.36 -39.03 60.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.964 0.412 . . . . 63.5 111.025 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -30.07 71.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 75.200000000000003 111.115 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.83 11.44 35.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 44.210000000000001 111.901 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.34 -43.34 99.06 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 120.238 -0.585 . . . . 63.399999999999999 110.123 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.0 Cg_exo -66.34 -22.43 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.819 2.346 . . . . 64.540000000000006 110.017 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.871 ' O ' HD11 ' A' ' 56' ' ' ILE . 79.6 t -96.2 -17.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.797 -1.092 . . . . 75.430000000000007 111.26 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.8 p -98.76 -27.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.939 -0.763 . . . . 72.510000000000005 108.939 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.0 m -82.38 -42.19 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.099 -0.955 . . . . 75.530000000000001 110.511 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.95 -29.46 2.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.731 -0.747 . . . . 72.329999999999998 112.011 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.57 -40.29 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 63.420000000000002 109.784 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -21.97 54.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.393 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.12 -24.1 28.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.792 -0.64 . . . . 51.210000000000001 110.439 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -96.63 -43.97 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 115.935 -0.575 . . . . 72.540000000000006 110.495 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.751 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -83.45 -4.97 89.03 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.628 -0.796 . . . . 55.310000000000002 111.291 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.248 -0.882 . . . . 52.409999999999997 110.996 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.487 -0.245 . . . . 55.420000000000002 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.55 -24.76 41.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.747 . . . . 71.230000000000004 112.608 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.36 -62.25 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.18 0.515 . . . . 74.329999999999998 110.925 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 15.4 mttt -65.54 -23.89 66.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.387 -0.824 . . . . 73.0 109.916 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -70.54 -34.7 72.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 71.319999999999993 110.728 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.4 tm? -81.98 -34.96 29.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 110.988 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.07 -58.77 5.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 51.399999999999999 112.605 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -37.32 65.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 64.319999999999993 111.114 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -65.03 -57.45 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 74.200000000000003 110.844 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.39 90.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 111.067 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -47.81 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.530000000000001 110.938 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.71 -48.92 59.93 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.807 -0.711 . . . . 52.539999999999999 112.383 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.28 -47.6 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 72.329999999999998 110.654 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.57 24.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.056 -0.592 . . . . 62.299999999999997 112.529 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 6.3 mmtp -65.12 -59.14 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.125 0.488 . . . . 64.329999999999998 110.031 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -28.77 63.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 64.420000000000002 110.139 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 38' ' ' ALA . 19.1 t -78.88 -43.68 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.575 -0.739 . . . . 54.32 111.638 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -50.07 -37.21 32.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.448 . . . . 75.420000000000002 109.789 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -76.28 -30.75 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 51.350000000000001 109.896 178.775 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.09 99.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.784 -0.644 . . . . 50.299999999999997 110.493 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 t -84.97 -35.78 21.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 110.47 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 1.9 mm-40 -56.5 -34.06 66.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.423 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -69.18 -31.57 70.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 64.230000000000004 110.757 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.772 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -106.11 12.8 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 54.420000000000002 111.636 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.912 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.42 -42.56 96.5 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.18 -0.608 . . . . 71.5 109.697 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.1 Cg_exo -65.58 -23.98 56.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.832 2.354 . . . . 72.109999999999999 109.875 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.877 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -94.93 -15.65 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.71 -1.132 . . . . 51.009999999999998 111.21 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 49' ' ' ALA . 77.7 t -100.14 -28.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.998 -0.742 . . . . 71.420000000000002 108.998 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.8 m -82.36 -42.05 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.994 -1.003 . . . . 75.430000000000007 110.475 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.9 -29.59 2.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.652 -0.785 . . . . 75.049999999999997 111.956 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.67 -39.95 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.093 0.473 . . . . 74.150000000000006 109.81 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -77.13 -21.59 53.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 71.430000000000007 109.514 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.26 -28.41 25.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.817 -0.629 . . . . 43.210000000000001 110.313 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -89.86 -45.12 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.965 -0.561 . . . . 73.019999999999996 110.444 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.4 -2.88 82.21 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.679 -0.772 . . . . 24.010000000000002 111.229 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.238 -0.887 . . . . 65.120000000000005 110.966 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.475 -0.25 . . . . 73.310000000000002 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.28 -21.99 59.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 54.020000000000003 112.672 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -48.02 -61.28 2.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.956 0.408 . . . . 63.049999999999997 110.721 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.6 tptt -60.41 -23.69 64.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.84 -0.618 . . . . 72.540000000000006 110.291 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.2 -42.32 80.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.944 -0.571 . . . . 70.540000000000006 110.74 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -78.31 -41.64 33.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 62.450000000000003 110.84 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.61 -22.98 66.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 64.010000000000005 112.643 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -94.1 -28.97 15.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 51.420000000000002 111.028 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -64.44 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.254 0.55 . . . . 64.25 110.907 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 -40.81 54.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 75.019999999999996 110.961 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.55 -37.85 73.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 70.25 110.917 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.91 91.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 23.219999999999999 112.448 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.881 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.39 -41.12 61.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 75.140000000000001 110.937 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.67 69.61 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.067 -0.587 . . . . 72.349999999999994 112.531 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.2 -58.13 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.933 0.396 . . . . 73.340000000000003 110.549 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.49 -19.88 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 73.400000000000006 110.15 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 38' ' ' ALA . 42.8 t -83.17 -48.14 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.848 -0.615 . . . . 71.319999999999993 110.714 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.44 -39.88 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 74.25 109.765 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -76.23 -28.97 57.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.726 -0.67 . . . . 74.099999999999994 109.558 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -64.3 -46.0 85.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.584 -0.734 . . . . 65.310000000000002 110.32 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -79.24 -35.07 42.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.84 -0.618 . . . . 73.540000000000006 110.072 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.29 -21.81 50.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 54.039999999999999 110.394 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.83 66.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.717 -0.475 . . . . 64.450000000000003 109.717 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.753 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -112.72 18.11 18.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.897 -0.592 . . . . 52.130000000000003 110.602 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.82 -36.27 24.64 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.788 -0.765 . . . . 70.200000000000003 110.444 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.846 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 49.7 Cg_endo -77.96 -12.18 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.772 2.314 . . . . 53.140000000000001 109.929 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.892 ' O ' HD11 ' A' ' 56' ' ' ILE . 65.0 t -105.86 -10.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.856 -1.065 . . . . 71.329999999999998 110.366 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.4 t -105.75 -31.14 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.676 -0.861 . . . . 65.230000000000004 108.676 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 50' ' ' LEU . 20.5 m -82.38 -39.92 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.41 -0.814 . . . . 74.099999999999994 110.393 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.18 -29.28 3.48 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.602 -0.809 . . . . 70.040000000000006 112.05 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.47 -37.73 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 74.5 109.724 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -78.01 -21.71 50.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 65.329999999999998 109.545 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.84 -27.15 25.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.887 -0.597 . . . . 45.140000000000001 110.367 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.15 -45.08 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.879 -0.601 . . . . 72.310000000000002 110.473 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.14 -1.42 79.17 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.773 . . . . 65.430000000000007 111.302 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.3 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 71.040000000000006 110.85 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.386 -0.286 . . . . 54.109999999999999 112.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -78.8 -22.86 65.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 72.510000000000005 112.6 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.25 -62.12 1.57 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.171 0.51 . . . . 72.239999999999995 111.008 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.4 ptmt -65.34 -23.89 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.471 -0.786 . . . . 74.409999999999997 110.038 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -71.32 -36.03 71.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 75.329999999999998 110.741 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -82.04 -42.59 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.873 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -22.02 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.129999999999995 112.799 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -97.07 -23.85 16.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.642 0.258 . . . . 51.030000000000001 111.24 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -67.32 -60.82 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 74.450000000000003 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -45.91 91.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 72.019999999999996 110.935 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.31 -40.44 71.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 62.530000000000001 111.125 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.97 -41.26 59.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.747 -0.739 . . . . 53.219999999999999 112.592 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.848 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.94 -47.14 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.129999999999995 110.814 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.82 69.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.927 -0.654 . . . . 45.130000000000003 112.596 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -63.02 -36.47 83.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.667 0.27 . . . . 72.310000000000002 110.426 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.224 0.535 . . . . 74.109999999999999 110.28 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.3 t -57.0 -24.05 19.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.346 -0.843 . . . . 34.240000000000002 111.858 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.42 -27.24 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.483 -0.326 . . . . 73.519999999999996 110.81 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -81.0 -36.83 30.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 109.941 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 71.120000000000005 109.928 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -85.29 -36.94 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 51.329999999999998 110.349 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.23 -36.48 73.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 62.039999999999999 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -67.02 -31.81 72.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 70.019999999999996 110.949 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -102.03 11.56 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.010000000000005 111.819 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.01 -43.62 99.16 Favored Pre-proline 0 C--O 1.224 -0.268 0 C-N-CA 120.263 -0.575 . . . . 71.010000000000005 110.064 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.2 Cg_exo -66.25 -21.52 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.885 2.39 . . . . 61.310000000000002 110.107 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.862 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -97.92 -17.24 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.944 -1.025 . . . . 70.430000000000007 111.289 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -98.85 -27.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.003 -0.74 . . . . 75.540000000000006 109.003 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.9 m -82.21 -42.4 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.14 -0.936 . . . . 61.329999999999998 110.583 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.87 -29.63 2.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.658 -0.782 . . . . 74.150000000000006 111.961 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.82 -40.84 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.707 -0.479 . . . . 73.319999999999993 109.707 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 -21.56 57.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 75.230000000000004 109.425 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.87 -26.86 25.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.871 -0.604 . . . . 64.019999999999996 110.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.7 -44.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.484 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.93 0.01 78.64 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.217 -0.753 . . . . 41.439999999999998 111.217 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.207 -0.902 . . . . 71.150000000000006 110.83 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.394 -0.282 . . . . 52.030000000000001 112.394 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -67.5 -29.12 73.76 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.682 -0.771 . . . . 63.310000000000002 112.417 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.95 -62.21 1.58 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.224 0.535 . . . . 62.539999999999999 110.799 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 1.2 mttt -64.61 -23.89 67.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.358 -0.837 . . . . 73.140000000000001 109.792 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.97 -41.9 77.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 110.581 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 tp -82.06 -36.52 27.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.498 . . . . 55.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -21.95 72.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.712 . . . . 64.540000000000006 112.654 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -101.42 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 75.519999999999996 111.173 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -64.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.966 0.412 . . . . 65.439999999999998 110.88 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -44.1 75.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 71.25 111.067 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -39.24 76.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 111.021 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.22 93.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.753 . . . . 65.329999999999998 112.333 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.871 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.94 -50.73 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 54.539999999999999 110.592 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 43' ' ' PHE . . . -52.37 -31.42 35.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.955 -0.641 . . . . 30.210000000000001 112.519 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 8.3 tttm -66.69 -35.85 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.184 0.516 . . . . 63.299999999999997 110.21 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -24.25 37.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 65.340000000000003 109.74 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 38' ' ' ALA . 11.8 t -85.28 -40.36 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 74.239999999999995 111.397 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -51.12 -33.16 25.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 109.788 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -79.63 -30.32 41.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 75.319999999999993 109.762 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.84 -44.74 84.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.774 -0.648 . . . . 54.140000000000001 110.167 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -77.56 -34.67 53.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 61.399999999999999 109.914 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.862 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.74 -21.72 61.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 73.510000000000005 110.436 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -73.14 -32.15 64.72 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.735 -0.468 . . . . 73.230000000000004 109.735 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -111.29 18.33 19.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.753 -0.658 . . . . 74.340000000000003 110.559 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.3 pp -62.92 -36.38 24.99 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.948 -0.701 . . . . 54.530000000000001 110.352 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.817 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 46.5 Cg_endo -77.52 -12.31 16.92 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.745 2.296 . . . . 63.119999999999997 110.033 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.888 ' O ' HD11 ' A' ' 56' ' ' ILE . 70.0 t -104.85 -12.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.718 -1.128 . . . . 75.049999999999997 110.225 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 49' ' ' ALA . 85.9 t -104.2 -31.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.631 -0.877 . . . . 70.019999999999996 108.631 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.32 -39.74 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.379 -0.828 . . . . 64.530000000000001 110.398 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.83 -29.53 3.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.55 -0.834 . . . . 71.239999999999995 112.053 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -84.05 -39.74 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.114 0.483 . . . . 73.200000000000003 109.839 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -21.84 54.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 63.119999999999997 109.422 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.22 -28.13 25.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.78 -0.645 . . . . 72.010000000000005 110.363 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.53 -45.12 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 115.967 -0.56 . . . . 73.230000000000004 110.396 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.51 -2.53 82.24 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.233 -0.747 . . . . 73.239999999999995 111.233 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.265 -0.874 . . . . 65.319999999999993 110.867 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.397 -0.281 . . . . 74.150000000000006 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 -21.93 50.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.409999999999997 112.599 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -47.67 -61.5 1.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.019 0.438 . . . . 63.520000000000003 110.748 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' HD13 ' A' ' 28' ' ' LEU . 8.0 tttp -61.21 -23.67 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.64 . . . . 71.5 110.42 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -68.86 -40.63 79.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 61.039999999999999 110.866 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -79.62 -39.91 30.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 62.240000000000002 111.015 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.35 -22.01 76.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.808 -0.71 . . . . 75.209999999999994 112.756 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -96.02 -26.8 15.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.202 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.16 -63.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 74.549999999999997 111.023 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -41.03 78.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 71.120000000000005 111.099 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -37.98 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.21 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.23 -38.02 66.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 75.510000000000005 112.769 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.88 -49.33 47.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 52.420000000000002 111.073 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.22 -21.88 27.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.651 -0.785 . . . . 55.43 112.911 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.633 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.69 -39.33 24.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.772 0.286 . . . . 75.209999999999994 111.116 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.67 -37.17 27.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.173 0.511 . . . . 65.049999999999997 110.625 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 38' ' ' ALA . 31.7 t -72.56 -22.67 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.604 -0.725 . . . . 71.420000000000002 111.839 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.87 -26.8 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 74.519999999999996 110.76 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.3 mttp -76.36 -34.29 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.101 0.477 . . . . 62.030000000000001 109.819 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -72.03 -35.12 69.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.604 -0.725 . . . . 65.040000000000006 110.405 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -50.86 6.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.616 . . . . 74.519999999999996 111.265 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 pp20? -50.56 -34.55 26.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.827 0.346 . . . . 53.329999999999998 111.049 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.78 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 111.011 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.1 11.81 38.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.358 . . . . 64.329999999999998 111.926 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.52 -43.35 99.1 Favored Pre-proline 0 C--O 1.223 -0.339 0 C-N-CA 120.213 -0.595 . . . . 64.109999999999999 110.052 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.8 Cg_exo -66.11 -22.73 54.08 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.866 2.377 . . . . 70.099999999999994 110.007 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 77.2 t -96.27 -16.97 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.814 -1.085 . . . . 74.540000000000006 111.266 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.34 -27.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.898 -0.778 . . . . 74.209999999999994 108.898 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.3 m -82.23 -42.43 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.047 -0.978 . . . . 62.520000000000003 110.548 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.55 2.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.627 -0.797 . . . . 72.319999999999993 112.032 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.93 -39.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 74.109999999999999 109.789 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -76.93 -22.01 53.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 72.430000000000007 109.475 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.31 -27.55 25.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.807 -0.633 . . . . 45.229999999999997 110.407 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.5 -45.28 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.975 -0.557 . . . . 61.43 110.392 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.748 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.66 -2.82 81.48 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.637 -0.792 . . . . 61.530000000000001 111.198 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 63.439999999999998 110.929 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.472 -0.251 . . . . 45.030000000000001 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.55 -21.97 77.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.52 -61.38 1.95 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.032 0.444 . . . . 74.329999999999998 110.748 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -60.5 -23.77 64.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 73.129999999999995 110.309 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -68.22 -42.84 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 75.340000000000003 110.744 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.02 -34.6 29.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 110.913 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.62 -21.93 71.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 33.140000000000001 112.89 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -105.45 -24.43 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 72.349999999999994 111.404 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.6 -60.62 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 75.340000000000003 110.919 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.514 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.1 tm? -62.76 -52.83 61.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.009 -0.541 . . . . 74.329999999999998 110.983 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -34.14 46.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 74.349999999999994 111.254 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.23 -36.49 68.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.673 -0.775 . . . . 42.240000000000002 112.424 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.66 -45.3 59.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 51.119999999999997 110.858 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -21.93 30.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 33.439999999999998 112.762 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 4.1 mttt -79.26 -40.57 30.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.66 0.23 . . . . 63.130000000000003 111.058 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.69 -39.28 24.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 70.150000000000006 110.732 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' ALA . 38.7 t -70.0 -22.34 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 74.019999999999996 111.696 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.91 -27.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.598 -0.274 . . . . 70.420000000000002 110.979 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -75.42 -34.75 61.05 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.174 0.511 . . . . 64.0 109.983 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -73.01 -34.39 66.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 75.209999999999994 110.416 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.1 p -85.19 -49.58 8.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 111.181 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -51.15 -34.75 32.54 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.942 0.401 . . . . 71.310000000000002 111.12 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -38.27 83.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.071 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -96.67 13.16 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 54.219999999999999 111.808 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 tt -56.15 -43.35 99.22 Favored Pre-proline 0 C--O 1.223 -0.333 0 C-N-CA 120.158 -0.617 . . . . 74.239999999999995 110.102 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.7 Cg_exo -66.53 -21.83 52.33 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.908 2.406 . . . . 72.230000000000004 110.125 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.875 ' O ' HD11 ' A' ' 56' ' ' ILE . 68.3 t -97.42 -17.08 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.861 -1.063 . . . . 71.25 111.211 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.18 -27.79 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.969 -0.752 . . . . 73.450000000000003 108.969 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.3 -42.34 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-N 115.099 -0.955 . . . . 75.019999999999996 110.588 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.68 2.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.056 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.7 -40.36 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.171 0.51 . . . . 65.420000000000002 109.841 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -21.8 56.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 109.479 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.56 -26.91 25.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 110.384 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.3 -44.75 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.034 -0.53 . . . . 74.549999999999997 110.389 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -88.55 -1.45 80.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.655 -0.783 . . . . 72.430000000000007 111.277 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 63.530000000000001 110.869 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 45.030000000000001 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -21.91 78.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 63.530000000000001 112.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -47.51 -61.07 2.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.894 0.378 . . . . 75.430000000000007 110.821 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -61.1 -23.83 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.085 -0.507 . . . . 62.100000000000001 110.4 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.99 -42.71 80.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 73.450000000000003 110.714 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.639 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -82.09 -39.95 22.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 72.319999999999993 110.811 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.61 -22.48 61.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.778 -0.725 . . . . 75.450000000000003 112.731 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -101.56 -36.7 8.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.772 0.32 . . . . 75.540000000000006 110.935 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -64.38 -57.83 8.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 110.729 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -44.13 94.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 63.409999999999997 110.875 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.69 -44.92 81.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.074 -0.512 . . . . 74.530000000000001 111.04 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.93 -47.07 89.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 35.409999999999997 112.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.3 -45.34 48.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 33.340000000000003 110.908 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.24 -23.35 47.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.968 -0.634 . . . . 65.150000000000006 112.356 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 1.9 mmtt -64.89 -57.88 7.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 41.5 110.332 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.632 ' HD2' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.8 -20.08 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 110.043 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' HD2' ' A' ' 41' ' ' ARG . 95.1 t -81.13 -48.87 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 116.054 -0.521 . . . . 65.129999999999995 110.463 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.79 -46.2 41.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 71.209999999999994 109.606 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -70.42 -30.55 67.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 109.612 178.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -59.34 -45.06 92.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.896 -0.593 . . . . 64.400000000000006 110.377 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -85.11 -35.08 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.524 . . . . 61.340000000000003 110.549 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.75 -31.23 64.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 75.319999999999993 110.59 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -71.74 -31.28 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.528 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.94 13.36 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.513 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.902 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -56.03 -42.95 98.8 Favored Pre-proline 0 C--O 1.223 -0.321 0 C-N-CA 120.173 -0.611 . . . . 72.340000000000003 109.934 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -24.78 55.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.88 2.387 . . . . 74.209999999999994 109.848 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.926 ' O ' HD11 ' A' ' 56' ' ' ILE . 47.3 t -96.63 -9.8 9.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.828 -1.078 . . . . 75.049999999999997 111.169 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 62.0 t -105.42 -28.13 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.717 -0.846 . . . . 73.230000000000004 108.717 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 50' ' ' LEU . 19.2 m -82.39 -42.05 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.079 -0.964 . . . . 64.25 110.456 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.21 -28.76 3.28 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.531 -0.842 . . . . 53.350000000000001 112.097 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.41 -35.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.568 -0.53 . . . . 52.329999999999998 109.568 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.84 -21.82 47.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.61 -0.723 . . . . 75.510000000000005 109.498 178.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.5 -21.45 25.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.937 -0.574 . . . . 54.219999999999999 110.858 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.49 -44.04 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 75.420000000000002 111.991 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -126.42 2.55 7.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.89 -0.671 . . . . 63.310000000000002 111.803 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 2.8 tttm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 51.520000000000003 111.045 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.493 -0.243 . . . . 45.030000000000001 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.95 78.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 62.32 112.658 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -47.0 -61.18 1.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.977 0.418 . . . . 45.310000000000002 110.826 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -23.82 66.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 64.450000000000003 110.387 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -69.12 -43.86 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.581 . . . . 72.299999999999997 110.703 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.7 tp -82.07 -39.1 23.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.209999999999994 110.861 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.3 66.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 75.140000000000001 112.655 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -26.08 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.701 0.286 . . . . 75.040000000000006 111.0 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -67.36 -64.5 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.258 0.552 . . . . 73.299999999999997 110.523 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 36' ' ' GLU . 3.9 pp -53.98 -47.76 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.85 . . . . 63.329999999999998 110.833 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -51.73 -37.74 52.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.41 -0.814 . . . . 63.119999999999997 111.049 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.41 -44.53 64.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 60.32 112.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -73.87 -34.55 64.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 73.230000000000004 110.907 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.04 -21.82 66.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.992 -0.623 . . . . 41.539999999999999 112.529 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.4 tttt -65.02 -58.22 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.955 0.407 . . . . 74.310000000000002 110.521 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -63.14 -19.87 64.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.973 0.416 . . . . 75.340000000000003 110.245 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 38' ' ' ALA . 40.3 t -84.32 -44.48 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.937 -0.574 . . . . 73.409999999999997 111.05 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.15 -39.65 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 109.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 3.2 mttm -75.1 -30.93 61.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 63.25 109.777 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.59 -41.63 99.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.751 -0.659 . . . . 74.120000000000005 110.565 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 t -85.08 -35.69 21.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.921 -0.581 . . . . 71.239999999999995 110.542 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.85 -34.0 67.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 54.310000000000002 110.499 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -69.27 -32.55 71.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 64.129999999999995 110.731 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.6 11.24 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.565 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.0 -43.58 99.12 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 120.243 -0.583 . . . . 72.129999999999995 110.106 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.5 Cg_exo -66.02 -22.06 55.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.857 2.371 . . . . 72.140000000000001 110.003 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.88 ' O ' HD11 ' A' ' 56' ' ' ILE . 75.0 t -97.31 -16.9 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.902 -1.044 . . . . 61.5 111.322 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -99.43 -27.61 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.985 -0.746 . . . . 73.340000000000003 108.985 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.6 m -82.23 -42.33 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 115.071 -0.968 . . . . 62.100000000000001 110.445 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.13 -29.65 2.36 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 74.329999999999998 112.003 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.88 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.73 -38.47 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.164 0.506 . . . . 74.239999999999995 109.654 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 4.5 mtmt -76.31 -21.7 55.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 70.109999999999999 109.458 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.6 -21.49 25.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.94 -0.573 . . . . 74.340000000000003 110.939 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -99.73 -43.61 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 73.209999999999994 111.905 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.732 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -125.03 1.46 8.4 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.586 -0.734 . . . . 73.219999999999999 111.828 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.197 -0.906 . . . . 62.130000000000003 110.945 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.494 -0.242 . . . . 54.329999999999998 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -83.03 -26.55 44.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 75.239999999999995 112.585 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -48.15 -62.2 1.6 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.225 0.536 . . . . 75.239999999999995 110.924 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -64.45 -23.95 67.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.382 -0.827 . . . . 75.040000000000006 109.885 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.74 -35.81 77.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.886 -0.597 . . . . 72.310000000000002 110.639 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.95 -35.73 28.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 72.409999999999997 110.911 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -57.5 7.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 42.399999999999999 112.612 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.98 -26.49 62.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.689 0.281 . . . . 63.130000000000003 111.016 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.95 -56.41 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.964 0.411 . . . . 65.219999999999999 110.644 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -51.99 15.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.951 -0.568 . . . . 62.409999999999997 110.752 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -32.5 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 72.299999999999997 110.977 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.16 -38.15 88.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.776 . . . . 63.310000000000002 112.456 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.26 -41.75 73.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 73.329999999999998 110.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.33 -21.84 35.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 71.099999999999994 112.574 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -81.07 -40.72 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 0.175 . . . . 72.099999999999994 110.977 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.33 -40.63 23.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 110.671 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.7 t -65.76 -22.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.677 -0.692 . . . . 70.129999999999995 111.415 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.83 -28.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 53.439999999999998 110.833 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -72.21 -43.4 64.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.659 0.742 . . . . 65.219999999999999 109.75 179.008 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 44' ' ' LYS . . . -66.69 -34.61 78.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.58 -1.191 . . . . 53.119999999999997 110.588 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 p -85.16 -45.92 11.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.544 . . . . 65.209999999999994 111.031 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.861 ' HA ' HD23 ' A' ' 50' ' ' LEU . 2.6 pp20? -58.63 -20.4 47.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 54.420000000000002 110.873 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -33.11 64.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.742 -0.466 . . . . 64.430000000000007 109.742 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -110.24 18.43 19.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.721 -0.672 . . . . 51.530000000000001 110.515 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.861 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.52 -36.37 26.67 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 119.917 -0.713 . . . . 72.420000000000002 110.44 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.805 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 50.1 Cg_endo -77.82 -11.36 16.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.794 2.329 . . . . 44.420000000000002 110.052 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.901 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -107.46 -10.77 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.697 -1.138 . . . . 75.430000000000007 110.333 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 49' ' ' ALA . 83.0 t -105.05 -30.77 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.682 -0.858 . . . . 71.209999999999994 108.682 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.35 -40.22 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.422 -0.808 . . . . 63.299999999999997 110.404 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.709 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.98 -29.37 3.29 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.533 -0.842 . . . . 74.25 112.072 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.901 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -85.12 -38.17 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.687 -0.486 . . . . 65.230000000000004 109.687 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -77.69 -21.79 51.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.717 -0.674 . . . . 62.299999999999997 109.483 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.77 -26.94 25.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.898 -0.592 . . . . 51.539999999999999 110.383 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.52 -45.01 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.936 -0.575 . . . . 64.200000000000003 110.498 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.0 -1.45 79.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 74.430000000000007 111.317 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.5 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.245 -0.883 . . . . 72.219999999999999 110.89 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.505 -0.238 . . . . 64.430000000000007 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.52 -25.24 65.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.571 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.68 -62.15 1.59 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.187 0.518 . . . . 62.219999999999999 111.018 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 20.6 pttt -63.72 -23.94 67.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 64.420000000000002 109.868 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -40.37 82.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 72.439999999999998 110.648 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.11 -35.74 28.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 110.898 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.2 -21.94 72.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 72.319999999999993 112.801 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -29.63 12.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 74.439999999999998 111.026 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -64.29 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 75.209999999999994 110.82 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -41.24 67.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.876 -0.602 . . . . 64.530000000000001 111.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -44.41 83.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 75.25 111.017 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.16 -47.02 76.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 73.200000000000003 112.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.878 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.9 -47.07 61.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 73.099999999999994 110.716 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.22 -28.53 26.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.933 -0.576 . . . . 63.130000000000003 112.389 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 5.2 mmtm -64.99 -59.62 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 75.430000000000007 109.991 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -23.32 52.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.089 -0.505 . . . . 74.420000000000002 110.252 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.8 t -85.63 -40.28 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 72.129999999999995 111.754 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.65 -39.0 34.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.761 -0.459 . . . . 71.200000000000003 109.761 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 mttm -72.74 -31.81 65.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 75.120000000000005 110.001 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.015 -0.539 . . . . 33.399999999999999 110.395 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 t -85.19 -31.76 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 110.608 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 7.7 tp10 -60.94 -36.46 79.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 65.310000000000002 110.636 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -75.43 -29.45 59.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 110.744 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.33 12.53 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 71.040000000000006 111.592 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.904 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.84 -43.42 99.19 Favored Pre-proline 0 C--O 1.223 -0.3 0 C-N-CA 120.308 -0.557 . . . . 72.140000000000001 110.032 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.2 Cg_exo -66.03 -20.39 57.21 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.818 2.345 . . . . 75.109999999999999 110.001 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.84 ' O ' HD11 ' A' ' 56' ' ' ILE . 66.0 t -98.55 -19.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.843 -1.071 . . . . 71.150000000000006 111.217 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -97.27 -27.58 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.066 -0.716 . . . . 42.229999999999997 109.066 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.26 -42.26 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.076 -0.966 . . . . 72.219999999999999 110.587 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.89 -29.72 2.15 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.696 -0.764 . . . . 72.140000000000001 111.992 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -82.68 -41.63 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.733 -0.469 . . . . 71.239999999999995 109.733 178.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -22.38 57.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 75.109999999999999 109.39 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.68 -26.72 27.56 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.746 -0.661 . . . . 62.229999999999997 110.396 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -93.27 -44.4 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.965 -0.561 . . . . 75.400000000000006 110.372 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.731 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -85.88 -3.02 86.0 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.696 -0.764 . . . . 64.0 111.246 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.192 -0.909 . . . . 74.239999999999995 110.924 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.521 -0.232 . . . . 64.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.1 -22.57 77.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 24.420000000000002 112.579 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.98 -62.22 1.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.202 0.525 . . . . 74.329999999999998 110.985 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -63.72 -23.81 67.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 74.549999999999997 109.961 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -70.79 -44.77 65.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.824 -0.625 . . . . 74.120000000000005 110.647 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -82.1 -37.78 25.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.816 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -22.03 57.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.825 -0.702 . . . . 73.120000000000005 112.696 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -94.38 -31.41 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 73.239999999999995 110.998 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -62.56 -57.79 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 63.210000000000001 110.551 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 -52.95 63.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 61.140000000000001 110.722 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.28 -40.98 62.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 65.0 110.964 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.49 88.41 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 70.129999999999995 112.286 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.915 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.39 -53.29 14.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 64.519999999999996 110.708 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.26 -29.4 22.19 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.091 -0.576 . . . . 61.149999999999999 112.461 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 mttt -65.14 -59.31 4.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.101 0.477 . . . . 62.32 110.025 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -29.92 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 64.209999999999994 109.911 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.4 t -75.99 -47.55 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.534 -0.757 . . . . 72.230000000000004 111.24 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.52 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.46 -40.42 50.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.721 -0.474 . . . . 74.239999999999995 109.721 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 14.1 mttt -75.25 -30.0 60.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 61.229999999999997 109.655 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.61 -42.55 99.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.801 -0.636 . . . . 74.010000000000005 110.556 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 t -85.12 -37.65 20.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.022 -0.535 . . . . 72.099999999999994 110.748 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.18 -33.5 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.57 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -70.16 -33.15 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 73.219999999999999 110.664 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.71 11.18 34.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 111.493 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.6 tt -55.23 -43.32 99.03 Favored Pre-proline 0 C--O 1.223 -0.32 0 C-N-CA 120.188 -0.605 . . . . 54.25 110.02 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.9 Cg_exo -66.44 -22.19 52.45 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.875 2.384 . . . . 60.439999999999998 110.045 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.896 ' O ' HD11 ' A' ' 56' ' ' ILE . 71.5 t -97.51 -14.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.93 -1.032 . . . . 63.539999999999999 111.374 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.731 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -101.54 -27.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.804 -0.814 . . . . 72.400000000000006 108.804 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.1 m -82.27 -41.97 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.076 -0.965 . . . . 55.25 110.41 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.69 -29.25 2.89 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.604 -0.808 . . . . 52.329999999999998 112.032 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -86.88 -35.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.605 -0.517 . . . . 74.319999999999993 109.605 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.43 -21.75 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.545 -0.752 . . . . 64.109999999999999 109.661 178.447 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.71 -21.45 25.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.878 -0.601 . . . . 73.219999999999999 110.96 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.745 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.04 -44.09 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 65.239999999999995 111.981 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.3 -0.12 8.78 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.768 -0.729 . . . . 65.439999999999998 111.762 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 12.8 tttm . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.204 -0.903 . . . . 64.040000000000006 111.35 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.521 -0.232 . . . . 51.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -69.56 -21.99 76.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.739 . . . . 75.150000000000006 112.584 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.62 -61.2 2.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.953 0.406 . . . . 62.520000000000003 110.118 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -63.16 -23.44 67.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 55.130000000000003 109.685 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -67.78 -44.25 77.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.879 -0.6 . . . . 62.439999999999998 110.79 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.79 -46.07 69.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.539999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.95 -36.94 93.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.738 -0.744 . . . . 44.25 112.465 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -70.45 -29.17 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 64.439999999999998 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -63.49 -57.07 11.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 55.140000000000001 110.827 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -67.65 -42.64 81.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 110.916 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -53.61 -40.24 65.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.120000000000005 111.071 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.64 -41.43 82.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 70.109999999999999 112.651 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.68 -43.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 74.120000000000005 110.941 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.09 34.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 40.329999999999998 112.706 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.09 -40.58 23.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.664 0.232 . . . . 72.400000000000006 110.967 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.66 -37.16 27.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.038 0.447 . . . . 71.120000000000005 110.663 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.8 t -71.88 -22.69 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 64.409999999999997 111.717 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -47.92 -27.64 2.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.517 -0.31 . . . . 72.109999999999999 110.838 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 5.6 mtpt -77.03 -33.74 57.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.171 0.51 . . . . 74.340000000000003 109.806 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -76.6 -32.69 58.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.476 -0.784 . . . . 54.520000000000003 110.302 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 p -85.22 -45.75 11.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 71.140000000000001 111.046 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -53.61 -35.55 61.01 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.998 0.428 . . . . 75.409999999999997 110.916 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -37.2 85.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 75.299999999999997 110.974 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.807 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -97.84 13.86 29.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 70.209999999999994 111.851 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.918 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.4 tt -56.96 -42.64 97.41 Favored Pre-proline 0 C--O 1.223 -0.317 0 C-N-CA 120.148 -0.621 . . . . 72.340000000000003 109.99 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.7 Cg_exo -66.27 -23.81 51.59 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.87 2.38 . . . . 74.540000000000006 109.915 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.937 ' O ' HD11 ' A' ' 56' ' ' ILE . 50.9 t -96.8 -10.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.878 -1.056 . . . . 73.310000000000002 111.215 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 t -104.58 -28.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.783 -0.821 . . . . 72.519999999999996 108.783 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.918 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.3 m -82.44 -41.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.932 -1.031 . . . . 75.109999999999999 110.517 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.61 -28.45 3.57 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.596 -0.812 . . . . 73.109999999999999 112.157 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.937 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.0 -33.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 64.340000000000003 109.798 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -82.19 -22.18 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 45.450000000000003 109.495 178.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.69 -21.51 25.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.948 -0.569 . . . . 44.149999999999999 111.2 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.25 -47.3 14.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 62.100000000000001 112.073 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.747 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -130.36 4.5 5.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.69 -0.686 . . . . 34.109999999999999 111.433 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 1.3 tttp . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.236 -0.887 . . . . 74.140000000000001 111.146 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.465 -0.254 . . . . 71.230000000000004 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 -21.75 52.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 63.420000000000002 112.717 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HA ' HD23 ' A' ' 31' ' ' LEU . 2.3 tm? -46.02 -61.35 1.79 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.84 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 28' ' ' LEU . 1.1 pttt -57.94 -23.8 55.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.58 . . . . 54.409999999999997 110.235 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 -35.35 65.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.923 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -81.99 -31.26 31.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 73.0 110.952 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.2 -21.99 78.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 64.109999999999999 112.812 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -29.98 13.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 72.099999999999994 110.959 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -65.77 -57.79 7.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 75.129999999999995 111.012 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -48.52 81.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.134 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -37.96 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 63.43 111.082 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.9 -39.78 63.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.778 -0.725 . . . . 52.340000000000003 112.584 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.9 -48.77 65.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 62.450000000000003 110.837 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.92 -36.48 60.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.904 -0.665 . . . . 44.229999999999997 112.667 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 8.1 mttt -62.34 -36.87 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.688 0.28 . . . . 64.030000000000001 110.323 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.28 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.195 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.1 t -55.89 -23.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 52.229999999999997 111.839 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.621 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.68 -28.19 5.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.449 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -77.65 -34.24 53.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 71.430000000000007 109.729 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -75.52 -32.86 60.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.528 -0.76 . . . . 72.25 110.252 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.15 -47.16 10.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 74.510000000000005 111.154 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -53.51 -37.39 62.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.926 0.393 . . . . 75.349999999999994 111.009 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -68.27 -33.48 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 61.409999999999997 111.094 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.72 13.11 34.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 74.340000000000003 111.872 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.29 -42.62 96.98 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.016 -0.674 . . . . 53.32 109.734 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.9 Cg_exo -65.35 -25.43 56.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.774 2.316 . . . . 74.219999999999999 109.842 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.904 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -94.17 -12.67 8.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.751 -1.113 . . . . 60.509999999999998 111.243 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 67.1 t -102.9 -28.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.793 -0.818 . . . . 64.319999999999993 108.793 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.36 -41.85 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.04 -0.982 . . . . 72.430000000000007 110.419 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.66 -29.11 2.79 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.515 -0.85 . . . . 42.409999999999997 112.113 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.904 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.93 -37.12 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.158 0.504 . . . . 75.439999999999998 109.697 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 5.0 mtmt -78.37 -21.47 49.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.664 -0.698 . . . . 74.310000000000002 109.456 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.57 -21.55 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.883 -0.598 . . . . 73.310000000000002 110.982 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.13 -43.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 74.030000000000001 111.933 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.08 -0.38 8.92 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.757 -0.735 . . . . 71.420000000000002 111.755 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.18 -0.914 . . . . 71.140000000000001 111.314 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.541 -0.223 . . . . 50.210000000000001 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.88 -21.89 78.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 54.310000000000002 112.661 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -46.54 -61.41 1.83 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.009 0.433 . . . . 72.340000000000003 110.93 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 26.1 mmtt -61.02 -23.85 65.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 74.319999999999993 110.356 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -69.65 -37.44 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 73.340000000000003 110.87 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -81.88 -43.59 17.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 42.200000000000003 111.079 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.8 52.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.678 -0.772 . . . . 75.120000000000005 112.617 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -30.49 66.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 110.956 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -63.11 -57.0 12.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.742 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.65 -55.54 16.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.525 . . . . 72.5 110.834 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -37.03 52.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.197 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.06 80.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 52.240000000000002 112.586 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -80.59 -37.64 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.917 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.73 -27.28 69.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 54.43 113.122 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.639 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 17.8 pttt -63.39 -38.63 91.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.149 0.474 . . . . 62.130000000000003 110.957 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -32.07 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 42.329999999999998 110.453 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.4 t -80.85 -22.93 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.528 -0.76 . . . . 63.420000000000002 112.212 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.62 -26.89 3.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.759 0.314 . . . . 65.420000000000002 110.803 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.5 tttt -77.66 -31.61 52.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.183 0.516 . . . . 75.530000000000001 109.671 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -77.87 -33.55 52.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.386 -0.825 . . . . 43.340000000000003 110.305 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -45.3 12.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.779 -0.646 . . . . 64.340000000000003 111.026 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -52.43 -36.87 55.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 110.789 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -64.17 -33.16 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.439999999999998 110.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.51 12.89 36.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 111.671 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.2 tt -55.87 -43.11 99.05 Favored Pre-proline 0 C--O 1.223 -0.331 0 C-N-CA 120.155 -0.618 . . . . 54.340000000000003 109.949 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 7.0 Cg_exo -65.27 -24.4 58.24 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.89 2.393 . . . . 74.209999999999994 109.945 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.885 ' O ' HD11 ' A' ' 56' ' ' ILE . 54.6 t -95.39 -15.14 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.765 -1.107 . . . . 64.510000000000005 111.216 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 61.1 t -100.08 -28.8 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 54.310000000000002 108.94 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.4 m -82.27 -42.29 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 114.995 -1.002 . . . . 44.509999999999998 110.589 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.98 -29.53 2.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.601 -0.809 . . . . 65.230000000000004 111.976 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.885 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.59 -40.72 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 73.25 109.758 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -21.75 56.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.654 . . . . 74.239999999999995 109.432 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.42 -27.21 25.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.742 -0.663 . . . . 44.32 110.411 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.79 -44.81 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.357 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.739 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.7 -2.28 81.99 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.65 -0.786 . . . . 54.310000000000002 111.245 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 74.140000000000001 110.932 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.484 -0.246 . . . . 72.409999999999997 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.82 71.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.694 -0.765 . . . . 74.310000000000002 112.679 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.37 -61.38 1.94 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.022 0.439 . . . . 73.019999999999996 110.799 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.8 tttt -60.62 -23.72 64.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 75.510000000000005 110.332 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -40.66 78.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.932 -0.576 . . . . 65.030000000000001 110.922 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.3 tp -74.39 -40.35 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 74.299999999999997 110.958 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.64 -54.72 24.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 60.109999999999999 112.589 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -26.98 62.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 75.109999999999999 111.113 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.42 -57.83 8.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 73.420000000000002 110.913 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -46.59 72.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 61.549999999999997 111.003 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.13 82.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 111.019 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.53 -47.9 67.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.819 -0.705 . . . . 35.240000000000002 112.549 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.01 -44.62 88.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.392 . . . . 72.430000000000007 110.842 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.9 -37.74 63.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.034 -0.603 . . . . 65.310000000000002 112.58 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mttt -62.13 -36.59 82.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.699 0.285 . . . . 53.119999999999997 110.43 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.53 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.577 . . . . 74.140000000000001 110.286 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 38' ' ' ALA . 17.2 t -55.44 -23.9 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 73.439999999999998 111.834 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.83 -27.96 5.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 64.230000000000004 110.444 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 mtmm -77.86 -33.94 51.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.171 0.51 . . . . 71.319999999999993 109.814 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.84 64.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.609 -0.723 . . . . 73.030000000000001 110.274 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -85.39 -50.33 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.756 -0.656 . . . . 73.299999999999997 111.16 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.7 pp20? -51.15 -34.41 31.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.911 0.386 . . . . 72.329999999999998 111.089 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -36.76 82.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 52.439999999999998 111.087 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.68 14.14 31.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 60.329999999999998 111.916 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -57.88 -42.57 96.02 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.084 -0.646 . . . . 61.119999999999997 109.861 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.6 Cg_exo -66.04 -24.06 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.884 2.389 . . . . 70.010000000000005 109.877 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 64.6 t -95.09 -15.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.766 -1.107 . . . . 62.32 111.161 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.9 t -100.15 -28.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 71.219999999999999 108.874 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.29 -41.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 115.082 -0.963 . . . . 73.400000000000006 110.534 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.96 -29.48 2.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.657 -0.783 . . . . 60.32 112.072 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.33 -40.74 16.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.493 . . . . 51.25 109.808 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -76.48 -21.96 55.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.75 -0.659 . . . . 71.299999999999997 109.465 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.633 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.93 -27.88 26.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.785 -0.643 . . . . 63.100000000000001 110.398 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.745 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.1 -44.99 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.92 -0.582 . . . . 51.32 110.349 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.68 -3.1 84.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.175 -0.77 . . . . 44.329999999999998 111.175 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.292 -0.861 . . . . 75.310000000000002 111.009 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.508 -0.237 . . . . 70.019999999999996 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -66.5 -21.99 71.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.772 . . . . 51.530000000000001 112.642 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -56.69 -61.29 2.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 74.409999999999997 110.105 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -23.46 67.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 72.329999999999998 109.756 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -66.89 -39.81 87.57 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.762 -0.653 . . . . 60.049999999999997 110.921 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 tp -79.2 -38.47 35.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 61.149999999999999 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.34 -22.34 78.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.779 -0.724 . . . . 73.109999999999999 112.643 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.06 -26.31 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 61.149999999999999 111.066 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -66.14 -60.5 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 64.120000000000005 110.783 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.2 tm? -58.5 -51.71 68.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 74.409999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.99 -34.39 59.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.556 . . . . 71.329999999999998 111.04 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.2 -37.2 71.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.771 -0.728 . . . . 72.319999999999993 112.464 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.43 -45.86 57.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.019999999999996 110.864 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.0 -21.78 32.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.829 -0.701 . . . . 72.25 112.747 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -73.12 -42.62 62.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.582 0.191 . . . . 55.5 111.25 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -81.56 -39.3 24.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 74.530000000000001 110.699 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 38' ' ' ALA . 41.6 t -67.94 -22.53 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 72.329999999999998 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.8 -26.95 1.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 111.226 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 1.1 mttt -78.61 -35.25 45.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.026 0.441 . . . . 71.439999999999998 110.111 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -58.9 -40.78 85.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 72.049999999999997 110.293 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -85.14 -33.04 22.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.891 -0.595 . . . . 62.140000000000001 110.211 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -57.19 -39.82 76.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 70.549999999999997 110.431 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -66.75 -29.14 69.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 65.299999999999997 110.999 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.72 11.48 32.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.419 -0.355 . . . . 54.409999999999997 111.833 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.79 -43.1 99.03 Favored Pre-proline 0 C--O 1.223 -0.312 0 C-N-CA 120.164 -0.614 . . . . 71.239999999999995 109.981 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.3 Cg_exo -67.13 -21.87 48.07 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.768 2.312 . . . . 72.409999999999997 110.02 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.942 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.6 t -97.77 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.008 -0.996 . . . . 74.430000000000007 111.415 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -102.25 -27.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 60.530000000000001 108.881 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.5 m -82.5 -42.06 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 114.992 -1.004 . . . . 75.329999999999998 110.637 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.962 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -47.16 -28.34 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.493 -0.861 . . . . 55.210000000000001 112.277 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.942 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -86.53 -29.32 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.483 . . . . 62.340000000000003 109.963 179.116 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 2.1 mtmt -86.45 -24.08 25.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 71.510000000000005 109.524 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.92 -21.21 25.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.581 . . . . 71.140000000000001 112.25 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.962 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.1 pp -62.05 -61.47 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.147 0.499 . . . . 72.209999999999994 112.17 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -135.08 8.25 4.44 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.911 -0.876 . . . . 52.32 110.911 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.5 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 72.019999999999996 111.197 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.529 -0.228 . . . . 52.119999999999997 112.529 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -73.32 -24.27 75.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 52.219999999999999 112.56 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.51 -62.2 1.55 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.278 0.561 . . . . 73.420000000000002 110.841 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -65.35 -23.92 67.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 71.319999999999993 110.008 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -71.02 -34.78 71.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.876 -0.602 . . . . 74.019999999999996 110.701 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.0 tp -81.91 -34.2 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 62.119999999999997 110.837 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.9 -21.97 77.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 73.340000000000003 112.822 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -95.03 -46.66 6.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.31 . . . . 71.409999999999997 111.154 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 3.3 pttt -57.41 -50.52 72.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.98 0.419 . . . . 72.099999999999994 110.856 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -64.71 -42.85 94.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.76 -0.655 . . . . 51.310000000000002 110.842 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -39.42 76.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 111.034 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.91 -41.99 68.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 74.430000000000007 112.647 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.64 -46.21 73.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 54.030000000000001 110.848 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.82 -34.03 56.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.973 -0.632 . . . . 63.32 112.692 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -64.39 -37.69 88.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.695 0.283 . . . . 72.439999999999998 110.436 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -51.2 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 72.120000000000005 110.252 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 15.8 t -56.97 -23.65 18.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 74.439999999999998 111.739 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.82 -27.05 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.338 . . . . 74.310000000000002 110.708 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 tttp -82.07 -35.04 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.083 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.98 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 73.109999999999999 110.05 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.99 -33.33 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 72.549999999999997 110.174 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mm-40 -58.66 -36.77 74.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 73.150000000000006 110.373 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -66.07 -31.02 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.91 -0.587 . . . . 74.430000000000007 110.794 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.779 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.18 13.54 30.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.519999999999996 111.638 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.7 tt -57.56 -42.65 96.82 Favored Pre-proline 0 C--O 1.223 -0.335 0 C-N-CA 120.09 -0.644 . . . . 63.25 109.756 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.47 -24.67 56.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.845 2.364 . . . . 73.129999999999995 109.826 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.858 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.5 t -94.36 -15.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 114.718 -1.128 . . . . 73.540000000000006 111.262 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 49' ' ' ALA . 86.4 t -100.58 -29.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.932 -0.766 . . . . 62.240000000000002 108.932 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.21 -42.0 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 114.986 -1.006 . . . . 70.340000000000003 110.511 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.62 2.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.688 -0.767 . . . . 55.229999999999997 111.974 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.858 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -82.8 -41.47 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.49 . . . . 74.239999999999995 109.808 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -22.29 56.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 64.129999999999995 109.341 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.6 -27.2 27.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.788 -0.642 . . . . 53.399999999999999 110.391 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.62 -44.45 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.911 -0.586 . . . . 64.200000000000003 110.341 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.67 -2.62 84.46 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.206 -0.758 . . . . 44.520000000000003 111.206 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.226 -0.893 . . . . 70.409999999999997 110.895 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.43 -0.268 . . . . 62.140000000000001 112.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.99 -27.49 31.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.767 -0.73 . . . . 74.310000000000002 112.6 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -50.5 -62.18 1.74 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.168 0.508 . . . . 64.439999999999998 110.647 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 14.0 mtpp -64.89 -23.91 67.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 73.219999999999999 109.734 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.85 -40.29 79.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.776 -0.647 . . . . 63.5 110.755 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -81.94 -35.87 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 73.25 110.875 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.04 -22.4 78.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 71.0 112.843 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -97.64 -27.19 14.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.312 . . . . 73.310000000000002 111.126 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -62.22 -56.4 19.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 74.510000000000005 110.724 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -64.09 -54.18 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.879 -0.6 . . . . 70.219999999999999 110.846 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -45.09 78.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 74.549999999999997 111.084 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.82 44.93 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.797 -0.716 . . . . 64.230000000000004 112.708 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.43 -48.72 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.863 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.05 50.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.015 -0.612 . . . . 73.430000000000007 112.66 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -59.78 -37.65 79.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.697 0.284 . . . . 71.030000000000001 110.464 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -52.25 7.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.202 0.525 . . . . 74.530000000000001 110.221 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.3 t -55.51 -25.27 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 64.200000000000003 111.742 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.72 -26.78 2.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 74.450000000000003 110.753 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.1 tttt -81.99 -35.13 29.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.106 0.479 . . . . 53.310000000000002 110.102 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.14 90.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 72.420000000000002 110.19 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.18 -34.76 22.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 65.420000000000002 110.342 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -57.85 -38.52 75.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.494 . . . . 73.310000000000002 110.524 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -66.71 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 71.420000000000002 111.118 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.11 11.97 32.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 63.32 111.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.916 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.9 tt -56.64 -42.73 97.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 C-N-CA 120.025 -0.67 . . . . 73.109999999999999 109.852 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -25.39 55.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.817 2.345 . . . . 73.219999999999999 109.811 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.898 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -93.98 -13.64 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 114.865 -1.061 . . . . 55.310000000000002 111.237 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' ALA . 58.4 t -101.81 -29.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.882 -0.785 . . . . 73.439999999999998 108.882 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.23 -42.09 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.042 -0.981 . . . . 73.340000000000003 110.398 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.27 -29.33 2.42 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 51.32 111.96 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.898 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.14 -39.74 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.625 -0.509 . . . . 62.210000000000001 109.625 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 1.1 mtmm -76.1 -21.02 57.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 63.119999999999997 109.602 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.53 -21.46 25.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 72.099999999999994 111.286 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 55' ' ' GLY . 23.7 pt -91.26 -47.12 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.079 0.466 . . . . 73.349999999999994 112.17 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' HG13 ' A' ' 59' ' ' ILE . . . -133.27 4.06 4.84 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.251 -0.739 . . . . 72.120000000000005 111.251 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.25 -0.881 . . . . 72.430000000000007 110.831 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.487 -0.245 . . . . 45.030000000000001 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 -21.8 74.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.624 -0.798 . . . . 55.240000000000002 112.68 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -46.53 -61.45 1.81 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 74.409999999999997 110.883 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.27 -23.79 64.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 63.039999999999999 110.405 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -41.14 76.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 72.409999999999997 111.0 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.438 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.3 tp -79.87 -35.35 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 111.034 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.41 -22.01 76.23 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 70.010000000000005 112.838 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -93.79 -43.3 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 73.150000000000006 111.158 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -58.79 -50.82 72.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.411 . . . . 34.340000000000003 111.021 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.438 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.12 -48.93 79.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 71.340000000000003 111.074 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -45.29 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 54.229999999999997 111.19 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.13 -44.27 51.18 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.837 -0.697 . . . . 60.409999999999997 112.732 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.96 -48.59 70.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.936 0.398 . . . . 51.149999999999999 110.907 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.14 -35.95 55.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.986 -0.626 . . . . 63.229999999999997 112.641 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mtpt -62.73 -37.49 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 73.439999999999998 110.421 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.7 -53.01 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 74.510000000000005 110.315 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 38' ' ' ALA . 14.6 t -55.8 -23.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.316 -0.856 . . . . 75.019999999999996 111.679 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.14 -27.85 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.348 . . . . 71.549999999999997 110.456 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 mttm -78.47 -32.79 48.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 61.020000000000003 109.798 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.32 -32.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.621 -0.718 . . . . 74.109999999999999 110.302 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.37 -47.98 9.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 63.350000000000001 111.044 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -51.9 -33.96 39.18 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 64.329999999999998 110.916 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -66.17 -38.32 87.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 65.209999999999994 111.053 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -100.37 12.94 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 34.310000000000002 111.82 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.908 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.0 tt -56.79 -42.81 98.21 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.068 -0.653 . . . . 75.109999999999999 109.837 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 5.1 Cg_exo -65.82 -25.07 53.4 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.747 2.298 . . . . 74.040000000000006 109.944 176.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.923 ' O ' HD11 ' A' ' 56' ' ' ILE . 56.0 t -95.43 -11.02 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.909 -1.042 . . . . 75.25 111.229 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 73.2 t -104.35 -28.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.798 -0.815 . . . . 63.049999999999997 108.798 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.908 HG13 ' O ' ' A' ' 50' ' ' LEU . 18.1 m -82.28 -41.82 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.002 -0.999 . . . . 63.439999999999998 110.443 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.769 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.28 -28.72 3.34 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.596 -0.811 . . . . 73.450000000000003 112.089 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.923 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.14 -35.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.593 -0.521 . . . . 73.019999999999996 109.593 178.912 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.05 -22.04 45.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.68 -0.691 . . . . 64.310000000000002 109.491 178.446 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.73 -21.42 25.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.059 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -96.67 -44.52 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 112.105 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -129.84 4.42 6.1 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.809 -0.71 . . . . 42.43 111.607 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 48.1 tttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.832 . . . . 72.120000000000005 110.952 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.534 -0.226 . . . . 65.299999999999997 112.534 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -72.28 -21.9 79.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 112.657 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.13 -61.1 2.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 75.430000000000007 110.222 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -23.39 67.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 74.519999999999996 109.719 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -68.4 -38.28 81.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.794 -0.639 . . . . 74.140000000000001 110.937 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -79.25 -36.65 39.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.8 -57.24 9.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 42.0 112.558 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -25.43 63.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 62.439999999999998 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -65.27 -59.09 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.100000000000001 110.833 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -46.35 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 72.349999999999994 111.003 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -54.9 -38.75 67.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 74.5 111.019 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.67 95.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 54.32 112.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -66.45 -43.65 84.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 73.120000000000005 110.843 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.51 -36.03 57.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.002 -0.618 . . . . 75.209999999999994 112.617 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -62.15 -36.61 82.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.724 0.297 . . . . 71.420000000000002 110.269 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -52.96 6.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.259 0.552 . . . . 62.409999999999997 110.152 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.7 t -56.62 -23.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.217 -0.901 . . . . 70.310000000000002 111.867 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.78 -27.77 5.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 75.230000000000004 110.553 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 23.2 mttt -77.79 -33.75 52.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.115 0.483 . . . . 65.319999999999993 109.787 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 -33.02 60.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.562 -0.744 . . . . 72.439999999999998 110.254 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.32 -47.87 9.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 72.519999999999996 111.121 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -52.36 -39.03 60.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.964 0.412 . . . . 63.5 111.025 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -30.07 71.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 75.200000000000003 111.115 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.83 11.44 35.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 44.210000000000001 111.901 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.34 -43.34 99.06 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 120.238 -0.585 . . . . 63.399999999999999 110.123 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.0 Cg_exo -66.34 -22.43 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.819 2.346 . . . . 64.540000000000006 110.017 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.871 ' O ' HD11 ' A' ' 56' ' ' ILE . 79.6 t -96.2 -17.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.797 -1.092 . . . . 75.430000000000007 111.26 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.8 p -98.76 -27.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.939 -0.763 . . . . 72.510000000000005 108.939 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.0 m -82.38 -42.19 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.099 -0.955 . . . . 75.530000000000001 110.511 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.95 -29.46 2.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.731 -0.747 . . . . 72.329999999999998 112.011 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.57 -40.29 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 63.420000000000002 109.784 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -21.97 54.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.393 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.12 -24.1 28.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.792 -0.64 . . . . 51.210000000000001 110.439 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -96.63 -43.97 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 115.935 -0.575 . . . . 72.540000000000006 110.495 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.751 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -83.45 -4.97 89.03 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.628 -0.796 . . . . 55.310000000000002 111.291 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.248 -0.882 . . . . 52.409999999999997 110.996 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.487 -0.245 . . . . 55.420000000000002 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.55 -24.76 41.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.747 . . . . 71.230000000000004 112.608 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.36 -62.25 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.18 0.515 . . . . 74.329999999999998 110.925 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 15.4 mttt -65.54 -23.89 66.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.387 -0.824 . . . . 73.0 109.916 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -70.54 -34.7 72.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 71.319999999999993 110.728 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.4 tm? -81.98 -34.96 29.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 110.988 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.07 -58.77 5.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 51.399999999999999 112.605 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -37.32 65.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 64.319999999999993 111.114 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -65.03 -57.45 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 74.200000000000003 110.844 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.39 90.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 111.067 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -47.81 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.530000000000001 110.938 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.71 -48.92 59.93 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.807 -0.711 . . . . 52.539999999999999 112.383 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.28 -47.6 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 72.329999999999998 110.654 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.57 24.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.056 -0.592 . . . . 62.299999999999997 112.529 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 6.3 mmtp -65.12 -59.14 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.125 0.488 . . . . 64.329999999999998 110.031 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -28.77 63.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 64.420000000000002 110.139 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 38' ' ' ALA . 19.1 t -78.88 -43.68 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.575 -0.739 . . . . 54.32 111.638 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -50.07 -37.21 32.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.448 . . . . 75.420000000000002 109.789 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -76.28 -30.75 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 51.350000000000001 109.896 178.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.09 99.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.784 -0.644 . . . . 50.299999999999997 110.493 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 t -84.97 -35.78 21.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 110.47 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 1.9 mm-40 -56.5 -34.06 66.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.423 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -69.18 -31.57 70.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 64.230000000000004 110.757 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.772 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -106.11 12.8 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 54.420000000000002 111.636 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.912 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.42 -42.56 96.5 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.18 -0.608 . . . . 71.5 109.697 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.1 Cg_exo -65.58 -23.98 56.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.832 2.354 . . . . 72.109999999999999 109.875 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.877 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -94.93 -15.65 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.71 -1.132 . . . . 51.009999999999998 111.21 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 49' ' ' ALA . 77.7 t -100.14 -28.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.998 -0.742 . . . . 71.420000000000002 108.998 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.8 m -82.36 -42.05 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.994 -1.003 . . . . 75.430000000000007 110.475 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.9 -29.59 2.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.652 -0.785 . . . . 75.049999999999997 111.956 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.67 -39.95 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.093 0.473 . . . . 74.150000000000006 109.81 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -77.13 -21.59 53.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 71.430000000000007 109.514 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.26 -28.41 25.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.817 -0.629 . . . . 43.210000000000001 110.313 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -89.86 -45.12 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.965 -0.561 . . . . 73.019999999999996 110.444 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.4 -2.88 82.21 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.679 -0.772 . . . . 24.010000000000002 111.229 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.238 -0.887 . . . . 65.120000000000005 110.966 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.475 -0.25 . . . . 73.310000000000002 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.28 -21.99 59.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 54.020000000000003 112.672 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -48.02 -61.28 2.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.956 0.408 . . . . 63.049999999999997 110.721 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.6 tptt -60.41 -23.69 64.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.84 -0.618 . . . . 72.540000000000006 110.291 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.2 -42.32 80.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.944 -0.571 . . . . 70.540000000000006 110.74 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -78.31 -41.64 33.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 62.450000000000003 110.84 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.61 -22.98 66.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 64.010000000000005 112.643 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -94.1 -28.97 15.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 51.420000000000002 111.028 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -64.44 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.254 0.55 . . . . 64.25 110.907 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 -40.81 54.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 75.019999999999996 110.961 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.55 -37.85 73.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 70.25 110.917 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.91 91.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 23.219999999999999 112.448 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.881 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.39 -41.12 61.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 75.140000000000001 110.937 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.67 69.61 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.067 -0.587 . . . . 72.349999999999994 112.531 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.2 -58.13 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.933 0.396 . . . . 73.340000000000003 110.549 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.49 -19.88 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 73.400000000000006 110.15 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 38' ' ' ALA . 42.8 t -83.17 -48.14 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.848 -0.615 . . . . 71.319999999999993 110.714 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.44 -39.88 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 74.25 109.765 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -76.23 -28.97 57.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.726 -0.67 . . . . 74.099999999999994 109.558 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -64.3 -46.0 85.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.584 -0.734 . . . . 65.310000000000002 110.32 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -79.24 -35.07 42.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.84 -0.618 . . . . 73.540000000000006 110.072 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.29 -21.81 50.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 54.039999999999999 110.394 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.83 66.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.717 -0.475 . . . . 64.450000000000003 109.717 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.753 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -112.72 18.11 18.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.897 -0.592 . . . . 52.130000000000003 110.602 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.82 -36.27 24.64 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.788 -0.765 . . . . 70.200000000000003 110.444 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.846 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 49.7 Cg_endo -77.96 -12.18 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.772 2.314 . . . . 53.140000000000001 109.929 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.892 ' O ' HD11 ' A' ' 56' ' ' ILE . 65.0 t -105.86 -10.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.856 -1.065 . . . . 71.329999999999998 110.366 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.4 t -105.75 -31.14 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.676 -0.861 . . . . 65.230000000000004 108.676 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 50' ' ' LEU . 20.5 m -82.38 -39.92 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.41 -0.814 . . . . 74.099999999999994 110.393 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.18 -29.28 3.48 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.602 -0.809 . . . . 70.040000000000006 112.05 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.47 -37.73 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 74.5 109.724 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -78.01 -21.71 50.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 65.329999999999998 109.545 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.84 -27.15 25.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.887 -0.597 . . . . 45.140000000000001 110.367 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.15 -45.08 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.879 -0.601 . . . . 72.310000000000002 110.473 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.14 -1.42 79.17 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.773 . . . . 65.430000000000007 111.302 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.3 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 71.040000000000006 110.85 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.386 -0.286 . . . . 54.109999999999999 112.386 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -78.8 -22.86 65.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 72.510000000000005 112.6 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.25 -62.12 1.57 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.171 0.51 . . . . 72.239999999999995 111.008 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.4 ptmt -65.34 -23.89 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.471 -0.786 . . . . 74.409999999999997 110.038 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -71.32 -36.03 71.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 75.329999999999998 110.741 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -82.04 -42.59 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.873 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -22.02 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.129999999999995 112.799 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -97.07 -23.85 16.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.642 0.258 . . . . 51.030000000000001 111.24 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -67.32 -60.82 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 74.450000000000003 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -45.91 91.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 72.019999999999996 110.935 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.31 -40.44 71.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 62.530000000000001 111.125 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.97 -41.26 59.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.747 -0.739 . . . . 53.219999999999999 112.592 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.848 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.94 -47.14 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.129999999999995 110.814 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.82 69.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.927 -0.654 . . . . 45.130000000000003 112.596 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -63.02 -36.47 83.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.667 0.27 . . . . 72.310000000000002 110.426 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.224 0.535 . . . . 74.109999999999999 110.28 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.3 t -57.0 -24.05 19.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.346 -0.843 . . . . 34.240000000000002 111.858 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.42 -27.24 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.483 -0.326 . . . . 73.519999999999996 110.81 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -81.0 -36.83 30.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 109.941 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 71.120000000000005 109.928 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -85.29 -36.94 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 51.329999999999998 110.349 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.23 -36.48 73.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 62.039999999999999 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -67.02 -31.81 72.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 70.019999999999996 110.949 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -102.03 11.56 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.010000000000005 111.819 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.01 -43.62 99.16 Favored Pre-proline 0 C--O 1.224 -0.268 0 C-N-CA 120.263 -0.575 . . . . 71.010000000000005 110.064 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.2 Cg_exo -66.25 -21.52 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.885 2.39 . . . . 61.310000000000002 110.107 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.862 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -97.92 -17.24 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.944 -1.025 . . . . 70.430000000000007 111.289 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -98.85 -27.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.003 -0.74 . . . . 75.540000000000006 109.003 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.9 m -82.21 -42.4 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.14 -0.936 . . . . 61.329999999999998 110.583 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.87 -29.63 2.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.658 -0.782 . . . . 74.150000000000006 111.961 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.82 -40.84 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.707 -0.479 . . . . 73.319999999999993 109.707 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 -21.56 57.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 75.230000000000004 109.425 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.87 -26.86 25.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.871 -0.604 . . . . 64.019999999999996 110.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.7 -44.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.484 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.93 0.01 78.64 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.217 -0.753 . . . . 41.439999999999998 111.217 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.207 -0.902 . . . . 71.150000000000006 110.83 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.394 -0.282 . . . . 52.030000000000001 112.394 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -67.5 -29.12 73.76 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.682 -0.771 . . . . 63.310000000000002 112.417 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.95 -62.21 1.58 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.224 0.535 . . . . 62.539999999999999 110.799 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 1.2 mttt -64.61 -23.89 67.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.358 -0.837 . . . . 73.140000000000001 109.792 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.97 -41.9 77.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 110.581 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 tp -82.06 -36.52 27.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.498 . . . . 55.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -21.95 72.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.712 . . . . 64.540000000000006 112.654 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -101.42 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 75.519999999999996 111.173 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -64.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.966 0.412 . . . . 65.439999999999998 110.88 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -44.1 75.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 71.25 111.067 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -39.24 76.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 111.021 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.22 93.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.753 . . . . 65.329999999999998 112.333 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.871 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.94 -50.73 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 54.539999999999999 110.592 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 43' ' ' PHE . . . -52.37 -31.42 35.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.955 -0.641 . . . . 30.210000000000001 112.519 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 8.3 tttm -66.69 -35.85 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.184 0.516 . . . . 63.299999999999997 110.21 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -24.25 37.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 65.340000000000003 109.74 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 38' ' ' ALA . 11.8 t -85.28 -40.36 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 74.239999999999995 111.397 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -51.12 -33.16 25.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 109.788 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -79.63 -30.32 41.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 75.319999999999993 109.762 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.84 -44.74 84.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.774 -0.648 . . . . 54.140000000000001 110.167 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -77.56 -34.67 53.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 61.399999999999999 109.914 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.862 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.74 -21.72 61.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 73.510000000000005 110.436 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -73.14 -32.15 64.72 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.735 -0.468 . . . . 73.230000000000004 109.735 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -111.29 18.33 19.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.753 -0.658 . . . . 74.340000000000003 110.559 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.3 pp -62.92 -36.38 24.99 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.948 -0.701 . . . . 54.530000000000001 110.352 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.817 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 46.5 Cg_endo -77.52 -12.31 16.92 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.745 2.296 . . . . 63.119999999999997 110.033 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.888 ' O ' HD11 ' A' ' 56' ' ' ILE . 70.0 t -104.85 -12.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.718 -1.128 . . . . 75.049999999999997 110.225 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 49' ' ' ALA . 85.9 t -104.2 -31.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.631 -0.877 . . . . 70.019999999999996 108.631 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.32 -39.74 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.379 -0.828 . . . . 64.530000000000001 110.398 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.83 -29.53 3.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.55 -0.834 . . . . 71.239999999999995 112.053 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -84.05 -39.74 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.114 0.483 . . . . 73.200000000000003 109.839 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -21.84 54.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 63.119999999999997 109.422 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.22 -28.13 25.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.78 -0.645 . . . . 72.010000000000005 110.363 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.53 -45.12 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 115.967 -0.56 . . . . 73.230000000000004 110.396 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.51 -2.53 82.24 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.233 -0.747 . . . . 73.239999999999995 111.233 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.265 -0.874 . . . . 65.319999999999993 110.867 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.397 -0.281 . . . . 74.150000000000006 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 -21.93 50.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.409999999999997 112.599 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -47.67 -61.5 1.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.019 0.438 . . . . 63.520000000000003 110.748 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' HD13 ' A' ' 28' ' ' LEU . 8.0 tttp -61.21 -23.67 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.64 . . . . 71.5 110.42 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -68.86 -40.63 79.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 61.039999999999999 110.866 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -79.62 -39.91 30.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 62.240000000000002 111.015 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.35 -22.01 76.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.808 -0.71 . . . . 75.209999999999994 112.756 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -96.02 -26.8 15.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.202 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.16 -63.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 74.549999999999997 111.023 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -41.03 78.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 71.120000000000005 111.099 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -37.98 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.21 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.23 -38.02 66.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 75.510000000000005 112.769 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.88 -49.33 47.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 52.420000000000002 111.073 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.22 -21.88 27.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.651 -0.785 . . . . 55.43 112.911 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.633 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.69 -39.33 24.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.772 0.286 . . . . 75.209999999999994 111.116 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.67 -37.17 27.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.173 0.511 . . . . 65.049999999999997 110.625 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 38' ' ' ALA . 31.7 t -72.56 -22.67 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.604 -0.725 . . . . 71.420000000000002 111.839 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.87 -26.8 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 74.519999999999996 110.76 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.504 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.3 mttp -76.36 -34.29 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.101 0.477 . . . . 62.030000000000001 109.819 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -72.03 -35.12 69.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.604 -0.725 . . . . 65.040000000000006 110.405 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -50.86 6.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.616 . . . . 74.519999999999996 111.265 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 pp20? -50.56 -34.55 26.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.827 0.346 . . . . 53.329999999999998 111.049 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.78 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 111.011 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.1 11.81 38.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.358 . . . . 64.329999999999998 111.926 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.52 -43.35 99.1 Favored Pre-proline 0 C--O 1.223 -0.339 0 C-N-CA 120.213 -0.595 . . . . 64.109999999999999 110.052 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.8 Cg_exo -66.11 -22.73 54.08 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.866 2.377 . . . . 70.099999999999994 110.007 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 77.2 t -96.27 -16.97 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.814 -1.085 . . . . 74.540000000000006 111.266 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.34 -27.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.898 -0.778 . . . . 74.209999999999994 108.898 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.3 m -82.23 -42.43 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.047 -0.978 . . . . 62.520000000000003 110.548 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.55 2.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.627 -0.797 . . . . 72.319999999999993 112.032 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.93 -39.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 74.109999999999999 109.789 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -76.93 -22.01 53.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 72.430000000000007 109.475 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.31 -27.55 25.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.807 -0.633 . . . . 45.229999999999997 110.407 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.5 -45.28 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.975 -0.557 . . . . 61.43 110.392 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.748 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.66 -2.82 81.48 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.637 -0.792 . . . . 61.530000000000001 111.198 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 63.439999999999998 110.929 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.472 -0.251 . . . . 45.030000000000001 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.55 -21.97 77.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.52 -61.38 1.95 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.032 0.444 . . . . 74.329999999999998 110.748 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -60.5 -23.77 64.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 73.129999999999995 110.309 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -68.22 -42.84 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 75.340000000000003 110.744 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.02 -34.6 29.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 110.913 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.62 -21.93 71.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 33.140000000000001 112.89 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -105.45 -24.43 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 72.349999999999994 111.404 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.6 -60.62 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 75.340000000000003 110.919 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.514 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.1 tm? -62.76 -52.83 61.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.009 -0.541 . . . . 74.329999999999998 110.983 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -34.14 46.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 74.349999999999994 111.254 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.23 -36.49 68.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.673 -0.775 . . . . 42.240000000000002 112.424 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.66 -45.3 59.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 51.119999999999997 110.858 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -21.93 30.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 33.439999999999998 112.762 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 4.1 mttt -79.26 -40.57 30.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.66 0.23 . . . . 63.130000000000003 111.058 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.69 -39.28 24.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 70.150000000000006 110.732 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' ALA . 38.7 t -70.0 -22.34 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 74.019999999999996 111.696 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.91 -27.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.598 -0.274 . . . . 70.420000000000002 110.979 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -75.42 -34.75 61.05 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.174 0.511 . . . . 64.0 109.983 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -73.01 -34.39 66.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 75.209999999999994 110.416 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.1 p -85.19 -49.58 8.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 111.181 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -51.15 -34.75 32.54 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.942 0.401 . . . . 71.310000000000002 111.12 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -38.27 83.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.071 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -96.67 13.16 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 54.219999999999999 111.808 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 tt -56.15 -43.35 99.22 Favored Pre-proline 0 C--O 1.223 -0.333 0 C-N-CA 120.158 -0.617 . . . . 74.239999999999995 110.102 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.7 Cg_exo -66.53 -21.83 52.33 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.908 2.406 . . . . 72.230000000000004 110.125 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.875 ' O ' HD11 ' A' ' 56' ' ' ILE . 68.3 t -97.42 -17.08 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.861 -1.063 . . . . 71.25 111.211 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.18 -27.79 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.969 -0.752 . . . . 73.450000000000003 108.969 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.3 -42.34 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-N 115.099 -0.955 . . . . 75.019999999999996 110.588 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.68 2.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.056 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.7 -40.36 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.171 0.51 . . . . 65.420000000000002 109.841 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -21.8 56.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 109.479 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.56 -26.91 25.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 110.384 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.3 -44.75 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.034 -0.53 . . . . 74.549999999999997 110.389 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -88.55 -1.45 80.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.655 -0.783 . . . . 72.430000000000007 111.277 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 63.530000000000001 110.869 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 45.030000000000001 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -21.91 78.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 63.530000000000001 112.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -47.51 -61.07 2.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.894 0.378 . . . . 75.430000000000007 110.821 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -61.1 -23.83 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.085 -0.507 . . . . 62.100000000000001 110.4 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.99 -42.71 80.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 73.450000000000003 110.714 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.639 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -82.09 -39.95 22.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 72.319999999999993 110.811 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.61 -22.48 61.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.778 -0.725 . . . . 75.450000000000003 112.731 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -101.56 -36.7 8.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.772 0.32 . . . . 75.540000000000006 110.935 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -64.38 -57.83 8.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 110.729 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -44.13 94.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 63.409999999999997 110.875 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.69 -44.92 81.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.074 -0.512 . . . . 74.530000000000001 111.04 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.93 -47.07 89.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 35.409999999999997 112.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.3 -45.34 48.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 33.340000000000003 110.908 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.24 -23.35 47.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.968 -0.634 . . . . 65.150000000000006 112.356 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 1.9 mmtt -64.89 -57.88 7.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 41.5 110.332 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.632 ' HD2' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.8 -20.08 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 110.043 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' HD2' ' A' ' 41' ' ' ARG . 95.1 t -81.13 -48.87 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 116.054 -0.521 . . . . 65.129999999999995 110.463 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.79 -46.2 41.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 71.209999999999994 109.606 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -70.42 -30.55 67.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 109.612 178.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -59.34 -45.06 92.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.896 -0.593 . . . . 64.400000000000006 110.377 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -85.11 -35.08 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.524 . . . . 61.340000000000003 110.549 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.75 -31.23 64.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 75.319999999999993 110.59 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -71.74 -31.28 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.528 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.94 13.36 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.513 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.902 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -56.03 -42.95 98.8 Favored Pre-proline 0 C--O 1.223 -0.321 0 C-N-CA 120.173 -0.611 . . . . 72.340000000000003 109.934 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -24.78 55.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.88 2.387 . . . . 74.209999999999994 109.848 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.926 ' O ' HD11 ' A' ' 56' ' ' ILE . 47.3 t -96.63 -9.8 9.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.828 -1.078 . . . . 75.049999999999997 111.169 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 62.0 t -105.42 -28.13 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.717 -0.846 . . . . 73.230000000000004 108.717 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 50' ' ' LEU . 19.2 m -82.39 -42.05 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.079 -0.964 . . . . 64.25 110.456 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.21 -28.76 3.28 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.531 -0.842 . . . . 53.350000000000001 112.097 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.41 -35.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.568 -0.53 . . . . 52.329999999999998 109.568 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.84 -21.82 47.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.61 -0.723 . . . . 75.510000000000005 109.498 178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.5 -21.45 25.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.937 -0.574 . . . . 54.219999999999999 110.858 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.49 -44.04 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 75.420000000000002 111.991 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -126.42 2.55 7.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.89 -0.671 . . . . 63.310000000000002 111.803 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 2.8 tttm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 51.520000000000003 111.045 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.493 -0.243 . . . . 45.030000000000001 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.95 78.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 62.32 112.658 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -47.0 -61.18 1.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.977 0.418 . . . . 45.310000000000002 110.826 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -23.82 66.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 64.450000000000003 110.387 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -69.12 -43.86 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.581 . . . . 72.299999999999997 110.703 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.7 tp -82.07 -39.1 23.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.209999999999994 110.861 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.3 66.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 75.140000000000001 112.655 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -26.08 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.701 0.286 . . . . 75.040000000000006 111.0 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -67.36 -64.5 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.258 0.552 . . . . 73.299999999999997 110.523 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 36' ' ' GLU . 3.9 pp -53.98 -47.76 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.85 . . . . 63.329999999999998 110.833 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -51.73 -37.74 52.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.41 -0.814 . . . . 63.119999999999997 111.049 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.41 -44.53 64.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 60.32 112.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -73.87 -34.55 64.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 73.230000000000004 110.907 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.04 -21.82 66.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.992 -0.623 . . . . 41.539999999999999 112.529 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.4 tttt -65.02 -58.22 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.955 0.407 . . . . 74.310000000000002 110.521 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -63.14 -19.87 64.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.973 0.416 . . . . 75.340000000000003 110.245 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 38' ' ' ALA . 40.3 t -84.32 -44.48 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.937 -0.574 . . . . 73.409999999999997 111.05 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.15 -39.65 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 109.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 3.2 mttm -75.1 -30.93 61.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 63.25 109.777 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.59 -41.63 99.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.751 -0.659 . . . . 74.120000000000005 110.565 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 t -85.08 -35.69 21.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.921 -0.581 . . . . 71.239999999999995 110.542 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.85 -34.0 67.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 54.310000000000002 110.499 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -69.27 -32.55 71.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 64.129999999999995 110.731 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.6 11.24 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.565 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.0 -43.58 99.12 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 120.243 -0.583 . . . . 72.129999999999995 110.106 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.5 Cg_exo -66.02 -22.06 55.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.857 2.371 . . . . 72.140000000000001 110.003 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.88 ' O ' HD11 ' A' ' 56' ' ' ILE . 75.0 t -97.31 -16.9 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.902 -1.044 . . . . 61.5 111.322 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -99.43 -27.61 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.985 -0.746 . . . . 73.340000000000003 108.985 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.6 m -82.23 -42.33 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 115.071 -0.968 . . . . 62.100000000000001 110.445 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.13 -29.65 2.36 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 74.329999999999998 112.003 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.88 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.73 -38.47 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.164 0.506 . . . . 74.239999999999995 109.654 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 4.5 mtmt -76.31 -21.7 55.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 70.109999999999999 109.458 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.6 -21.49 25.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.94 -0.573 . . . . 74.340000000000003 110.939 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -99.73 -43.61 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 73.209999999999994 111.905 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.732 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -125.03 1.46 8.4 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.586 -0.734 . . . . 73.219999999999999 111.828 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.197 -0.906 . . . . 62.130000000000003 110.945 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.494 -0.242 . . . . 54.329999999999998 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -83.03 -26.55 44.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 75.239999999999995 112.585 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -48.15 -62.2 1.6 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.225 0.536 . . . . 75.239999999999995 110.924 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -64.45 -23.95 67.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.382 -0.827 . . . . 75.040000000000006 109.885 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.74 -35.81 77.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.886 -0.597 . . . . 72.310000000000002 110.639 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.95 -35.73 28.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 72.409999999999997 110.911 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -57.5 7.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 42.399999999999999 112.612 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.98 -26.49 62.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.689 0.281 . . . . 63.130000000000003 111.016 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.95 -56.41 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.964 0.411 . . . . 65.219999999999999 110.644 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -51.99 15.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.951 -0.568 . . . . 62.409999999999997 110.752 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -32.5 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 72.299999999999997 110.977 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.16 -38.15 88.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.776 . . . . 63.310000000000002 112.456 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.26 -41.75 73.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 73.329999999999998 110.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.33 -21.84 35.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 71.099999999999994 112.574 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.573 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -81.07 -40.72 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 0.175 . . . . 72.099999999999994 110.977 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.33 -40.63 23.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 110.671 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.7 t -65.76 -22.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.677 -0.692 . . . . 70.129999999999995 111.415 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.83 -28.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 53.439999999999998 110.833 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -72.21 -43.4 64.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.659 0.742 . . . . 65.219999999999999 109.75 179.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 44' ' ' LYS . . . -66.69 -34.61 78.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.58 -1.191 . . . . 53.119999999999997 110.588 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 p -85.16 -45.92 11.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.544 . . . . 65.209999999999994 111.031 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.861 ' HA ' HD23 ' A' ' 50' ' ' LEU . 2.6 pp20? -58.63 -20.4 47.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 54.420000000000002 110.873 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -33.11 64.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.742 -0.466 . . . . 64.430000000000007 109.742 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -110.24 18.43 19.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.721 -0.672 . . . . 51.530000000000001 110.515 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.861 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.52 -36.37 26.67 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 119.917 -0.713 . . . . 72.420000000000002 110.44 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.805 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 50.1 Cg_endo -77.82 -11.36 16.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.794 2.329 . . . . 44.420000000000002 110.052 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.901 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -107.46 -10.77 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.697 -1.138 . . . . 75.430000000000007 110.333 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 49' ' ' ALA . 83.0 t -105.05 -30.77 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.682 -0.858 . . . . 71.209999999999994 108.682 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.35 -40.22 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.422 -0.808 . . . . 63.299999999999997 110.404 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.709 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.98 -29.37 3.29 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.533 -0.842 . . . . 74.25 112.072 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.901 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -85.12 -38.17 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.687 -0.486 . . . . 65.230000000000004 109.687 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -77.69 -21.79 51.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.717 -0.674 . . . . 62.299999999999997 109.483 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.77 -26.94 25.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.898 -0.592 . . . . 51.539999999999999 110.383 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.52 -45.01 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.936 -0.575 . . . . 64.200000000000003 110.498 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.0 -1.45 79.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 74.430000000000007 111.317 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.5 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.245 -0.883 . . . . 72.219999999999999 110.89 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.505 -0.238 . . . . 64.430000000000007 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.52 -25.24 65.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.571 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.68 -62.15 1.59 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.187 0.518 . . . . 62.219999999999999 111.018 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.442 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 20.6 pttt -63.72 -23.94 67.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 64.420000000000002 109.868 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -40.37 82.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 72.439999999999998 110.648 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.11 -35.74 28.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 110.898 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.2 -21.94 72.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 72.319999999999993 112.801 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -29.63 12.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 74.439999999999998 111.026 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -64.29 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 75.209999999999994 110.82 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -41.24 67.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.876 -0.602 . . . . 64.530000000000001 111.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -44.41 83.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 75.25 111.017 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.16 -47.02 76.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 73.200000000000003 112.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.878 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.9 -47.07 61.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 73.099999999999994 110.716 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.22 -28.53 26.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.933 -0.576 . . . . 63.130000000000003 112.389 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 5.2 mmtm -64.99 -59.62 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 75.430000000000007 109.991 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -23.32 52.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.089 -0.505 . . . . 74.420000000000002 110.252 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.8 t -85.63 -40.28 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 72.129999999999995 111.754 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.65 -39.0 34.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.761 -0.459 . . . . 71.200000000000003 109.761 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 mttm -72.74 -31.81 65.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 75.120000000000005 110.001 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.015 -0.539 . . . . 33.399999999999999 110.395 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 t -85.19 -31.76 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 110.608 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 7.7 tp10 -60.94 -36.46 79.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 65.310000000000002 110.636 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -75.43 -29.45 59.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 110.744 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.33 12.53 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 71.040000000000006 111.592 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.904 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.84 -43.42 99.19 Favored Pre-proline 0 C--O 1.223 -0.3 0 C-N-CA 120.308 -0.557 . . . . 72.140000000000001 110.032 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.2 Cg_exo -66.03 -20.39 57.21 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.818 2.345 . . . . 75.109999999999999 110.001 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.84 ' O ' HD11 ' A' ' 56' ' ' ILE . 66.0 t -98.55 -19.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.843 -1.071 . . . . 71.150000000000006 111.217 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -97.27 -27.58 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.066 -0.716 . . . . 42.229999999999997 109.066 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.26 -42.26 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.076 -0.966 . . . . 72.219999999999999 110.587 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.89 -29.72 2.15 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.696 -0.764 . . . . 72.140000000000001 111.992 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -82.68 -41.63 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.733 -0.469 . . . . 71.239999999999995 109.733 178.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -22.38 57.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 75.109999999999999 109.39 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.68 -26.72 27.56 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.746 -0.661 . . . . 62.229999999999997 110.396 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -93.27 -44.4 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.965 -0.561 . . . . 75.400000000000006 110.372 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.731 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -85.88 -3.02 86.0 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.696 -0.764 . . . . 64.0 111.246 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.192 -0.909 . . . . 74.239999999999995 110.924 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.521 -0.232 . . . . 64.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.1 -22.57 77.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 24.420000000000002 112.579 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.98 -62.22 1.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.202 0.525 . . . . 74.329999999999998 110.985 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -63.72 -23.81 67.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 74.549999999999997 109.961 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -70.79 -44.77 65.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.824 -0.625 . . . . 74.120000000000005 110.647 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -82.1 -37.78 25.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.816 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -22.03 57.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.825 -0.702 . . . . 73.120000000000005 112.696 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -94.38 -31.41 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 73.239999999999995 110.998 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -62.56 -57.79 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 63.210000000000001 110.551 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 -52.95 63.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 61.140000000000001 110.722 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.28 -40.98 62.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 65.0 110.964 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.49 88.41 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 70.129999999999995 112.286 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.915 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.39 -53.29 14.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 64.519999999999996 110.708 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.26 -29.4 22.19 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.091 -0.576 . . . . 61.149999999999999 112.461 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 mttt -65.14 -59.31 4.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.101 0.477 . . . . 62.32 110.025 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -29.92 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 64.209999999999994 109.911 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.4 t -75.99 -47.55 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.534 -0.757 . . . . 72.230000000000004 111.24 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.52 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.46 -40.42 50.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.721 -0.474 . . . . 74.239999999999995 109.721 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 14.1 mttt -75.25 -30.0 60.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 61.229999999999997 109.655 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.61 -42.55 99.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.801 -0.636 . . . . 74.010000000000005 110.556 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 t -85.12 -37.65 20.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.022 -0.535 . . . . 72.099999999999994 110.748 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.18 -33.5 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.57 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -70.16 -33.15 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 73.219999999999999 110.664 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.71 11.18 34.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 111.493 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.6 tt -55.23 -43.32 99.03 Favored Pre-proline 0 C--O 1.223 -0.32 0 C-N-CA 120.188 -0.605 . . . . 54.25 110.02 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.9 Cg_exo -66.44 -22.19 52.45 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.875 2.384 . . . . 60.439999999999998 110.045 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.896 ' O ' HD11 ' A' ' 56' ' ' ILE . 71.5 t -97.51 -14.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.93 -1.032 . . . . 63.539999999999999 111.374 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.731 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -101.54 -27.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.804 -0.814 . . . . 72.400000000000006 108.804 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.1 m -82.27 -41.97 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.076 -0.965 . . . . 55.25 110.41 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.69 -29.25 2.89 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.604 -0.808 . . . . 52.329999999999998 112.032 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -86.88 -35.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.605 -0.517 . . . . 74.319999999999993 109.605 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.43 -21.75 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.545 -0.752 . . . . 64.109999999999999 109.661 178.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.71 -21.45 25.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.878 -0.601 . . . . 73.219999999999999 110.96 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.745 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.04 -44.09 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 65.239999999999995 111.981 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.3 -0.12 8.78 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.768 -0.729 . . . . 65.439999999999998 111.762 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 12.8 tttm . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.204 -0.903 . . . . 64.040000000000006 111.35 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.521 -0.232 . . . . 51.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -69.56 -21.99 76.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.739 . . . . 75.150000000000006 112.584 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.62 -61.2 2.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.953 0.406 . . . . 62.520000000000003 110.118 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -63.16 -23.44 67.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 55.130000000000003 109.685 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -67.78 -44.25 77.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.879 -0.6 . . . . 62.439999999999998 110.79 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.79 -46.07 69.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.539999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.95 -36.94 93.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.738 -0.744 . . . . 44.25 112.465 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -70.45 -29.17 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 64.439999999999998 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -63.49 -57.07 11.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 55.140000000000001 110.827 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -67.65 -42.64 81.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 110.916 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -53.61 -40.24 65.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.120000000000005 111.071 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.64 -41.43 82.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 70.109999999999999 112.651 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.68 -43.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 74.120000000000005 110.941 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.09 34.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 40.329999999999998 112.706 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.09 -40.58 23.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.664 0.232 . . . . 72.400000000000006 110.967 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.66 -37.16 27.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.038 0.447 . . . . 71.120000000000005 110.663 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.8 t -71.88 -22.69 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 64.409999999999997 111.717 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -47.92 -27.64 2.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.517 -0.31 . . . . 72.109999999999999 110.838 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 5.6 mtpt -77.03 -33.74 57.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.171 0.51 . . . . 74.340000000000003 109.806 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -76.6 -32.69 58.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.476 -0.784 . . . . 54.520000000000003 110.302 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 p -85.22 -45.75 11.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 71.140000000000001 111.046 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -53.61 -35.55 61.01 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.998 0.428 . . . . 75.409999999999997 110.916 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -37.2 85.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 75.299999999999997 110.974 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.807 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -97.84 13.86 29.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 70.209999999999994 111.851 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.918 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.4 tt -56.96 -42.64 97.41 Favored Pre-proline 0 C--O 1.223 -0.317 0 C-N-CA 120.148 -0.621 . . . . 72.340000000000003 109.99 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.7 Cg_exo -66.27 -23.81 51.59 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.87 2.38 . . . . 74.540000000000006 109.915 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.937 ' O ' HD11 ' A' ' 56' ' ' ILE . 50.9 t -96.8 -10.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.878 -1.056 . . . . 73.310000000000002 111.215 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 t -104.58 -28.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.783 -0.821 . . . . 72.519999999999996 108.783 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.918 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.3 m -82.44 -41.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.932 -1.031 . . . . 75.109999999999999 110.517 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.61 -28.45 3.57 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.596 -0.812 . . . . 73.109999999999999 112.157 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.937 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.0 -33.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 64.340000000000003 109.798 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -82.19 -22.18 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 45.450000000000003 109.495 178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.69 -21.51 25.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.948 -0.569 . . . . 44.149999999999999 111.2 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.25 -47.3 14.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 62.100000000000001 112.073 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.747 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -130.36 4.5 5.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.69 -0.686 . . . . 34.109999999999999 111.433 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 1.3 tttp . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.236 -0.887 . . . . 74.140000000000001 111.146 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.465 -0.254 . . . . 71.230000000000004 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 -21.75 52.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 63.420000000000002 112.717 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HA ' HD23 ' A' ' 31' ' ' LEU . 2.3 tm? -46.02 -61.35 1.79 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.84 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 28' ' ' LEU . 1.1 pttt -57.94 -23.8 55.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.58 . . . . 54.409999999999997 110.235 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 -35.35 65.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.923 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -81.99 -31.26 31.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 73.0 110.952 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.2 -21.99 78.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 64.109999999999999 112.812 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -29.98 13.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 72.099999999999994 110.959 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -65.77 -57.79 7.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 75.129999999999995 111.012 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -48.52 81.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.134 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -37.96 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 63.43 111.082 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.9 -39.78 63.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.778 -0.725 . . . . 52.340000000000003 112.584 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.9 -48.77 65.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 62.450000000000003 110.837 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.92 -36.48 60.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.904 -0.665 . . . . 44.229999999999997 112.667 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 8.1 mttt -62.34 -36.87 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.688 0.28 . . . . 64.030000000000001 110.323 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.28 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.195 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.1 t -55.89 -23.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 52.229999999999997 111.839 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.621 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.68 -28.19 5.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.449 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -77.65 -34.24 53.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 71.430000000000007 109.729 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -75.52 -32.86 60.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.528 -0.76 . . . . 72.25 110.252 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.15 -47.16 10.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 74.510000000000005 111.154 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -53.51 -37.39 62.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.926 0.393 . . . . 75.349999999999994 111.009 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -68.27 -33.48 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 61.409999999999997 111.094 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.72 13.11 34.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 74.340000000000003 111.872 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.29 -42.62 96.98 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.016 -0.674 . . . . 53.32 109.734 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.9 Cg_exo -65.35 -25.43 56.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.774 2.316 . . . . 74.219999999999999 109.842 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.904 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -94.17 -12.67 8.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.751 -1.113 . . . . 60.509999999999998 111.243 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 67.1 t -102.9 -28.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.793 -0.818 . . . . 64.319999999999993 108.793 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.36 -41.85 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.04 -0.982 . . . . 72.430000000000007 110.419 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.66 -29.11 2.79 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.515 -0.85 . . . . 42.409999999999997 112.113 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.904 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.93 -37.12 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.158 0.504 . . . . 75.439999999999998 109.697 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 5.0 mtmt -78.37 -21.47 49.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.664 -0.698 . . . . 74.310000000000002 109.456 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.57 -21.55 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.883 -0.598 . . . . 73.310000000000002 110.982 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.13 -43.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 74.030000000000001 111.933 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.08 -0.38 8.92 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.757 -0.735 . . . . 71.420000000000002 111.755 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.18 -0.914 . . . . 71.140000000000001 111.314 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.541 -0.223 . . . . 50.210000000000001 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.88 -21.89 78.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 54.310000000000002 112.661 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -46.54 -61.41 1.83 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.009 0.433 . . . . 72.340000000000003 110.93 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 26.1 mmtt -61.02 -23.85 65.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 74.319999999999993 110.356 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -69.65 -37.44 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 73.340000000000003 110.87 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -81.88 -43.59 17.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 42.200000000000003 111.079 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.8 52.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.678 -0.772 . . . . 75.120000000000005 112.617 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -30.49 66.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 110.956 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -63.11 -57.0 12.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.742 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.65 -55.54 16.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.525 . . . . 72.5 110.834 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -37.03 52.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.197 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.06 80.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 52.240000000000002 112.586 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -80.59 -37.64 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.917 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.73 -27.28 69.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 54.43 113.122 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.639 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 17.8 pttt -63.39 -38.63 91.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.149 0.474 . . . . 62.130000000000003 110.957 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -32.07 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 42.329999999999998 110.453 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.4 t -80.85 -22.93 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.528 -0.76 . . . . 63.420000000000002 112.212 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.62 -26.89 3.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.759 0.314 . . . . 65.420000000000002 110.803 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.5 tttt -77.66 -31.61 52.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.183 0.516 . . . . 75.530000000000001 109.671 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -77.87 -33.55 52.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.386 -0.825 . . . . 43.340000000000003 110.305 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -45.3 12.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.779 -0.646 . . . . 64.340000000000003 111.026 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -52.43 -36.87 55.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 110.789 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -64.17 -33.16 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.439999999999998 110.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.51 12.89 36.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 111.671 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.2 tt -55.87 -43.11 99.05 Favored Pre-proline 0 C--O 1.223 -0.331 0 C-N-CA 120.155 -0.618 . . . . 54.340000000000003 109.949 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 7.0 Cg_exo -65.27 -24.4 58.24 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.89 2.393 . . . . 74.209999999999994 109.945 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.885 ' O ' HD11 ' A' ' 56' ' ' ILE . 54.6 t -95.39 -15.14 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.765 -1.107 . . . . 64.510000000000005 111.216 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 61.1 t -100.08 -28.8 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 54.310000000000002 108.94 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.4 m -82.27 -42.29 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 114.995 -1.002 . . . . 44.509999999999998 110.589 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.98 -29.53 2.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.601 -0.809 . . . . 65.230000000000004 111.976 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.885 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.59 -40.72 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 73.25 109.758 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -21.75 56.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.654 . . . . 74.239999999999995 109.432 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.42 -27.21 25.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.742 -0.663 . . . . 44.32 110.411 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.79 -44.81 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.357 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.739 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.7 -2.28 81.99 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.65 -0.786 . . . . 54.310000000000002 111.245 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 74.140000000000001 110.932 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.484 -0.246 . . . . 72.409999999999997 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.82 71.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.694 -0.765 . . . . 74.310000000000002 112.679 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.37 -61.38 1.94 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.022 0.439 . . . . 73.019999999999996 110.799 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.8 tttt -60.62 -23.72 64.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 75.510000000000005 110.332 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -40.66 78.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.932 -0.576 . . . . 65.030000000000001 110.922 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.3 tp -74.39 -40.35 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 74.299999999999997 110.958 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.64 -54.72 24.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 60.109999999999999 112.589 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -26.98 62.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 75.109999999999999 111.113 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.42 -57.83 8.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 73.420000000000002 110.913 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -46.59 72.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 61.549999999999997 111.003 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.13 82.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 111.019 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.53 -47.9 67.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.819 -0.705 . . . . 35.240000000000002 112.549 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.01 -44.62 88.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.392 . . . . 72.430000000000007 110.842 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.9 -37.74 63.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.034 -0.603 . . . . 65.310000000000002 112.58 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mttt -62.13 -36.59 82.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.699 0.285 . . . . 53.119999999999997 110.43 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.53 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.577 . . . . 74.140000000000001 110.286 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 38' ' ' ALA . 17.2 t -55.44 -23.9 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 73.439999999999998 111.834 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.83 -27.96 5.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 64.230000000000004 110.444 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 mtmm -77.86 -33.94 51.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.171 0.51 . . . . 71.319999999999993 109.814 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.84 64.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.609 -0.723 . . . . 73.030000000000001 110.274 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -85.39 -50.33 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.756 -0.656 . . . . 73.299999999999997 111.16 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.7 pp20? -51.15 -34.41 31.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.911 0.386 . . . . 72.329999999999998 111.089 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -36.76 82.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 52.439999999999998 111.087 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.68 14.14 31.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 60.329999999999998 111.916 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -57.88 -42.57 96.02 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.084 -0.646 . . . . 61.119999999999997 109.861 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.6 Cg_exo -66.04 -24.06 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.884 2.389 . . . . 70.010000000000005 109.877 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 64.6 t -95.09 -15.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.766 -1.107 . . . . 62.32 111.161 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.9 t -100.15 -28.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 71.219999999999999 108.874 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.29 -41.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 115.082 -0.963 . . . . 73.400000000000006 110.534 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.96 -29.48 2.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.657 -0.783 . . . . 60.32 112.072 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.33 -40.74 16.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.493 . . . . 51.25 109.808 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -76.48 -21.96 55.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.75 -0.659 . . . . 71.299999999999997 109.465 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.633 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.93 -27.88 26.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.785 -0.643 . . . . 63.100000000000001 110.398 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.745 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.1 -44.99 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.92 -0.582 . . . . 51.32 110.349 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.68 -3.1 84.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.175 -0.77 . . . . 44.329999999999998 111.175 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.292 -0.861 . . . . 75.310000000000002 111.009 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.508 -0.237 . . . . 70.019999999999996 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -66.5 -21.99 71.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.772 . . . . 51.530000000000001 112.642 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -56.69 -61.29 2.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 74.409999999999997 110.105 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -23.46 67.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 72.329999999999998 109.756 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -66.89 -39.81 87.57 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.762 -0.653 . . . . 60.049999999999997 110.921 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 tp -79.2 -38.47 35.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 61.149999999999999 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.34 -22.34 78.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.779 -0.724 . . . . 73.109999999999999 112.643 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.06 -26.31 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 61.149999999999999 111.066 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -66.14 -60.5 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 64.120000000000005 110.783 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.2 tm? -58.5 -51.71 68.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 74.409999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.99 -34.39 59.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.556 . . . . 71.329999999999998 111.04 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.2 -37.2 71.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.771 -0.728 . . . . 72.319999999999993 112.464 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.43 -45.86 57.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.019999999999996 110.864 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.0 -21.78 32.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.829 -0.701 . . . . 72.25 112.747 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -73.12 -42.62 62.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.582 0.191 . . . . 55.5 111.25 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -81.56 -39.3 24.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 74.530000000000001 110.699 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 38' ' ' ALA . 41.6 t -67.94 -22.53 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 72.329999999999998 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.8 -26.95 1.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 111.226 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 1.1 mttt -78.61 -35.25 45.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.026 0.441 . . . . 71.439999999999998 110.111 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -58.9 -40.78 85.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 72.049999999999997 110.293 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -85.14 -33.04 22.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.891 -0.595 . . . . 62.140000000000001 110.211 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -57.19 -39.82 76.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 70.549999999999997 110.431 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -66.75 -29.14 69.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 65.299999999999997 110.999 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.72 11.48 32.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.419 -0.355 . . . . 54.409999999999997 111.833 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.79 -43.1 99.03 Favored Pre-proline 0 C--O 1.223 -0.312 0 C-N-CA 120.164 -0.614 . . . . 71.239999999999995 109.981 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.3 Cg_exo -67.13 -21.87 48.07 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.768 2.312 . . . . 72.409999999999997 110.02 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.942 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.6 t -97.77 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.008 -0.996 . . . . 74.430000000000007 111.415 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -102.25 -27.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 60.530000000000001 108.881 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.5 m -82.5 -42.06 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 114.992 -1.004 . . . . 75.329999999999998 110.637 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.962 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -47.16 -28.34 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.493 -0.861 . . . . 55.210000000000001 112.277 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.942 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -86.53 -29.32 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.483 . . . . 62.340000000000003 109.963 179.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 2.1 mtmt -86.45 -24.08 25.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 71.510000000000005 109.524 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.92 -21.21 25.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.581 . . . . 71.140000000000001 112.25 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.962 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.1 pp -62.05 -61.47 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.147 0.499 . . . . 72.209999999999994 112.17 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -135.08 8.25 4.44 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.911 -0.876 . . . . 52.32 110.911 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.5 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 72.019999999999996 111.197 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.529 -0.228 . . . . 52.119999999999997 112.529 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -73.32 -24.27 75.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 52.219999999999999 112.56 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.51 -62.2 1.55 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.278 0.561 . . . . 73.420000000000002 110.841 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -65.35 -23.92 67.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 71.319999999999993 110.008 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -71.02 -34.78 71.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.876 -0.602 . . . . 74.019999999999996 110.701 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.0 tp -81.91 -34.2 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 62.119999999999997 110.837 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.9 -21.97 77.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 73.340000000000003 112.822 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -95.03 -46.66 6.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.31 . . . . 71.409999999999997 111.154 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 3.3 pttt -57.41 -50.52 72.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.98 0.419 . . . . 72.099999999999994 110.856 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -64.71 -42.85 94.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.76 -0.655 . . . . 51.310000000000002 110.842 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -39.42 76.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 111.034 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.91 -41.99 68.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 74.430000000000007 112.647 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.64 -46.21 73.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 54.030000000000001 110.848 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.82 -34.03 56.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.973 -0.632 . . . . 63.32 112.692 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -64.39 -37.69 88.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.695 0.283 . . . . 72.439999999999998 110.436 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -51.2 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 72.120000000000005 110.252 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 15.8 t -56.97 -23.65 18.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 74.439999999999998 111.739 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.82 -27.05 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.338 . . . . 74.310000000000002 110.708 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 tttp -82.07 -35.04 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.083 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.98 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 73.109999999999999 110.05 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.99 -33.33 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 72.549999999999997 110.174 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mm-40 -58.66 -36.77 74.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 73.150000000000006 110.373 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -66.07 -31.02 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.91 -0.587 . . . . 74.430000000000007 110.794 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.779 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.18 13.54 30.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.519999999999996 111.638 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.7 tt -57.56 -42.65 96.82 Favored Pre-proline 0 C--O 1.223 -0.335 0 C-N-CA 120.09 -0.644 . . . . 63.25 109.756 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.47 -24.67 56.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.845 2.364 . . . . 73.129999999999995 109.826 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.858 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.5 t -94.36 -15.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 114.718 -1.128 . . . . 73.540000000000006 111.262 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 49' ' ' ALA . 86.4 t -100.58 -29.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.932 -0.766 . . . . 62.240000000000002 108.932 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.21 -42.0 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 114.986 -1.006 . . . . 70.340000000000003 110.511 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.62 2.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.688 -0.767 . . . . 55.229999999999997 111.974 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.858 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -82.8 -41.47 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.49 . . . . 74.239999999999995 109.808 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -22.29 56.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 64.129999999999995 109.341 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.6 -27.2 27.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.788 -0.642 . . . . 53.399999999999999 110.391 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.62 -44.45 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.911 -0.586 . . . . 64.200000000000003 110.341 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.67 -2.62 84.46 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.206 -0.758 . . . . 44.520000000000003 111.206 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.226 -0.893 . . . . 70.409999999999997 110.895 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.43 -0.268 . . . . 62.140000000000001 112.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.99 -27.49 31.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.767 -0.73 . . . . 74.310000000000002 112.6 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -50.5 -62.18 1.74 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.168 0.508 . . . . 64.439999999999998 110.647 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 14.0 mtpp -64.89 -23.91 67.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 73.219999999999999 109.734 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.85 -40.29 79.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.776 -0.647 . . . . 63.5 110.755 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -81.94 -35.87 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 73.25 110.875 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.04 -22.4 78.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 71.0 112.843 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -97.64 -27.19 14.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.312 . . . . 73.310000000000002 111.126 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -62.22 -56.4 19.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 74.510000000000005 110.724 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -64.09 -54.18 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.879 -0.6 . . . . 70.219999999999999 110.846 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -45.09 78.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 74.549999999999997 111.084 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.82 44.93 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.797 -0.716 . . . . 64.230000000000004 112.708 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.43 -48.72 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.863 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.05 50.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.015 -0.612 . . . . 73.430000000000007 112.66 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -59.78 -37.65 79.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.697 0.284 . . . . 71.030000000000001 110.464 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -52.25 7.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.202 0.525 . . . . 74.530000000000001 110.221 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.3 t -55.51 -25.27 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 64.200000000000003 111.742 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.72 -26.78 2.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 74.450000000000003 110.753 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.1 tttt -81.99 -35.13 29.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.106 0.479 . . . . 53.310000000000002 110.102 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.14 90.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 72.420000000000002 110.19 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.18 -34.76 22.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 65.420000000000002 110.342 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -57.85 -38.52 75.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.494 . . . . 73.310000000000002 110.524 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -66.71 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 71.420000000000002 111.118 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.11 11.97 32.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 63.32 111.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.916 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.9 tt -56.64 -42.73 97.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 C-N-CA 120.025 -0.67 . . . . 73.109999999999999 109.852 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -25.39 55.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.817 2.345 . . . . 73.219999999999999 109.811 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.898 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -93.98 -13.64 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 114.865 -1.061 . . . . 55.310000000000002 111.237 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' ALA . 58.4 t -101.81 -29.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.882 -0.785 . . . . 73.439999999999998 108.882 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.23 -42.09 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.042 -0.981 . . . . 73.340000000000003 110.398 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.27 -29.33 2.42 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 51.32 111.96 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.898 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.14 -39.74 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.625 -0.509 . . . . 62.210000000000001 109.625 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 1.1 mtmm -76.1 -21.02 57.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 63.119999999999997 109.602 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.53 -21.46 25.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 72.099999999999994 111.286 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 55' ' ' GLY . 23.7 pt -91.26 -47.12 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.079 0.466 . . . . 73.349999999999994 112.17 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' HG13 ' A' ' 59' ' ' ILE . . . -133.27 4.06 4.84 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.251 -0.739 . . . . 72.120000000000005 111.251 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.25 -0.881 . . . . 72.430000000000007 110.831 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.487 -0.245 . . . . 45.030000000000001 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 -21.8 74.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.624 -0.798 . . . . 55.240000000000002 112.68 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -46.53 -61.45 1.81 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 74.409999999999997 110.883 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.27 -23.79 64.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 63.039999999999999 110.405 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -41.14 76.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 72.409999999999997 111.0 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.438 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.3 tp -79.87 -35.35 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 111.034 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.41 -22.01 76.23 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 70.010000000000005 112.838 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -93.79 -43.3 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 73.150000000000006 111.158 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -58.79 -50.82 72.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.411 . . . . 34.340000000000003 111.021 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.438 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.12 -48.93 79.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 71.340000000000003 111.074 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -45.29 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 54.229999999999997 111.19 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.13 -44.27 51.18 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.837 -0.697 . . . . 60.409999999999997 112.732 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.96 -48.59 70.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.936 0.398 . . . . 51.149999999999999 110.907 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.14 -35.95 55.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.986 -0.626 . . . . 63.229999999999997 112.641 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mtpt -62.73 -37.49 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 73.439999999999998 110.421 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.7 -53.01 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 74.510000000000005 110.315 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 38' ' ' ALA . 14.6 t -55.8 -23.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.316 -0.856 . . . . 75.019999999999996 111.679 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.14 -27.85 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.348 . . . . 71.549999999999997 110.456 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 mttm -78.47 -32.79 48.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 61.020000000000003 109.798 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.32 -32.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.621 -0.718 . . . . 74.109999999999999 110.302 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.37 -47.98 9.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 63.350000000000001 111.044 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -51.9 -33.96 39.18 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 64.329999999999998 110.916 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -66.17 -38.32 87.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 65.209999999999994 111.053 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -100.37 12.94 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 34.310000000000002 111.82 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.908 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.0 tt -56.79 -42.81 98.21 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.068 -0.653 . . . . 75.109999999999999 109.837 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 5.1 Cg_exo -65.82 -25.07 53.4 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.747 2.298 . . . . 74.040000000000006 109.944 176.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.923 ' O ' HD11 ' A' ' 56' ' ' ILE . 56.0 t -95.43 -11.02 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.909 -1.042 . . . . 75.25 111.229 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 73.2 t -104.35 -28.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.798 -0.815 . . . . 63.049999999999997 108.798 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.908 HG13 ' O ' ' A' ' 50' ' ' LEU . 18.1 m -82.28 -41.82 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.002 -0.999 . . . . 63.439999999999998 110.443 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.769 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.28 -28.72 3.34 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.596 -0.811 . . . . 73.450000000000003 112.089 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.923 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.14 -35.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.593 -0.521 . . . . 73.019999999999996 109.593 178.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.05 -22.04 45.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.68 -0.691 . . . . 64.310000000000002 109.491 178.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.73 -21.42 25.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.059 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -96.67 -44.52 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 112.105 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -129.84 4.42 6.1 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.809 -0.71 . . . . 42.43 111.607 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 48.1 tttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.832 . . . . 72.120000000000005 110.952 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.534 -0.226 . . . . 65.299999999999997 112.534 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -72.28 -21.9 79.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 112.657 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.13 -61.1 2.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 75.430000000000007 110.222 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -23.39 67.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 74.519999999999996 109.719 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -68.4 -38.28 81.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.794 -0.639 . . . . 74.140000000000001 110.937 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -79.25 -36.65 39.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.8 -57.24 9.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 42.0 112.558 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -25.43 63.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 62.439999999999998 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -65.27 -59.09 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.100000000000001 110.833 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -46.35 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 72.349999999999994 111.003 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -54.9 -38.75 67.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 74.5 111.019 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.67 95.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 54.32 112.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -66.45 -43.65 84.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 73.120000000000005 110.843 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.51 -36.03 57.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.002 -0.618 . . . . 75.209999999999994 112.617 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -62.15 -36.61 82.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.724 0.297 . . . . 71.420000000000002 110.269 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -52.96 6.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.259 0.552 . . . . 62.409999999999997 110.152 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.7 t -56.62 -23.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.217 -0.901 . . . . 70.310000000000002 111.867 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.78 -27.77 5.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 75.230000000000004 110.553 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 23.2 mttt -77.79 -33.75 52.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.115 0.483 . . . . 65.319999999999993 109.787 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 -33.02 60.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.562 -0.744 . . . . 72.439999999999998 110.254 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.32 -47.87 9.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 72.519999999999996 111.121 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -52.36 -39.03 60.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.964 0.412 . . . . 63.5 111.025 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -30.07 71.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 75.200000000000003 111.115 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.83 11.44 35.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 44.210000000000001 111.901 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.34 -43.34 99.06 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 120.238 -0.585 . . . . 63.399999999999999 110.123 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.0 Cg_exo -66.34 -22.43 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.819 2.346 . . . . 64.540000000000006 110.017 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.871 ' O ' HD11 ' A' ' 56' ' ' ILE . 79.6 t -96.2 -17.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.797 -1.092 . . . . 75.430000000000007 111.26 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.8 p -98.76 -27.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.939 -0.763 . . . . 72.510000000000005 108.939 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.0 m -82.38 -42.19 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.099 -0.955 . . . . 75.530000000000001 110.511 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.95 -29.46 2.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.731 -0.747 . . . . 72.329999999999998 112.011 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.57 -40.29 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 63.420000000000002 109.784 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -21.97 54.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.393 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.12 -24.1 28.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.792 -0.64 . . . . 51.210000000000001 110.439 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -96.63 -43.97 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 115.935 -0.575 . . . . 72.540000000000006 110.495 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.751 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -83.45 -4.97 89.03 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.628 -0.796 . . . . 55.310000000000002 111.291 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.248 -0.882 . . . . 52.409999999999997 110.996 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.487 -0.245 . . . . 55.420000000000002 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.55 -24.76 41.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.747 . . . . 71.230000000000004 112.608 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.36 -62.25 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.18 0.515 . . . . 74.329999999999998 110.925 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 15.4 mttt -65.54 -23.89 66.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.387 -0.824 . . . . 73.0 109.916 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -70.54 -34.7 72.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 71.319999999999993 110.728 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.4 tm? -81.98 -34.96 29.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 110.988 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.07 -58.77 5.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 51.399999999999999 112.605 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -37.32 65.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 64.319999999999993 111.114 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -65.03 -57.45 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 74.200000000000003 110.844 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.39 90.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 111.067 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -47.81 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.530000000000001 110.938 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.71 -48.92 59.93 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.807 -0.711 . . . . 52.539999999999999 112.383 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.28 -47.6 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 72.329999999999998 110.654 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.57 24.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.056 -0.592 . . . . 62.299999999999997 112.529 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 6.3 mmtp -65.12 -59.14 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.125 0.488 . . . . 64.329999999999998 110.031 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -28.77 63.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 64.420000000000002 110.139 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 38' ' ' ALA . 19.1 t -78.88 -43.68 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.575 -0.739 . . . . 54.32 111.638 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.497 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -50.07 -37.21 32.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.448 . . . . 75.420000000000002 109.789 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -76.28 -30.75 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 51.350000000000001 109.896 178.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.09 99.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.784 -0.644 . . . . 50.299999999999997 110.493 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 t -84.97 -35.78 21.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 110.47 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 1.9 mm-40 -56.5 -34.06 66.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.423 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -69.18 -31.57 70.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 64.230000000000004 110.757 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.772 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -106.11 12.8 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 54.420000000000002 111.636 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.912 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.42 -42.56 96.5 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.18 -0.608 . . . . 71.5 109.697 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.1 Cg_exo -65.58 -23.98 56.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.832 2.354 . . . . 72.109999999999999 109.875 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.877 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -94.93 -15.65 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.71 -1.132 . . . . 51.009999999999998 111.21 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 49' ' ' ALA . 77.7 t -100.14 -28.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.998 -0.742 . . . . 71.420000000000002 108.998 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.8 m -82.36 -42.05 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.994 -1.003 . . . . 75.430000000000007 110.475 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.9 -29.59 2.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.652 -0.785 . . . . 75.049999999999997 111.956 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.67 -39.95 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.093 0.473 . . . . 74.150000000000006 109.81 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -77.13 -21.59 53.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 71.430000000000007 109.514 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.26 -28.41 25.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.817 -0.629 . . . . 43.210000000000001 110.313 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -89.86 -45.12 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.965 -0.561 . . . . 73.019999999999996 110.444 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.4 -2.88 82.21 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.679 -0.772 . . . . 24.010000000000002 111.229 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.238 -0.887 . . . . 65.120000000000005 110.966 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.475 -0.25 . . . . 73.310000000000002 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.28 -21.99 59.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 54.020000000000003 112.672 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -48.02 -61.28 2.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.956 0.408 . . . . 63.049999999999997 110.721 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.6 tptt -60.41 -23.69 64.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.84 -0.618 . . . . 72.540000000000006 110.291 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.2 -42.32 80.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.944 -0.571 . . . . 70.540000000000006 110.74 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -78.31 -41.64 33.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 62.450000000000003 110.84 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.61 -22.98 66.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 64.010000000000005 112.643 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -94.1 -28.97 15.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 51.420000000000002 111.028 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -64.44 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.254 0.55 . . . . 64.25 110.907 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 -40.81 54.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 75.019999999999996 110.961 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.55 -37.85 73.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 70.25 110.917 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.91 91.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 23.219999999999999 112.448 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.881 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.39 -41.12 61.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 75.140000000000001 110.937 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.67 69.61 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.067 -0.587 . . . . 72.349999999999994 112.531 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.2 -58.13 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.933 0.396 . . . . 73.340000000000003 110.549 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.49 -19.88 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 73.400000000000006 110.15 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 38' ' ' ALA . 42.8 t -83.17 -48.14 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.848 -0.615 . . . . 71.319999999999993 110.714 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.44 -39.88 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 74.25 109.765 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -76.23 -28.97 57.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.726 -0.67 . . . . 74.099999999999994 109.558 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -64.3 -46.0 85.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.584 -0.734 . . . . 65.310000000000002 110.32 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -79.24 -35.07 42.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.84 -0.618 . . . . 73.540000000000006 110.072 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.29 -21.81 50.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 54.039999999999999 110.394 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.83 66.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.717 -0.475 . . . . 64.450000000000003 109.717 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.753 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -112.72 18.11 18.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.897 -0.592 . . . . 52.130000000000003 110.602 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.82 -36.27 24.64 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.788 -0.765 . . . . 70.200000000000003 110.444 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.846 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 49.7 Cg_endo -77.96 -12.18 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.772 2.314 . . . . 53.140000000000001 109.929 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.892 ' O ' HD11 ' A' ' 56' ' ' ILE . 65.0 t -105.86 -10.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.856 -1.065 . . . . 71.329999999999998 110.366 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.4 t -105.75 -31.14 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.676 -0.861 . . . . 65.230000000000004 108.676 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 50' ' ' LEU . 20.5 m -82.38 -39.92 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.41 -0.814 . . . . 74.099999999999994 110.393 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.18 -29.28 3.48 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.602 -0.809 . . . . 70.040000000000006 112.05 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.47 -37.73 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 74.5 109.724 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -78.01 -21.71 50.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 65.329999999999998 109.545 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.84 -27.15 25.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.887 -0.597 . . . . 45.140000000000001 110.367 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.15 -45.08 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.879 -0.601 . . . . 72.310000000000002 110.473 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.14 -1.42 79.17 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.773 . . . . 65.430000000000007 111.302 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.3 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 71.040000000000006 110.85 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.386 -0.286 . . . . 54.109999999999999 112.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -78.8 -22.86 65.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 72.510000000000005 112.6 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.25 -62.12 1.57 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.171 0.51 . . . . 72.239999999999995 111.008 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.4 ptmt -65.34 -23.89 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.471 -0.786 . . . . 74.409999999999997 110.038 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -71.32 -36.03 71.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 75.329999999999998 110.741 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -82.04 -42.59 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.873 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -22.02 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.129999999999995 112.799 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -97.07 -23.85 16.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.642 0.258 . . . . 51.030000000000001 111.24 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -67.32 -60.82 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 74.450000000000003 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -45.91 91.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 72.019999999999996 110.935 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.31 -40.44 71.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 62.530000000000001 111.125 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.97 -41.26 59.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.747 -0.739 . . . . 53.219999999999999 112.592 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.848 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.94 -47.14 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.129999999999995 110.814 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.82 69.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.927 -0.654 . . . . 45.130000000000003 112.596 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -63.02 -36.47 83.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.667 0.27 . . . . 72.310000000000002 110.426 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.224 0.535 . . . . 74.109999999999999 110.28 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.3 t -57.0 -24.05 19.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.346 -0.843 . . . . 34.240000000000002 111.858 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.42 -27.24 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.483 -0.326 . . . . 73.519999999999996 110.81 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -81.0 -36.83 30.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 109.941 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 71.120000000000005 109.928 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -85.29 -36.94 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 51.329999999999998 110.349 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.23 -36.48 73.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 62.039999999999999 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -67.02 -31.81 72.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 70.019999999999996 110.949 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -102.03 11.56 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.010000000000005 111.819 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.01 -43.62 99.16 Favored Pre-proline 0 C--O 1.224 -0.268 0 C-N-CA 120.263 -0.575 . . . . 71.010000000000005 110.064 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.2 Cg_exo -66.25 -21.52 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.885 2.39 . . . . 61.310000000000002 110.107 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.862 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -97.92 -17.24 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.944 -1.025 . . . . 70.430000000000007 111.289 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -98.85 -27.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.003 -0.74 . . . . 75.540000000000006 109.003 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.9 m -82.21 -42.4 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.14 -0.936 . . . . 61.329999999999998 110.583 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.87 -29.63 2.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.658 -0.782 . . . . 74.150000000000006 111.961 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.82 -40.84 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.707 -0.479 . . . . 73.319999999999993 109.707 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 -21.56 57.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 75.230000000000004 109.425 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.87 -26.86 25.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.871 -0.604 . . . . 64.019999999999996 110.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.7 -44.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.484 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.93 0.01 78.64 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.217 -0.753 . . . . 41.439999999999998 111.217 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.207 -0.902 . . . . 71.150000000000006 110.83 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.394 -0.282 . . . . 52.030000000000001 112.394 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -67.5 -29.12 73.76 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.682 -0.771 . . . . 63.310000000000002 112.417 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.95 -62.21 1.58 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.224 0.535 . . . . 62.539999999999999 110.799 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 1.2 mttt -64.61 -23.89 67.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.358 -0.837 . . . . 73.140000000000001 109.792 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.97 -41.9 77.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 110.581 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 tp -82.06 -36.52 27.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.498 . . . . 55.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -21.95 72.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.712 . . . . 64.540000000000006 112.654 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -101.42 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 75.519999999999996 111.173 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -64.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.966 0.412 . . . . 65.439999999999998 110.88 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -44.1 75.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 71.25 111.067 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -39.24 76.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 111.021 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.22 93.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.753 . . . . 65.329999999999998 112.333 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.871 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.94 -50.73 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 54.539999999999999 110.592 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 43' ' ' PHE . . . -52.37 -31.42 35.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.955 -0.641 . . . . 30.210000000000001 112.519 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 8.3 tttm -66.69 -35.85 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.184 0.516 . . . . 63.299999999999997 110.21 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -24.25 37.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 65.340000000000003 109.74 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 38' ' ' ALA . 11.8 t -85.28 -40.36 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 74.239999999999995 111.397 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -51.12 -33.16 25.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 109.788 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -79.63 -30.32 41.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 75.319999999999993 109.762 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.84 -44.74 84.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.774 -0.648 . . . . 54.140000000000001 110.167 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -77.56 -34.67 53.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 61.399999999999999 109.914 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.862 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.74 -21.72 61.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 73.510000000000005 110.436 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -73.14 -32.15 64.72 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.735 -0.468 . . . . 73.230000000000004 109.735 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -111.29 18.33 19.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.753 -0.658 . . . . 74.340000000000003 110.559 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.3 pp -62.92 -36.38 24.99 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.948 -0.701 . . . . 54.530000000000001 110.352 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.817 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 46.5 Cg_endo -77.52 -12.31 16.92 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.745 2.296 . . . . 63.119999999999997 110.033 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.888 ' O ' HD11 ' A' ' 56' ' ' ILE . 70.0 t -104.85 -12.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.718 -1.128 . . . . 75.049999999999997 110.225 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 49' ' ' ALA . 85.9 t -104.2 -31.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.631 -0.877 . . . . 70.019999999999996 108.631 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.32 -39.74 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.379 -0.828 . . . . 64.530000000000001 110.398 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.83 -29.53 3.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.55 -0.834 . . . . 71.239999999999995 112.053 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -84.05 -39.74 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.114 0.483 . . . . 73.200000000000003 109.839 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -21.84 54.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 63.119999999999997 109.422 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.22 -28.13 25.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.78 -0.645 . . . . 72.010000000000005 110.363 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.53 -45.12 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 115.967 -0.56 . . . . 73.230000000000004 110.396 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.51 -2.53 82.24 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.233 -0.747 . . . . 73.239999999999995 111.233 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.265 -0.874 . . . . 65.319999999999993 110.867 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 112.397 -0.281 . . . . 74.150000000000006 112.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.99 -21.93 50.96 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.762 -0.732 . . . . 71.409999999999997 112.599 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.526 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -47.67 -61.5 1.91 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.019 0.438 . . . . 63.520000000000003 110.748 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' N ' HD13 ' A' ' 28' ' ' LEU . 8.0 tttp -61.21 -23.67 65.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.791 -0.64 . . . . 71.5 110.42 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -68.86 -40.63 79.23 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.991 -0.549 . . . . 61.039999999999999 110.866 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.642 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -79.62 -39.91 30.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.465 . . . . 62.240000000000002 111.015 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.35 -22.01 76.14 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.808 -0.71 . . . . 75.209999999999994 112.756 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.7 tttp -96.02 -26.8 15.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.68 0.276 . . . . 61.409999999999997 111.202 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.3 tmtt? -71.16 -63.39 1.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.835 0.35 . . . . 74.549999999999997 111.023 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.08 -41.03 78.09 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 71.120000000000005 111.099 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.4 -37.98 57.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 72.540000000000006 111.21 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.23 -38.02 66.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.828 -0.701 . . . . 75.510000000000005 112.769 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.88 -49.33 47.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 52.420000000000002 111.073 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.22 -21.88 27.41 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.651 -0.785 . . . . 55.43 112.911 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.633 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.69 -39.33 24.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.772 0.286 . . . . 75.209999999999994 111.116 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.67 -37.17 27.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.173 0.511 . . . . 65.049999999999997 110.625 179.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 38' ' ' ALA . 31.7 t -72.56 -22.67 20.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.604 -0.725 . . . . 71.420000000000002 111.839 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.87 -26.8 2.64 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.752 0.31 . . . . 74.519999999999996 110.76 -179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.504 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.3 mttp -76.36 -34.29 58.93 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.101 0.477 . . . . 62.030000000000001 109.819 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -72.03 -35.12 69.28 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.604 -0.725 . . . . 65.040000000000006 110.405 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.37 -50.86 6.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.844 -0.616 . . . . 74.519999999999996 111.265 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.5 pp20? -50.56 -34.55 26.0 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.827 0.346 . . . . 53.329999999999998 111.049 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.78 75.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 72.129999999999995 111.011 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -100.1 11.81 38.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.411 -0.358 . . . . 64.329999999999998 111.926 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.52 -43.35 99.1 Favored Pre-proline 0 C--O 1.223 -0.339 0 C-N-CA 120.213 -0.595 . . . . 64.109999999999999 110.052 179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.8 Cg_exo -66.11 -22.73 54.08 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.866 2.377 . . . . 70.099999999999994 110.007 176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 77.2 t -96.27 -16.97 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.814 -1.085 . . . . 74.540000000000006 111.266 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.718 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.34 -27.79 3.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 108.898 -0.778 . . . . 74.209999999999994 108.898 178.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.3 m -82.23 -42.43 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.047 -0.978 . . . . 62.520000000000003 110.548 178.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.719 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.55 2.12 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.627 -0.797 . . . . 72.319999999999993 112.032 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.93 -39.63 15.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.099 0.476 . . . . 74.109999999999999 109.789 178.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? -76.93 -22.01 53.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 72.430000000000007 109.475 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.31 -27.55 25.85 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.807 -0.633 . . . . 45.229999999999997 110.407 179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.748 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.5 -45.28 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.975 -0.557 . . . . 61.43 110.392 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.748 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.66 -2.82 81.48 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.637 -0.792 . . . . 61.530000000000001 111.198 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.6 mttt . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.231 -0.89 . . . . 63.439999999999998 110.929 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.472 -0.251 . . . . 45.030000000000001 112.472 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -70.55 -21.97 77.77 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 74.299999999999997 112.6 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.52 -61.38 1.95 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.032 0.444 . . . . 74.329999999999998 110.748 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.519 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -60.5 -23.77 64.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.782 -0.645 . . . . 73.129999999999995 110.309 179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -68.22 -42.84 79.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.943 -0.571 . . . . 75.340000000000003 110.744 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.6 tp -82.02 -34.6 29.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 110.913 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.62 -21.93 71.24 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.846 -0.692 . . . . 33.140000000000001 112.89 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -105.45 -24.43 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.683 0.278 . . . . 72.349999999999994 111.404 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -66.6 -60.62 2.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.896 0.379 . . . . 75.340000000000003 110.919 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.514 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.1 tm? -62.76 -52.83 61.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.009 -0.541 . . . . 74.329999999999998 110.983 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -52.41 -34.14 46.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.985 -0.552 . . . . 74.349999999999994 111.254 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.23 -36.49 68.92 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.673 -0.775 . . . . 42.240000000000002 112.424 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.587 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.66 -45.3 59.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.919 0.39 . . . . 51.119999999999997 110.858 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -55.63 -21.93 30.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.69 -0.767 . . . . 33.439999999999998 112.762 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.623 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 4.1 mttt -79.26 -40.57 30.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.66 0.23 . . . . 63.130000000000003 111.058 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.476 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -81.69 -39.28 24.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.073 0.463 . . . . 70.150000000000006 110.732 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 38' ' ' ALA . 38.7 t -70.0 -22.34 24.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.621 -0.718 . . . . 74.019999999999996 111.696 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.623 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.91 -27.14 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.598 -0.274 . . . . 70.420000000000002 110.979 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.8 OUTLIER -75.42 -34.75 61.05 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.174 0.511 . . . . 64.0 109.983 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -73.01 -34.39 66.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.505 -0.77 . . . . 75.209999999999994 110.416 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.1 p -85.19 -49.58 8.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 111.181 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -51.15 -34.75 32.54 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.942 0.401 . . . . 71.310000000000002 111.12 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.52 -38.27 83.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.127 -0.488 . . . . 73.200000000000003 111.071 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -96.67 13.16 29.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.295 -0.411 . . . . 54.219999999999999 111.808 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.7 tt -56.15 -43.35 99.22 Favored Pre-proline 0 C--O 1.223 -0.333 0 C-N-CA 120.158 -0.617 . . . . 74.239999999999995 110.102 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.7 Cg_exo -66.53 -21.83 52.33 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.908 2.406 . . . . 72.230000000000004 110.125 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.875 ' O ' HD11 ' A' ' 56' ' ' ILE . 68.3 t -97.42 -17.08 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 114.861 -1.063 . . . . 71.25 111.211 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.9 p -99.18 -27.79 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 108.969 -0.752 . . . . 73.450000000000003 108.969 178.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.3 -42.34 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-N 115.099 -0.955 . . . . 75.019999999999996 110.588 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.715 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.68 2.16 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.667 -0.778 . . . . 74.219999999999999 112.056 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.875 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.7 -40.36 15.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.171 0.51 . . . . 65.420000000000002 109.841 178.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.21 -21.8 56.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.728 -0.669 . . . . 60.340000000000003 109.479 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.599 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.56 -26.91 25.88 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.78 -0.645 . . . . 74.420000000000002 110.384 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.3 -44.75 14.2 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 116.034 -0.53 . . . . 74.549999999999997 110.389 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -88.55 -1.45 80.76 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.655 -0.783 . . . . 72.430000000000007 111.277 178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.9 mptt . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.216 -0.897 . . . . 63.530000000000001 110.869 179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 45.030000000000001 112.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.22 -21.91 78.37 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.755 -0.736 . . . . 63.530000000000001 112.611 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -47.51 -61.07 2.1 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.894 0.378 . . . . 75.430000000000007 110.821 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.6 pttt -61.1 -23.83 65.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.085 -0.507 . . . . 62.100000000000001 110.4 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -67.99 -42.71 80.39 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.989 -0.55 . . . . 73.450000000000003 110.714 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.639 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.2 tm? -82.09 -39.95 22.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 72.319999999999993 110.811 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.61 -22.48 61.74 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.778 -0.725 . . . . 75.450000000000003 112.731 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -101.56 -36.7 8.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.772 0.32 . . . . 75.540000000000006 110.935 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.5 tttt -64.38 -57.83 8.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 110.729 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.03 -44.13 94.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.051 -0.522 . . . . 63.409999999999997 110.875 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.69 -44.92 81.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.074 -0.512 . . . . 74.530000000000001 111.04 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.93 -47.07 89.7 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.75 -0.738 . . . . 35.409999999999997 112.476 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.3 -45.34 48.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 33.340000000000003 110.908 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -57.24 -23.35 47.32 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.968 -0.634 . . . . 65.150000000000006 112.356 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.522 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 1.9 mmtt -64.89 -57.88 7.64 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.904 0.383 . . . . 41.5 110.332 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.632 ' HD2' HG23 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -60.8 -20.08 60.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.956 0.408 . . . . 64.239999999999995 110.043 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.632 HG23 ' HD2' ' A' ' 41' ' ' ARG . 95.1 t -81.13 -48.87 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 116.054 -0.521 . . . . 65.129999999999995 110.463 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.522 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -48.79 -46.2 41.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.92 -0.582 . . . . 71.209999999999994 109.606 179.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' N ' ' CG ' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -70.42 -30.55 67.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 109.612 178.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -59.34 -45.06 92.4 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 115.896 -0.593 . . . . 64.400000000000006 110.377 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.6 t -85.11 -35.08 22.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.524 . . . . 61.340000000000003 110.549 179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.75 -31.23 64.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.052 -0.522 . . . . 75.319999999999993 110.59 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -71.74 -31.28 66.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.103 -0.499 . . . . 75.310000000000002 110.528 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.94 13.36 35.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 111.513 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.902 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -56.03 -42.95 98.8 Favored Pre-proline 0 C--O 1.223 -0.321 0 C-N-CA 120.173 -0.611 . . . . 72.340000000000003 109.934 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -24.78 55.95 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.88 2.387 . . . . 74.209999999999994 109.848 176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.926 ' O ' HD11 ' A' ' 56' ' ' ILE . 47.3 t -96.63 -9.8 9.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 114.828 -1.078 . . . . 75.049999999999997 111.169 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 62.0 t -105.42 -28.13 2.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.717 -0.846 . . . . 73.230000000000004 108.717 178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 50' ' ' LEU . 19.2 m -82.39 -42.05 18.28 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 115.079 -0.964 . . . . 64.25 110.456 178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.749 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.21 -28.76 3.28 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.531 -0.842 . . . . 53.350000000000001 112.097 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.926 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.41 -35.46 8.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 109.568 -0.53 . . . . 52.329999999999998 109.568 178.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.84 -21.82 47.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.61 -0.723 . . . . 75.510000000000005 109.498 178.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.62 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.5 -21.45 25.47 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.937 -0.574 . . . . 54.219999999999999 110.858 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.49 -44.04 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.949 -0.569 . . . . 75.420000000000002 111.991 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.719 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -126.42 2.55 7.67 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.89 -0.671 . . . . 63.310000000000002 111.803 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 2.8 tttm . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.201 -0.904 . . . . 51.520000000000003 111.045 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.493 -0.243 . . . . 45.030000000000001 112.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.25 -21.95 78.29 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.696 -0.764 . . . . 62.32 112.658 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -47.0 -61.18 1.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.977 0.418 . . . . 45.310000000000002 110.826 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.75 -23.82 66.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.995 -0.548 . . . . 64.450000000000003 110.387 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.3 tppt? -69.12 -43.86 73.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.921 -0.581 . . . . 72.299999999999997 110.703 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.7 tp -82.07 -39.1 23.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.112 -0.495 . . . . 74.209999999999994 110.861 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.52 -29.3 66.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.755 -0.736 . . . . 75.140000000000001 112.655 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.96 -26.08 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.701 0.286 . . . . 75.040000000000006 111.0 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 mmtt -67.36 -64.5 0.84 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.258 0.552 . . . . 73.299999999999997 110.523 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.72 HD12 ' N ' ' A' ' 36' ' ' GLU . 3.9 pp -53.98 -47.76 71.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.331 -0.85 . . . . 63.329999999999998 110.833 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.72 ' N ' HD12 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -51.73 -37.74 52.34 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.41 -0.814 . . . . 63.119999999999997 111.049 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -69.41 -44.53 64.46 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 60.32 112.414 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.902 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -73.87 -34.55 64.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.879 0.371 . . . . 73.230000000000004 110.907 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -64.04 -21.82 66.2 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.992 -0.623 . . . . 41.539999999999999 112.529 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.457 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 2.4 tttt -65.02 -58.22 6.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.955 0.407 . . . . 74.310000000000002 110.521 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -63.14 -19.87 64.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.973 0.416 . . . . 75.340000000000003 110.245 179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.902 HG23 ' O ' ' A' ' 38' ' ' ALA . 40.3 t -84.32 -44.48 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-N 115.937 -0.574 . . . . 73.409999999999997 111.05 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.15 -39.65 29.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 64.430000000000007 109.807 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 3.2 mttm -75.1 -30.93 61.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.713 -0.676 . . . . 63.25 109.777 178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.59 -41.63 99.08 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.751 -0.659 . . . . 74.120000000000005 110.565 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.7 t -85.08 -35.69 21.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.921 -0.581 . . . . 71.239999999999995 110.542 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.85 -34.0 67.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 54.310000000000002 110.499 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -69.27 -32.55 71.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 64.129999999999995 110.731 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.6 11.24 36.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.232 -0.44 . . . . 74.420000000000002 111.565 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.0 -43.58 99.12 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 120.243 -0.583 . . . . 72.129999999999995 110.106 179.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.5 Cg_exo -66.02 -22.06 55.6 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.857 2.371 . . . . 72.140000000000001 110.003 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.88 ' O ' HD11 ' A' ' 56' ' ' ILE . 75.0 t -97.31 -16.9 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-N 114.902 -1.044 . . . . 61.5 111.322 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.74 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -99.43 -27.61 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 108.985 -0.746 . . . . 73.340000000000003 108.985 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.6 m -82.23 -42.33 18.66 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-N 115.071 -0.968 . . . . 62.100000000000001 110.445 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.753 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.13 -29.65 2.36 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 74.329999999999998 112.003 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.88 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -85.73 -38.47 12.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.164 0.506 . . . . 74.239999999999995 109.654 178.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 4.5 mtmt -76.31 -21.7 55.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 70.109999999999999 109.458 178.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.6 -21.49 25.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.94 -0.573 . . . . 74.340000000000003 110.939 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -99.73 -43.61 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.052 -0.522 . . . . 73.209999999999994 111.905 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.732 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -125.03 1.46 8.4 Favored Glycine 0 N--CA 1.446 -0.669 0 CA-C-N 115.586 -0.734 . . . . 73.219999999999999 111.828 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.197 -0.906 . . . . 62.130000000000003 110.945 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.494 -0.242 . . . . 54.329999999999998 112.494 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.413 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -83.03 -26.55 44.28 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.717 -0.754 . . . . 75.239999999999995 112.585 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.498 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -48.15 -62.2 1.6 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.225 0.536 . . . . 75.239999999999995 110.924 -179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.2 OUTLIER -64.45 -23.95 67.46 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.382 -0.827 . . . . 75.040000000000006 109.885 178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.413 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.74 -35.81 77.59 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.886 -0.597 . . . . 72.310000000000002 110.639 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 61.4 tp -81.95 -35.73 28.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.156 -0.475 . . . . 72.409999999999997 110.911 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.73 -57.5 7.92 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 42.399999999999999 112.612 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 26.4 mttt -57.98 -26.49 62.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.689 0.281 . . . . 63.130000000000003 111.016 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -61.95 -56.41 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.964 0.411 . . . . 65.219999999999999 110.644 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.19 -51.99 15.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.951 -0.568 . . . . 62.409999999999997 110.752 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.59 -32.5 65.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.5 . . . . 72.299999999999997 110.977 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.16 -38.15 88.79 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.671 -0.776 . . . . 63.310000000000002 112.456 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.643 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.26 -41.75 73.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.919 0.39 . . . . 73.329999999999998 110.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.33 -21.84 35.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 71.099999999999994 112.574 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.573 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -81.07 -40.72 23.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.55 0.175 . . . . 72.099999999999994 110.977 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -81.33 -40.63 23.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.076 0.465 . . . . 73.349999999999994 110.671 179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.7 t -65.76 -22.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.677 -0.692 . . . . 70.129999999999995 111.415 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.3 OUTLIER -44.83 -28.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 53.439999999999998 110.833 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -72.21 -43.4 64.5 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.659 0.742 . . . . 65.219999999999999 109.75 179.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 44' ' ' LYS . . . -66.69 -34.61 78.25 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.58 -1.191 . . . . 53.119999999999997 110.588 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.1 p -85.16 -45.92 11.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.544 . . . . 65.209999999999994 111.031 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.861 ' HA ' HD23 ' A' ' 50' ' ' LEU . 2.6 pp20? -58.63 -20.4 47.36 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.775 0.321 . . . . 54.420000000000002 110.873 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -33.11 64.64 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.742 -0.466 . . . . 64.430000000000007 109.742 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.762 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -110.24 18.43 19.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.721 -0.672 . . . . 51.530000000000001 110.515 178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.861 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.52 -36.37 26.67 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 119.917 -0.713 . . . . 72.420000000000002 110.44 178.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.805 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 50.1 Cg_endo -77.82 -11.36 16.76 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.794 2.329 . . . . 44.420000000000002 110.052 177.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.901 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -107.46 -10.77 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 114.697 -1.138 . . . . 75.430000000000007 110.333 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 49' ' ' ALA . 83.0 t -105.05 -30.77 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 108.682 -0.858 . . . . 71.209999999999994 108.682 178.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.35 -40.22 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.487 0 CA-C-N 115.422 -0.808 . . . . 63.299999999999997 110.404 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.709 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.98 -29.37 3.29 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.533 -0.842 . . . . 74.25 112.072 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.901 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -85.12 -38.17 12.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.687 -0.486 . . . . 65.230000000000004 109.687 179.009 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 9.7 mtmt -77.69 -21.79 51.49 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.717 -0.674 . . . . 62.299999999999997 109.483 178.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.77 -26.94 25.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 115.898 -0.592 . . . . 51.539999999999999 110.383 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.52 -45.01 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.247 0 CA-C-N 115.936 -0.575 . . . . 64.200000000000003 110.498 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.0 -1.45 79.59 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.668 -0.777 . . . . 74.430000000000007 111.317 178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.5 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.245 -0.883 . . . . 72.219999999999999 110.89 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.505 -0.238 . . . . 64.430000000000007 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.52 -25.24 65.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.694 -0.765 . . . . 73.019999999999996 112.571 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.68 -62.15 1.59 Allowed 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.187 0.518 . . . . 62.219999999999999 111.018 -179.912 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.442 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 20.6 pttt -63.72 -23.94 67.57 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.416 -0.811 . . . . 64.420000000000002 109.868 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -40.37 82.43 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.841 -0.618 . . . . 72.439999999999998 110.648 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.2 tp -82.11 -35.74 28.24 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 110.898 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.2 -21.94 72.33 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.795 -0.717 . . . . 72.319999999999993 112.801 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.47 -29.63 12.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.762 0.315 . . . . 74.439999999999998 111.026 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -64.29 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.317 -0.401 . . . . 75.209999999999994 110.82 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.84 -41.24 67.2 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.876 -0.602 . . . . 64.530000000000001 111.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.2 -44.41 83.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.482 . . . . 75.25 111.017 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.16 -47.02 76.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.802 -0.713 . . . . 73.200000000000003 112.443 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.878 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.9 -47.07 61.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 73.099999999999994 110.716 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -52.22 -28.53 26.96 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.933 -0.576 . . . . 63.130000000000003 112.389 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.504 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 5.2 mmtm -64.99 -59.62 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 75.430000000000007 109.991 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 -23.32 52.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.089 -0.505 . . . . 74.420000000000002 110.252 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.8 t -85.63 -40.28 14.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.599 . . . . 72.129999999999995 111.754 -179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.516 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -49.65 -39.0 34.69 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.761 -0.459 . . . . 71.200000000000003 109.761 179.742 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 mttm -72.74 -31.81 65.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.73 -0.668 . . . . 75.120000000000005 110.001 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -60.59 -41.78 95.39 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.015 -0.539 . . . . 33.399999999999999 110.395 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.1 t -85.19 -31.76 23.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.816 -0.629 . . . . 74.430000000000007 110.608 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 7.7 tp10 -60.94 -36.46 79.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 65.310000000000002 110.636 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -75.43 -29.45 59.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.230000000000004 110.744 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.584 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.33 12.53 33.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.244 -0.435 . . . . 71.040000000000006 111.592 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.904 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.84 -43.42 99.19 Favored Pre-proline 0 C--O 1.223 -0.3 0 C-N-CA 120.308 -0.557 . . . . 72.140000000000001 110.032 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.2 Cg_exo -66.03 -20.39 57.21 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.818 2.345 . . . . 75.109999999999999 110.001 176.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.84 ' O ' HD11 ' A' ' 56' ' ' ILE . 66.0 t -98.55 -19.09 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 114.843 -1.071 . . . . 71.150000000000006 111.217 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -97.27 -27.58 3.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.066 -0.716 . . . . 42.229999999999997 109.066 178.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.26 -42.26 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.546 0 CA-C-N 115.076 -0.966 . . . . 72.219999999999999 110.587 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.71 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.89 -29.72 2.15 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.696 -0.764 . . . . 72.140000000000001 111.992 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.84 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -82.68 -41.63 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.733 -0.469 . . . . 71.239999999999995 109.733 178.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.47 -22.38 57.29 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.883 -0.599 . . . . 75.109999999999999 109.39 178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.617 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.68 -26.72 27.56 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.746 -0.661 . . . . 62.229999999999997 110.396 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -93.27 -44.4 13.78 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 115.965 -0.561 . . . . 75.400000000000006 110.372 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.731 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -85.88 -3.02 86.0 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.696 -0.764 . . . . 64.0 111.246 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.192 -0.909 . . . . 74.239999999999995 110.924 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.521 -0.232 . . . . 64.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -74.1 -22.57 77.65 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 24.420000000000002 112.579 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.98 -62.22 1.58 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.202 0.525 . . . . 74.329999999999998 110.985 -179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -63.72 -23.81 67.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 74.549999999999997 109.961 179.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -70.79 -44.77 65.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.824 -0.625 . . . . 74.120000000000005 110.647 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.4 tp -82.1 -37.78 25.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 64.329999999999998 110.816 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -22.03 57.88 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.825 -0.702 . . . . 73.120000000000005 112.696 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -94.38 -31.41 14.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.769 0.319 . . . . 73.239999999999995 110.998 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -62.56 -57.79 9.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.015 0.436 . . . . 63.210000000000001 110.551 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.0 tp -59.69 -52.95 63.29 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.82 -0.627 . . . . 61.140000000000001 110.722 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -52.28 -40.98 62.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.732 -0.667 . . . . 65.0 110.964 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.08 -43.49 88.41 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.706 -0.759 . . . . 70.129999999999995 112.286 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.915 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.39 -53.29 14.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 64.519999999999996 110.708 179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.26 -29.4 22.19 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.091 -0.576 . . . . 61.149999999999999 112.461 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.52 ' HA ' ' HD2' ' A' ' 43' ' ' PHE . 2.5 mttt -65.14 -59.31 4.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.101 0.477 . . . . 62.32 110.025 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -29.92 62.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.079 -0.509 . . . . 64.209999999999994 109.911 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.915 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.4 t -75.99 -47.55 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.534 -0.757 . . . . 72.230000000000004 111.24 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.52 ' HD2' ' HA ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.46 -40.42 50.73 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.721 -0.474 . . . . 74.239999999999995 109.721 179.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.428 ' HG3' ' CZ ' ' A' ' 43' ' ' PHE . 14.1 mttt -75.25 -30.0 60.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.698 -0.683 . . . . 61.229999999999997 109.655 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -62.61 -42.55 99.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 115.801 -0.636 . . . . 74.010000000000005 110.556 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.9 t -85.12 -37.65 20.0 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.022 -0.535 . . . . 72.099999999999994 110.748 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.18 -33.5 63.05 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.186 -0.461 . . . . 74.530000000000001 110.57 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -70.16 -33.15 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 73.219999999999999 110.664 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -104.71 11.18 34.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 63.420000000000002 111.493 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.921 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.6 tt -55.23 -43.32 99.03 Favored Pre-proline 0 C--O 1.223 -0.32 0 C-N-CA 120.188 -0.605 . . . . 54.25 110.02 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 2.9 Cg_exo -66.44 -22.19 52.45 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.875 2.384 . . . . 60.439999999999998 110.045 176.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.896 ' O ' HD11 ' A' ' 56' ' ' ILE . 71.5 t -97.51 -14.96 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 114.93 -1.032 . . . . 63.539999999999999 111.374 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.731 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.0 p -101.54 -27.7 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 108.804 -0.814 . . . . 72.400000000000006 108.804 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.921 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.1 m -82.27 -41.97 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 CA-C-N 115.076 -0.965 . . . . 55.25 110.41 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.745 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.69 -29.25 2.89 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.604 -0.808 . . . . 52.329999999999998 112.032 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.896 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.5 OUTLIER -86.88 -35.99 9.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.605 -0.517 . . . . 74.319999999999993 109.605 178.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.598 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -78.43 -21.75 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.545 -0.752 . . . . 64.109999999999999 109.661 178.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.616 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.71 -21.45 25.2 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.878 -0.601 . . . . 73.219999999999999 110.96 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.745 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.04 -44.09 12.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.001 -0.545 . . . . 65.239999999999995 111.981 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.73 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.3 -0.12 8.78 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.768 -0.729 . . . . 65.439999999999998 111.762 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.598 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 12.8 tttm . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.204 -0.903 . . . . 64.040000000000006 111.35 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.521 -0.232 . . . . 51.219999999999999 112.521 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.417 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -69.56 -21.99 76.43 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.739 . . . . 75.150000000000006 112.584 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.713 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.62 -61.2 2.51 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.953 0.406 . . . . 62.520000000000003 110.118 179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -63.16 -23.44 67.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.883 -0.599 . . . . 55.130000000000003 109.685 178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.417 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -67.78 -44.25 77.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.879 -0.6 . . . . 62.439999999999998 110.79 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 54.3 tp -68.79 -46.07 69.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 54.539999999999999 110.859 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.95 -36.94 93.67 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.738 -0.744 . . . . 44.25 112.465 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -70.45 -29.17 65.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 64.439999999999998 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -63.49 -57.07 11.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 55.140000000000001 110.827 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.4 ' O ' HD23 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -67.65 -42.64 81.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.977 -0.556 . . . . 74.219999999999999 110.916 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -53.61 -40.24 65.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 70.120000000000005 111.071 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.64 -41.43 82.15 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.752 -0.737 . . . . 70.109999999999999 112.651 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.769 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.68 -43.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.412 . . . . 74.120000000000005 110.941 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.09 34.66 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.736 -0.745 . . . . 40.329999999999998 112.706 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -81.09 -40.58 23.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.664 0.232 . . . . 72.400000000000006 110.967 -179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -81.66 -37.16 27.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.038 0.447 . . . . 71.120000000000005 110.663 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.8 t -71.88 -22.69 21.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.727 -0.67 . . . . 64.409999999999997 111.717 -179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.61 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -47.92 -27.64 2.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.517 -0.31 . . . . 72.109999999999999 110.838 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 5.6 mtpt -77.03 -33.74 57.37 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.171 0.51 . . . . 74.340000000000003 109.806 179.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -76.6 -32.69 58.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.476 -0.784 . . . . 54.520000000000003 110.302 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.8 p -85.22 -45.75 11.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.765 -0.652 . . . . 71.140000000000001 111.046 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -53.61 -35.55 61.01 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 120.998 0.428 . . . . 75.409999999999997 110.916 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.85 -37.2 85.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.955 -0.566 . . . . 75.299999999999997 110.974 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.807 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -97.84 13.86 29.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 70.209999999999994 111.851 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.918 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.4 tt -56.96 -42.64 97.41 Favored Pre-proline 0 C--O 1.223 -0.317 0 C-N-CA 120.148 -0.621 . . . . 72.340000000000003 109.99 178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.675 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.7 Cg_exo -66.27 -23.81 51.59 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.87 2.38 . . . . 74.540000000000006 109.915 176.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.937 ' O ' HD11 ' A' ' 56' ' ' ILE . 50.9 t -96.8 -10.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 114.878 -1.056 . . . . 73.310000000000002 111.215 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 49' ' ' ALA . 71.4 t -104.58 -28.76 2.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.783 -0.821 . . . . 72.519999999999996 108.783 178.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.918 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.3 m -82.44 -41.7 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 114.932 -1.031 . . . . 75.109999999999999 110.517 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.801 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.61 -28.45 3.57 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.596 -0.812 . . . . 73.109999999999999 112.157 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.937 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.0 -33.34 6.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.198 0.523 . . . . 64.340000000000003 109.798 179.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.607 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -82.19 -22.18 36.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.671 -0.695 . . . . 45.450000000000003 109.495 178.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.614 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.69 -21.51 25.19 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.948 -0.569 . . . . 44.149999999999999 111.2 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -91.25 -47.3 14.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.046 0.451 . . . . 62.100000000000001 112.073 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.747 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -130.36 4.5 5.92 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.69 -0.686 . . . . 34.109999999999999 111.433 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 1.3 tttp . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.236 -0.887 . . . . 74.140000000000001 111.146 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.465 -0.254 . . . . 71.230000000000004 112.465 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -85.84 -21.75 52.07 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.726 -0.75 . . . . 63.420000000000002 112.717 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.629 ' HA ' HD23 ' A' ' 31' ' ' LEU . 2.3 tm? -46.02 -61.35 1.79 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.84 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.512 ' N ' HD13 ' A' ' 28' ' ' LEU . 1.1 pttt -57.94 -23.8 55.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.58 . . . . 54.409999999999997 110.235 179.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.76 -35.35 65.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.77 -0.65 . . . . 74.319999999999993 110.923 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.629 HD23 ' HA ' ' A' ' 28' ' ' LEU . 0.7 OUTLIER -81.99 -31.26 31.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.197 -0.456 . . . . 73.0 110.952 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.2 -21.99 78.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 64.109999999999999 112.812 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -29.98 13.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.743 0.306 . . . . 72.099999999999994 110.959 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.5 tttt -65.77 -57.79 7.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 75.129999999999995 111.012 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -48.52 81.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 53.409999999999997 111.134 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.77 -37.96 66.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 63.43 111.082 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.9 -39.78 63.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.778 -0.725 . . . . 52.340000000000003 112.584 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.811 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.9 -48.77 65.08 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.971 0.415 . . . . 62.450000000000003 110.837 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.92 -36.48 60.4 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.904 -0.665 . . . . 44.229999999999997 112.667 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.621 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 8.1 mttt -62.34 -36.87 83.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.688 0.28 . . . . 64.030000000000001 110.323 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.28 6.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.195 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.1 t -55.89 -23.09 14.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.314 -0.857 . . . . 52.229999999999997 111.839 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.621 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.68 -28.19 5.66 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.818 0.342 . . . . 74.310000000000002 110.449 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -77.65 -34.24 53.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.207 0.527 . . . . 71.430000000000007 109.729 179.073 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -75.52 -32.86 60.65 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.528 -0.76 . . . . 72.25 110.252 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.15 -47.16 10.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.794 -0.639 . . . . 74.510000000000005 111.154 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER -53.51 -37.39 62.72 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.926 0.393 . . . . 75.349999999999994 111.009 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -68.27 -33.48 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 61.409999999999997 111.094 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.72 13.11 34.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.307 -0.406 . . . . 74.340000000000003 111.872 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.29 -42.62 96.98 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.016 -0.674 . . . . 53.32 109.734 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.9 Cg_exo -65.35 -25.43 56.6 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.774 2.316 . . . . 74.219999999999999 109.842 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.904 ' O ' HD11 ' A' ' 56' ' ' ILE . 53.2 t -94.17 -12.67 8.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 114.751 -1.113 . . . . 60.509999999999998 111.243 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 67.1 t -102.9 -28.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.793 -0.818 . . . . 64.319999999999993 108.793 178.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.7 m -82.36 -41.85 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 CA-C-N 115.04 -0.982 . . . . 72.430000000000007 110.419 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.786 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.66 -29.11 2.79 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.515 -0.85 . . . . 42.409999999999997 112.113 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.904 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.93 -37.12 11.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.158 0.504 . . . . 75.439999999999998 109.697 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 5.0 mtmt -78.37 -21.47 49.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.664 -0.698 . . . . 74.310000000000002 109.456 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.63 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.57 -21.55 25.32 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.883 -0.598 . . . . 73.310000000000002 110.982 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.786 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -98.13 -43.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.041 -0.527 . . . . 74.030000000000001 111.933 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -124.08 -0.38 8.92 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.757 -0.735 . . . . 71.420000000000002 111.755 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.18 -0.914 . . . . 71.140000000000001 111.314 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 112.541 -0.223 . . . . 50.210000000000001 112.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.88 -21.89 78.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.74 -0.743 . . . . 54.310000000000002 112.661 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.8 tm? -46.54 -61.41 1.83 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.009 0.433 . . . . 72.340000000000003 110.93 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 26.1 mmtt -61.02 -23.85 65.73 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.803 -0.635 . . . . 74.319999999999993 110.356 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -69.65 -37.44 76.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.97 -0.559 . . . . 73.340000000000003 110.87 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 53.0 tp -81.88 -43.59 17.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 42.200000000000003 111.079 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.87 -51.8 52.94 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.678 -0.772 . . . . 75.120000000000005 112.617 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.11 -30.49 66.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.219999999999999 110.956 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -63.11 -57.0 12.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 72.030000000000001 110.742 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.3 tp -65.65 -55.54 16.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.044 -0.525 . . . . 72.5 110.834 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.04 -37.03 52.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.197 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -67.55 -33.06 80.19 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 52.240000000000002 112.586 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -80.59 -37.64 30.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.868 0.366 . . . . 75.140000000000001 110.917 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -72.73 -27.28 69.45 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.965 -0.636 . . . . 54.43 113.122 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.639 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 17.8 pttt -63.39 -38.63 91.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 117.149 0.474 . . . . 62.130000000000003 110.957 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.97 -32.07 30.88 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 42.329999999999998 110.453 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 43.4 t -80.85 -22.93 10.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.528 -0.76 . . . . 63.420000000000002 112.212 -178.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.639 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.62 -26.89 3.99 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.759 0.314 . . . . 65.420000000000002 110.803 -179.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.5 tttt -77.66 -31.61 52.71 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.183 0.516 . . . . 75.530000000000001 109.671 178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -77.87 -33.55 52.02 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.386 -0.825 . . . . 43.340000000000003 110.305 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -45.3 12.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.779 -0.646 . . . . 64.340000000000003 111.026 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.421 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 3.0 pp20? -52.43 -36.87 55.48 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.939 0.4 . . . . 71.450000000000003 110.789 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.8 tptm -64.17 -33.16 75.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.439999999999998 110.816 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.815 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -101.51 12.89 36.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 111.671 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.914 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.2 tt -55.87 -43.11 99.05 Favored Pre-proline 0 C--O 1.223 -0.331 0 C-N-CA 120.155 -0.618 . . . . 54.340000000000003 109.949 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 7.0 Cg_exo -65.27 -24.4 58.24 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.89 2.393 . . . . 74.209999999999994 109.945 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.885 ' O ' HD11 ' A' ' 56' ' ' ILE . 54.6 t -95.39 -15.14 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.765 -1.107 . . . . 64.510000000000005 111.216 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 49' ' ' ALA . 61.1 t -100.08 -28.8 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.94 -0.763 . . . . 54.310000000000002 108.94 178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.914 HG13 ' O ' ' A' ' 50' ' ' LEU . 17.4 m -82.27 -42.29 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.523 0 CA-C-N 114.995 -1.002 . . . . 44.509999999999998 110.589 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.98 -29.53 2.14 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.601 -0.809 . . . . 65.230000000000004 111.976 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.885 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.59 -40.72 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.163 0.506 . . . . 73.25 109.758 178.891 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.13 -21.75 56.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.76 -0.654 . . . . 74.239999999999995 109.432 178.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.611 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.42 -27.21 25.92 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.742 -0.663 . . . . 44.32 110.411 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.739 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.79 -44.81 14.39 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.357 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.739 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.7 -2.28 81.99 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.65 -0.786 . . . . 54.310000000000002 111.245 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.25 -0.881 . . . . 74.140000000000001 110.932 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.118 0 N-CA-C 112.484 -0.246 . . . . 72.409999999999997 112.484 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.82 71.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.694 -0.765 . . . . 74.310000000000002 112.679 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.515 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -47.37 -61.38 1.94 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.022 0.439 . . . . 73.019999999999996 110.799 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.8 tttt -60.62 -23.72 64.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 75.510000000000005 110.332 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.99 -40.66 78.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.932 -0.576 . . . . 65.030000000000001 110.922 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 68.3 tp -74.39 -40.35 62.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.078 -0.51 . . . . 74.299999999999997 110.958 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.64 -54.72 24.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.683 -0.77 . . . . 60.109999999999999 112.589 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -26.98 62.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 75.109999999999999 111.113 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.3 tttt -64.42 -57.83 8.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.32 -0.4 . . . . 73.420000000000002 110.913 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.47 -46.59 72.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.995 -0.548 . . . . 61.549999999999997 111.003 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.42 -47.13 82.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 73.109999999999999 111.019 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.53 -47.9 67.74 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.819 -0.705 . . . . 35.240000000000002 112.549 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.816 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.01 -44.62 88.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.922 0.392 . . . . 72.430000000000007 110.842 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.9 -37.74 63.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.034 -0.603 . . . . 65.310000000000002 112.58 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.614 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mttt -62.13 -36.59 82.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.699 0.285 . . . . 53.119999999999997 110.43 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.74 -53.53 6.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.311 0.577 . . . . 74.140000000000001 110.286 179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 38' ' ' ALA . 17.2 t -55.44 -23.9 14.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.269 -0.878 . . . . 73.439999999999998 111.834 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.614 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.83 -27.96 5.78 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.831 0.348 . . . . 64.230000000000004 110.444 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 mtmm -77.86 -33.94 51.96 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.171 0.51 . . . . 71.319999999999993 109.814 179.109 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -73.56 -33.84 64.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.609 -0.723 . . . . 73.030000000000001 110.274 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -85.39 -50.33 7.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.756 -0.656 . . . . 73.299999999999997 111.16 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 1.7 pp20? -51.15 -34.41 31.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.911 0.386 . . . . 72.329999999999998 111.089 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -36.76 82.82 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.074 -0.512 . . . . 52.439999999999998 111.087 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.791 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -99.68 14.14 31.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.382 -0.372 . . . . 60.329999999999998 111.916 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.1 tt -57.88 -42.57 96.02 Favored Pre-proline 0 C--O 1.222 -0.356 0 C-N-CA 120.084 -0.646 . . . . 61.119999999999997 109.861 178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.683 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 4.6 Cg_exo -66.04 -24.06 52.99 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.884 2.389 . . . . 70.010000000000005 109.877 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.868 ' O ' HD11 ' A' ' 56' ' ' ILE . 64.6 t -95.09 -15.49 7.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 CA-C-N 114.766 -1.107 . . . . 62.32 111.161 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.9 t -100.15 -28.9 3.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.874 -0.787 . . . . 71.219999999999999 108.874 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.29 -41.98 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.55 0 CA-C-N 115.082 -0.963 . . . . 73.400000000000006 110.534 178.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.96 -29.48 2.12 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.657 -0.783 . . . . 60.32 112.072 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.868 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.33 -40.74 16.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.136 0.493 . . . . 51.25 109.808 178.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -76.48 -21.96 55.14 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.75 -0.659 . . . . 71.299999999999997 109.465 178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.633 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.93 -27.88 26.26 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.785 -0.643 . . . . 63.100000000000001 110.398 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.745 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.1 -44.99 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 CA-C-N 115.92 -0.582 . . . . 51.32 110.349 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.745 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.68 -3.1 84.03 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.175 -0.77 . . . . 44.329999999999998 111.175 178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.292 -0.861 . . . . 75.310000000000002 111.009 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.508 -0.237 . . . . 70.019999999999996 112.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -66.5 -21.99 71.07 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.68 -0.772 . . . . 51.530000000000001 112.642 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.723 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -56.69 -61.29 2.53 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.958 0.408 . . . . 74.409999999999997 110.105 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -63.83 -23.46 67.36 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 72.329999999999998 109.756 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.419 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -66.89 -39.81 87.57 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 115.762 -0.653 . . . . 60.049999999999997 110.921 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.7 tp -79.2 -38.47 35.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 61.149999999999999 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.34 -22.34 78.57 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.779 -0.724 . . . . 73.109999999999999 112.643 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -97.06 -26.31 15.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 61.149999999999999 111.066 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 tppt? -66.14 -60.5 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.972 0.415 . . . . 64.120000000000005 110.783 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.515 ' C ' HD13 ' A' ' 35' ' ' LEU . 3.2 tm? -58.5 -51.71 68.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.877 -0.601 . . . . 74.409999999999997 110.871 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -53.99 -34.39 59.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.556 . . . . 71.329999999999998 111.04 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.2 -37.2 71.54 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.771 -0.728 . . . . 72.319999999999993 112.464 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -72.43 -45.86 57.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.019999999999996 110.864 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.0 -21.78 32.49 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.829 -0.701 . . . . 72.25 112.747 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -73.12 -42.62 62.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.582 0.191 . . . . 55.5 111.25 -179.691 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.451 ' HD2' HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -81.56 -39.3 24.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.997 0.427 . . . . 74.530000000000001 110.699 179.932 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 38' ' ' ALA . 41.6 t -67.94 -22.53 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 72.329999999999998 111.5 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -46.8 -26.95 1.06 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 73.140000000000001 111.226 -179.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 1.1 mttt -78.61 -35.25 45.9 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.026 0.441 . . . . 71.439999999999998 110.111 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' VAL . . . -58.9 -40.78 85.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.801 -0.636 . . . . 72.049999999999997 110.293 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.7 t -85.14 -33.04 22.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.891 -0.595 . . . . 62.140000000000001 110.211 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.567 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -57.19 -39.82 76.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.843 -0.617 . . . . 70.549999999999997 110.431 179.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 pttm -66.75 -29.14 69.03 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.895 -0.593 . . . . 65.299999999999997 110.999 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -105.72 11.48 32.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.419 -0.355 . . . . 54.409999999999997 111.833 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.922 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.79 -43.1 99.03 Favored Pre-proline 0 C--O 1.223 -0.312 0 C-N-CA 120.164 -0.614 . . . . 71.239999999999995 109.981 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.67 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.3 Cg_exo -67.13 -21.87 48.07 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.768 2.312 . . . . 72.409999999999997 110.02 177.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.942 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.6 t -97.77 -14.03 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 115.008 -0.996 . . . . 74.430000000000007 111.415 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.72 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -102.25 -27.68 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 108.881 -0.785 . . . . 60.530000000000001 108.881 178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.5 m -82.5 -42.06 18.17 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 CA-C-N 114.992 -1.004 . . . . 75.329999999999998 110.637 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.962 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -47.16 -28.34 4.21 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.493 -0.861 . . . . 55.210000000000001 112.277 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.942 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.4 OUTLIER -86.53 -29.32 5.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.113 0.483 . . . . 62.340000000000003 109.963 179.116 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 2.1 mtmt -86.45 -24.08 25.78 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.752 -0.658 . . . . 71.510000000000005 109.524 178.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.92 -21.21 25.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.581 . . . . 71.140000000000001 112.25 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.962 HG23 ' O ' ' A' ' 55' ' ' GLY . 1.1 pp -62.05 -61.47 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.415 0 CA-C-O 121.147 0.499 . . . . 72.209999999999994 112.17 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -135.08 8.25 4.44 Favored Glycine 0 N--CA 1.443 -0.888 0 N-CA-C 110.911 -0.876 . . . . 52.32 110.911 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 57' ' ' LYS . 1.5 mttt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.221 -0.895 . . . . 72.019999999999996 111.197 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.529 -0.228 . . . . 52.119999999999997 112.529 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.415 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -73.32 -24.27 75.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.676 -0.773 . . . . 52.219999999999999 112.56 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.51 -62.2 1.55 Allowed 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.278 0.561 . . . . 73.420000000000002 110.841 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.423 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 0.4 OUTLIER -65.35 -23.92 67.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.386 -0.825 . . . . 71.319999999999993 110.008 179.042 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.415 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -71.02 -34.78 71.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.876 -0.602 . . . . 74.019999999999996 110.701 179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 58.0 tp -81.91 -34.2 30.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 62.119999999999997 110.837 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -74.9 -21.97 77.63 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 73.340000000000003 112.822 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 3.9 mtmt -95.03 -46.66 6.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.75 0.31 . . . . 71.409999999999997 111.154 -179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.418 ' CG ' ' N ' ' A' ' 35' ' ' LEU . 3.3 pttt -57.41 -50.52 72.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.98 0.419 . . . . 72.099999999999994 110.856 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -64.71 -42.85 94.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.76 -0.655 . . . . 51.310000000000002 110.842 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -39.42 76.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.111 -0.495 . . . . 61.329999999999998 111.034 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.91 -41.99 68.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.857 -0.687 . . . . 74.430000000000007 112.647 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.817 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.64 -46.21 73.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.891 0.377 . . . . 54.030000000000001 110.848 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.82 -34.03 56.59 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.973 -0.632 . . . . 63.32 112.692 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.599 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -64.39 -37.69 88.42 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.695 0.283 . . . . 72.439999999999998 110.436 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.59 -51.2 8.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 72.120000000000005 110.252 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 38' ' ' ALA . 15.8 t -56.97 -23.65 18.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.319 -0.855 . . . . 74.439999999999998 111.739 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.599 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.82 -27.05 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.338 . . . . 74.310000000000002 110.708 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.4 tttp -82.07 -35.04 29.11 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.124 -0.489 . . . . 73.430000000000007 110.083 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.47 -36.98 85.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.783 -0.644 . . . . 73.109999999999999 110.05 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.99 -33.33 22.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.685 -0.689 . . . . 72.549999999999997 110.174 179.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 2.7 mm-40 -58.66 -36.77 74.68 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.94 -0.573 . . . . 73.150000000000006 110.373 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -66.07 -31.02 71.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.91 -0.587 . . . . 74.430000000000007 110.794 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.779 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.18 13.54 30.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.519999999999996 111.638 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.92 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.7 tt -57.56 -42.65 96.82 Favored Pre-proline 0 C--O 1.223 -0.335 0 C-N-CA 120.09 -0.644 . . . . 63.25 109.756 178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.678 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.47 -24.67 56.45 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.845 2.364 . . . . 73.129999999999995 109.826 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.858 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.5 t -94.36 -15.02 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-N 114.718 -1.128 . . . . 73.540000000000006 111.262 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 49' ' ' ALA . 86.4 t -100.58 -29.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 108.932 -0.766 . . . . 62.240000000000002 108.932 178.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.92 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.4 m -82.21 -42.0 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-N 114.986 -1.006 . . . . 70.340000000000003 110.511 179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.721 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.92 -29.62 2.14 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.688 -0.767 . . . . 55.229999999999997 111.974 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.858 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -82.8 -41.47 17.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.13 0.49 . . . . 74.239999999999995 109.808 178.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.77 -22.29 56.59 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.742 -0.663 . . . . 64.129999999999995 109.341 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -84.6 -27.2 27.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.788 -0.642 . . . . 53.399999999999999 110.391 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.746 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.62 -44.45 14.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.911 -0.586 . . . . 64.200000000000003 110.341 179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.746 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -86.67 -2.62 84.46 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.206 -0.758 . . . . 44.520000000000003 111.206 178.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.226 -0.893 . . . . 70.409999999999997 110.895 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 112.43 -0.268 . . . . 62.140000000000001 112.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.99 -27.49 31.21 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.767 -0.73 . . . . 74.310000000000002 112.6 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -50.5 -62.18 1.74 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-O 121.168 0.508 . . . . 64.439999999999998 110.647 -179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.407 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 14.0 mtpp -64.89 -23.91 67.37 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.383 -0.826 . . . . 73.219999999999999 109.734 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.425 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.85 -40.29 79.47 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.776 -0.647 . . . . 63.5 110.755 179.7 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.3 tp -81.94 -35.87 28.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 73.25 110.875 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.04 -22.4 78.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.809 -0.71 . . . . 71.0 112.843 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -97.64 -27.19 14.48 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.754 0.312 . . . . 73.310000000000002 111.126 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -62.22 -56.4 19.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.011 0.434 . . . . 74.510000000000005 110.724 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.5 tp -64.09 -54.18 38.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.879 -0.6 . . . . 70.219999999999999 110.846 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -45.09 78.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.884 -0.598 . . . . 74.549999999999997 111.084 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.82 44.93 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.797 -0.716 . . . . 64.230000000000004 112.708 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.631 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.43 -48.72 66.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.89 0.376 . . . . 63.219999999999999 110.863 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -53.87 -34.05 50.85 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.015 -0.612 . . . . 73.430000000000007 112.66 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.611 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 5.1 mttm -59.78 -37.65 79.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.697 0.284 . . . . 71.030000000000001 110.464 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -52.25 7.33 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.202 0.525 . . . . 74.530000000000001 110.221 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 38' ' ' ALA . 21.3 t -55.51 -25.27 17.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.415 -0.811 . . . . 64.200000000000003 111.742 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.611 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.72 -26.78 2.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.386 -0.37 . . . . 74.450000000000003 110.753 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.1 tttt -81.99 -35.13 29.26 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 121.106 0.479 . . . . 53.310000000000002 110.102 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.14 90.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.741 -0.663 . . . . 72.420000000000002 110.19 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.18 -34.76 22.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.713 -0.676 . . . . 65.420000000000002 110.342 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.438 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -57.85 -38.52 75.83 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.112 -0.494 . . . . 73.310000000000002 110.524 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.8 mtmt -66.71 -29.48 69.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.9 -0.591 . . . . 71.420000000000002 111.118 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.822 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -105.11 11.97 32.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 63.32 111.923 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.916 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.9 tt -56.64 -42.73 97.78 Favored Pre-proline 0 C--O 1.224 -0.265 0 C-N-CA 120.025 -0.67 . . . . 73.109999999999999 109.852 178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.676 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.5 Cg_exo -65.52 -25.39 55.37 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.817 2.345 . . . . 73.219999999999999 109.811 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.898 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -93.98 -13.64 8.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 114.865 -1.061 . . . . 55.310000000000002 111.237 179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 49' ' ' ALA . 58.4 t -101.81 -29.03 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.882 -0.785 . . . . 73.439999999999998 108.882 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.5 m -82.23 -42.09 18.48 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.496 0 CA-C-N 115.042 -0.981 . . . . 73.340000000000003 110.398 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.27 -29.33 2.42 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.618 -0.801 . . . . 51.32 111.96 179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.898 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.14 -39.74 14.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.625 -0.509 . . . . 62.210000000000001 109.625 178.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 1.1 mtmm -76.1 -21.02 57.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.681 -0.69 . . . . 63.119999999999997 109.602 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.53 -21.46 25.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 72.099999999999994 111.286 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.848 HG23 ' O ' ' A' ' 55' ' ' GLY . 23.7 pt -91.26 -47.12 14.45 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.335 0 CA-C-O 121.079 0.466 . . . . 73.349999999999994 112.17 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.521 ' N ' HG13 ' A' ' 59' ' ' ILE . . . -133.27 4.06 4.84 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 111.251 -0.739 . . . . 72.120000000000005 111.251 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.617 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.25 -0.881 . . . . 72.430000000000007 110.831 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.487 -0.245 . . . . 45.030000000000001 112.487 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 -21.8 74.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.624 -0.798 . . . . 55.240000000000002 112.68 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.527 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -46.53 -61.45 1.81 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.992 0.425 . . . . 74.409999999999997 110.883 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.0 OUTLIER -60.27 -23.79 64.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.818 -0.628 . . . . 63.039999999999999 110.405 179.249 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.53 -41.14 76.38 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.014 -0.539 . . . . 72.409999999999997 111.0 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.438 HD12 ' HD3' ' A' ' 34' ' ' LYS . 61.3 tp -79.87 -35.35 38.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.466 . . . . 74.340000000000003 111.034 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.41 -22.01 76.23 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 70.010000000000005 112.838 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -93.79 -43.3 8.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.752 0.311 . . . . 73.150000000000006 111.158 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -58.79 -50.82 72.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.297 -0.411 . . . . 34.340000000000003 111.021 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.438 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -61.12 -48.93 79.37 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.616 . . . . 71.340000000000003 111.074 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.81 -45.29 82.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 54.229999999999997 111.19 -179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.13 -44.27 51.18 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.837 -0.697 . . . . 60.409999999999997 112.732 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.797 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -65.96 -48.59 70.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.936 0.398 . . . . 51.149999999999999 110.907 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.14 -35.95 55.72 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.986 -0.626 . . . . 63.229999999999997 112.641 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 2.3 mtpt -62.73 -37.49 86.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.721 0.296 . . . . 73.439999999999998 110.421 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -81.7 -53.01 6.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.279 0.562 . . . . 74.510000000000005 110.315 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 38' ' ' ALA . 14.6 t -55.8 -23.11 14.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.316 -0.856 . . . . 75.019999999999996 111.679 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -50.14 -27.85 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.348 . . . . 71.549999999999997 110.456 179.833 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 mttm -78.47 -32.79 48.52 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.123 -0.49 . . . . 61.020000000000003 109.798 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -76.32 -32.83 58.93 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.621 -0.718 . . . . 74.109999999999999 110.302 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.37 -47.98 9.47 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.734 -0.666 . . . . 63.350000000000001 111.044 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -51.9 -33.96 39.18 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 64.329999999999998 110.916 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 7.3 tttt -66.17 -38.32 87.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.51 . . . . 65.209999999999994 111.053 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -100.37 12.94 36.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.397 -0.365 . . . . 34.310000000000002 111.82 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.908 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.0 tt -56.79 -42.81 98.21 Favored Pre-proline 0 C--O 1.223 -0.311 0 C-N-CA 120.068 -0.653 . . . . 75.109999999999999 109.837 178.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.673 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 5.1 Cg_exo -65.82 -25.07 53.4 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.747 2.298 . . . . 74.040000000000006 109.944 176.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.923 ' O ' HD11 ' A' ' 56' ' ' ILE . 56.0 t -95.43 -11.02 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-N 114.909 -1.042 . . . . 75.25 111.229 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 49' ' ' ALA . 73.2 t -104.35 -28.81 2.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 108.798 -0.815 . . . . 63.049999999999997 108.798 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.908 HG13 ' O ' ' A' ' 50' ' ' LEU . 18.1 m -82.28 -41.82 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.002 -0.999 . . . . 63.439999999999998 110.443 178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.769 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.28 -28.72 3.34 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.596 -0.811 . . . . 73.450000000000003 112.089 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.923 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -87.14 -35.45 8.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.593 -0.521 . . . . 73.019999999999996 109.593 178.912 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.63 ' O ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.05 -22.04 45.96 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.68 -0.691 . . . . 64.310000000000002 109.491 178.446 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.626 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -87.73 -21.42 25.19 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.911 -0.586 . . . . 73.209999999999994 111.059 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.769 HG23 ' O ' ' A' ' 55' ' ' GLY . 2.7 pp -96.67 -44.52 12.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-N 116.202 -0.454 . . . . 71.219999999999999 112.105 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -129.84 4.42 6.1 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.809 -0.71 . . . . 42.43 111.607 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 48.1 tttm . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.354 -0.832 . . . . 72.120000000000005 110.952 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.534 -0.226 . . . . 65.299999999999997 112.534 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -72.28 -21.9 79.11 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 62.420000000000002 112.657 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.697 ' N ' HD13 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -55.13 -61.1 2.54 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.93 0.395 . . . . 75.430000000000007 110.222 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.66 -23.39 67.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.907 -0.588 . . . . 74.519999999999996 109.719 178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.401 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.5 OUTLIER -68.4 -38.28 81.15 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.794 -0.639 . . . . 74.140000000000001 110.937 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 63.9 tp -79.25 -36.65 39.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 63.0 110.927 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.8 -57.24 9.1 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.743 -0.742 . . . . 42.0 112.558 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.86 -25.43 63.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.764 0.316 . . . . 62.439999999999998 111.092 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 tppt? -65.27 -59.09 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 63.100000000000001 110.833 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.34 -46.35 67.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.01 -0.541 . . . . 72.349999999999994 111.003 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -54.9 -38.75 67.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.483 . . . . 74.5 111.019 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -58.03 -42.67 95.1 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.72 -0.753 . . . . 54.32 112.407 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -66.45 -43.65 84.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.892 0.377 . . . . 73.120000000000005 110.843 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -54.51 -36.03 57.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.002 -0.618 . . . . 75.209999999999994 112.617 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.618 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -62.15 -36.61 82.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.724 0.297 . . . . 71.420000000000002 110.269 179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.76 -52.96 6.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.259 0.552 . . . . 62.409999999999997 110.152 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 38' ' ' ALA . 16.7 t -56.62 -23.08 16.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.217 -0.901 . . . . 70.310000000000002 111.867 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.618 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -49.78 -27.77 5.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 75.230000000000004 110.553 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.511 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 23.2 mttt -77.79 -33.75 52.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.115 0.483 . . . . 65.319999999999993 109.787 178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -75.41 -33.02 60.93 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.562 -0.744 . . . . 72.439999999999998 110.254 179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.32 -47.87 9.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 72.519999999999996 111.121 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HA ' ' A' ' 44' ' ' LYS . 2.9 pp20? -52.36 -39.03 60.23 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.964 0.412 . . . . 63.5 111.025 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -64.76 -30.07 71.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.973 -0.558 . . . . 75.200000000000003 111.115 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.581 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -103.83 11.44 35.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 44.210000000000001 111.901 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.8 tt -55.34 -43.34 99.06 Favored Pre-proline 0 C--O 1.224 -0.285 0 C-N-CA 120.238 -0.585 . . . . 63.399999999999999 110.123 179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.0 Cg_exo -66.34 -22.43 52.81 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.819 2.346 . . . . 64.540000000000006 110.017 176.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.871 ' O ' HD11 ' A' ' 56' ' ' ILE . 79.6 t -96.2 -17.78 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.797 -1.092 . . . . 75.430000000000007 111.26 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 50' ' ' LEU . 1.8 p -98.76 -27.92 3.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.939 -0.763 . . . . 72.510000000000005 108.939 178.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.0 m -82.38 -42.19 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 CA-C-N 115.099 -0.955 . . . . 75.530000000000001 110.511 178.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.693 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.95 -29.46 2.11 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.731 -0.747 . . . . 72.329999999999998 112.011 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.871 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -83.57 -40.29 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.146 0.498 . . . . 63.420000000000002 109.784 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -21.97 54.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.756 -0.656 . . . . 74.109999999999999 109.393 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.593 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.12 -24.1 28.16 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.792 -0.64 . . . . 51.210000000000001 110.439 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -96.63 -43.97 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.296 0 CA-C-N 115.935 -0.575 . . . . 72.540000000000006 110.495 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.751 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -83.45 -4.97 89.03 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.628 -0.796 . . . . 55.310000000000002 111.291 178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.248 -0.882 . . . . 52.409999999999997 110.996 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.218 0 N-CA-C 112.487 -0.245 . . . . 55.420000000000002 112.487 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.423 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -85.55 -24.76 41.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.747 . . . . 71.230000000000004 112.608 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.497 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.36 -62.25 1.52 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.18 0.515 . . . . 74.329999999999998 110.925 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.422 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 15.4 mttt -65.54 -23.89 66.98 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.387 -0.824 . . . . 73.0 109.916 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.423 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -70.54 -34.7 72.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.956 -0.565 . . . . 71.319999999999993 110.728 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.693 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.4 tm? -81.98 -34.96 29.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 73.049999999999997 110.988 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -70.07 -58.77 5.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 51.399999999999999 112.605 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.6 -37.32 65.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.788 0.327 . . . . 64.319999999999993 111.114 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -65.03 -57.45 8.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.306 -0.406 . . . . 74.200000000000003 110.844 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -42.39 90.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 111.067 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -47.81 81.38 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 63.530000000000001 110.938 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -53.71 -48.92 59.93 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.807 -0.711 . . . . 52.539999999999999 112.383 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -71.28 -47.6 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.933 0.397 . . . . 72.329999999999998 110.654 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -51.9 -28.57 24.66 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.056 -0.592 . . . . 62.299999999999997 112.529 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.485 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 6.3 mmtp -65.12 -59.14 4.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.125 0.488 . . . . 64.329999999999998 110.031 179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -28.77 63.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.096 -0.502 . . . . 64.420000000000002 110.139 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 38' ' ' ALA . 19.1 t -78.88 -43.68 24.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.575 -0.739 . . . . 54.32 111.638 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.497 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -50.07 -37.21 32.46 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.789 -0.448 . . . . 75.420000000000002 109.789 179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.4 OUTLIER -76.28 -30.75 57.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.737 -0.665 . . . . 51.350000000000001 109.896 178.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -62.99 -41.09 99.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.784 -0.644 . . . . 50.299999999999997 110.493 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 15.8 t -84.97 -35.78 21.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.887 -0.597 . . . . 74.409999999999997 110.47 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 44' ' ' LYS . 1.9 mm-40 -56.5 -34.06 66.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.159 -0.473 . . . . 74.140000000000001 110.423 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -69.18 -31.57 70.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.976 -0.556 . . . . 64.230000000000004 110.757 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.772 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -106.11 12.8 29.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.282 -0.417 . . . . 54.420000000000002 111.636 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.912 ' O ' HG13 ' A' ' 54' ' ' VAL . 4.8 tt -57.42 -42.56 96.5 Favored Pre-proline 0 C--O 1.222 -0.37 0 C-N-CA 120.18 -0.608 . . . . 71.5 109.697 178.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.686 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 6.1 Cg_exo -65.58 -23.98 56.41 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.832 2.354 . . . . 72.109999999999999 109.875 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.877 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -94.93 -15.65 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 114.71 -1.132 . . . . 51.009999999999998 111.21 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 49' ' ' ALA . 77.7 t -100.14 -28.8 3.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.998 -0.742 . . . . 71.420000000000002 108.998 178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.912 HG13 ' O ' ' A' ' 50' ' ' LEU . 16.8 m -82.36 -42.05 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 114.994 -1.003 . . . . 75.430000000000007 110.475 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.737 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.9 -29.59 2.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.652 -0.785 . . . . 75.049999999999997 111.956 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.877 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.67 -39.95 15.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.093 0.473 . . . . 74.150000000000006 109.81 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.5 mtmt -77.13 -21.59 53.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.788 -0.642 . . . . 71.430000000000007 109.514 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.627 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.26 -28.41 25.37 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.817 -0.629 . . . . 43.210000000000001 110.313 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.744 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -89.86 -45.12 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.25 0 CA-C-N 115.965 -0.561 . . . . 73.019999999999996 110.444 179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.744 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.4 -2.88 82.21 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.679 -0.772 . . . . 24.010000000000002 111.229 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.238 -0.887 . . . . 65.120000000000005 110.966 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.181 0 N-CA-C 112.475 -0.25 . . . . 73.310000000000002 112.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.28 -21.99 59.66 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.733 -0.746 . . . . 54.020000000000003 112.672 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.509 HD13 ' N ' ' A' ' 29' ' ' LYS . 1.9 tm? -48.02 -61.28 2.05 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.956 0.408 . . . . 63.049999999999997 110.721 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.509 ' N ' HD13 ' A' ' 28' ' ' LEU . 6.6 tptt -60.41 -23.69 64.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.84 -0.618 . . . . 72.540000000000006 110.291 179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.2 ttpt -68.2 -42.32 80.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.944 -0.571 . . . . 70.540000000000006 110.74 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.614 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -78.31 -41.64 33.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.005 -0.543 . . . . 62.450000000000003 110.84 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.61 -22.98 66.55 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.795 -0.717 . . . . 64.010000000000005 112.643 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -94.1 -28.97 15.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 51.420000000000002 111.028 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.79 -64.44 0.88 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.254 0.55 . . . . 64.25 110.907 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.66 -40.81 54.51 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 75.019999999999996 110.961 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.55 -37.85 73.78 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.951 -0.568 . . . . 70.25 110.917 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.56 -45.91 91.69 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.694 -0.765 . . . . 23.219999999999999 112.448 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.881 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -74.39 -41.12 61.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.923 0.392 . . . . 75.140000000000001 110.937 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -65.85 -21.67 69.61 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 121.067 -0.587 . . . . 72.349999999999994 112.531 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.406 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -64.2 -58.13 7.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.933 0.396 . . . . 73.340000000000003 110.549 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.49 -19.88 64.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.995 0.426 . . . . 73.400000000000006 110.15 179.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 38' ' ' ALA . 42.8 t -83.17 -48.14 17.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.203 0 CA-C-N 115.848 -0.615 . . . . 71.319999999999993 110.714 179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -50.44 -39.88 48.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.909 -0.587 . . . . 74.25 109.765 179.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -76.23 -28.97 57.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.726 -0.67 . . . . 74.099999999999994 109.558 178.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 42' ' ' VAL . . . -64.3 -46.0 85.5 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.584 -0.734 . . . . 65.310000000000002 110.32 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.1 t -79.24 -35.07 42.12 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.84 -0.618 . . . . 73.540000000000006 110.072 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.884 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -58.29 -21.81 50.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.008 -0.542 . . . . 54.039999999999999 110.394 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.33 -30.83 66.67 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.717 -0.475 . . . . 64.450000000000003 109.717 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.753 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -112.72 18.11 18.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.897 -0.592 . . . . 52.130000000000003 110.602 178.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.2 pp -62.82 -36.27 24.64 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.788 -0.765 . . . . 70.200000000000003 110.444 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.846 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 49.7 Cg_endo -77.96 -12.18 16.28 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.772 2.314 . . . . 53.140000000000001 109.929 177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.892 ' O ' HD11 ' A' ' 56' ' ' ILE . 65.0 t -105.86 -10.6 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-N 114.856 -1.065 . . . . 71.329999999999998 110.366 178.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.753 HG23 ' O ' ' A' ' 49' ' ' ALA . 78.4 t -105.75 -31.14 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.676 -0.861 . . . . 65.230000000000004 108.676 178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.805 HG22 ' O ' ' A' ' 50' ' ' LEU . 20.5 m -82.38 -39.92 16.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 CA-C-N 115.41 -0.814 . . . . 74.099999999999994 110.393 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -46.18 -29.28 3.48 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.602 -0.809 . . . . 70.040000000000006 112.05 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.892 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -85.47 -37.73 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.172 0.51 . . . . 74.5 109.724 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -78.01 -21.71 50.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.685 -0.689 . . . . 65.329999999999998 109.545 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.637 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.84 -27.15 25.27 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.887 -0.597 . . . . 45.140000000000001 110.367 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -91.15 -45.08 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 115.879 -0.601 . . . . 72.310000000000002 110.473 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.14 -1.42 79.17 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.676 -0.773 . . . . 65.430000000000007 111.302 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.3 mttt . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.19 -0.91 . . . . 71.040000000000006 110.85 179.945 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.386 -0.286 . . . . 54.109999999999999 112.386 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -78.8 -22.86 65.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.697 -0.763 . . . . 72.510000000000005 112.6 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.25 -62.12 1.57 Allowed 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.171 0.51 . . . . 72.239999999999995 111.008 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 4.4 ptmt -65.34 -23.89 67.12 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.471 -0.786 . . . . 74.409999999999997 110.038 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.403 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 1.0 OUTLIER -71.32 -36.03 71.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.985 -0.552 . . . . 75.329999999999998 110.741 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.62 ' O ' HD13 ' A' ' 31' ' ' LEU . 3.1 tm? -82.04 -42.59 19.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.435 . . . . 64.230000000000004 110.873 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -22.02 72.29 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.758 -0.734 . . . . 73.129999999999995 112.799 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 6.6 tttp -97.07 -23.85 16.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.642 0.258 . . . . 51.030000000000001 111.24 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.7 tppt? -67.32 -60.82 2.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 74.450000000000003 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.82 -45.91 91.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.579 . . . . 72.019999999999996 110.935 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.31 -40.44 71.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.082 -0.508 . . . . 62.530000000000001 111.125 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -52.97 -41.26 59.12 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.747 -0.739 . . . . 53.219999999999999 112.592 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.848 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -67.94 -47.14 69.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.129999999999995 110.814 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -56.19 -36.82 69.86 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.927 -0.654 . . . . 45.130000000000003 112.596 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.607 ' O ' ' CD1' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -63.02 -36.47 83.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.667 0.27 . . . . 72.310000000000002 110.426 179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -81.8 -52.08 7.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.224 0.535 . . . . 74.109999999999999 110.28 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 38' ' ' ALA . 20.3 t -57.0 -24.05 19.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.346 -0.843 . . . . 34.240000000000002 111.858 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CD1' ' O ' ' A' ' 40' ' ' LYS . 0.2 OUTLIER -48.42 -27.24 2.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.483 -0.326 . . . . 73.519999999999996 110.81 -179.867 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.507 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -81.0 -36.83 30.14 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.175 -0.466 . . . . 72.129999999999995 109.941 179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.14 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.785 -0.643 . . . . 71.120000000000005 109.928 179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.8 p -85.29 -36.94 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.617 -0.719 . . . . 51.329999999999998 110.349 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.23 -36.48 73.25 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.033 -0.531 . . . . 62.039999999999999 110.653 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 tptp -67.02 -31.81 72.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.061 -0.518 . . . . 70.019999999999996 110.949 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 53' ' ' VAL . . . -102.03 11.56 38.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.273 -0.421 . . . . 65.010000000000005 111.819 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 54' ' ' VAL . 5.9 tt -55.01 -43.62 99.16 Favored Pre-proline 0 C--O 1.224 -0.268 0 C-N-CA 120.263 -0.575 . . . . 71.010000000000005 110.064 179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 50' ' ' LEU . 3.2 Cg_exo -66.25 -21.52 54.71 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.885 2.39 . . . . 61.310000000000002 110.107 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.862 ' O ' HD11 ' A' ' 56' ' ' ILE . 69.0 t -97.92 -17.24 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 114.944 -1.025 . . . . 70.430000000000007 111.289 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 50' ' ' LEU . 2.1 p -98.85 -27.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 109.003 -0.74 . . . . 75.540000000000006 109.003 178.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 50' ' ' LEU . 15.9 m -82.21 -42.4 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.549 0 CA-C-N 115.14 -0.936 . . . . 61.329999999999998 110.583 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.701 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -44.87 -29.63 2.11 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.658 -0.782 . . . . 74.150000000000006 111.961 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.862 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -83.82 -40.84 16.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.707 -0.479 . . . . 73.319999999999993 109.707 178.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 -21.56 57.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.735 -0.666 . . . . 75.230000000000004 109.425 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.632 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.87 -26.86 25.41 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.871 -0.604 . . . . 64.019999999999996 110.507 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -92.7 -44.5 14.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.484 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.742 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -89.93 0.01 78.64 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.217 -0.753 . . . . 41.439999999999998 111.217 178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.2 mptt . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.207 -0.902 . . . . 71.150000000000006 110.83 -179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.394 -0.282 . . . . 52.030000000000001 112.394 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.42 ' HA2' ' HB2' ' A' ' 30' ' ' LYS . . . -67.5 -29.12 73.76 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.682 -0.771 . . . . 63.310000000000002 112.417 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 ' H ' HD23 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -47.95 -62.21 1.58 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.224 0.535 . . . . 62.539999999999999 110.799 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' H ' ' HG ' ' A' ' 28' ' ' LEU . 1.2 mttt -64.61 -23.89 67.41 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.358 -0.837 . . . . 73.140000000000001 109.792 178.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.42 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -68.97 -41.9 77.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 110.581 179.585 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 60.8 tp -82.06 -36.52 27.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.498 . . . . 55.0 110.849 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.16 -21.95 72.25 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.804 -0.712 . . . . 64.540000000000006 112.654 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -101.42 -26.16 13.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.814 0.34 . . . . 75.519999999999996 111.173 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -64.0 0.99 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.966 0.412 . . . . 65.439999999999998 110.88 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -44.1 75.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.995 -0.548 . . . . 71.25 111.067 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.5 -39.24 76.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.510000000000005 111.021 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.67 -45.22 93.55 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.72 -0.753 . . . . 65.329999999999998 112.333 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.871 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -70.94 -50.73 31.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 54.539999999999999 110.592 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 43' ' ' PHE . . . -52.37 -31.42 35.31 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.955 -0.641 . . . . 30.210000000000001 112.519 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' O ' ' CD2' ' A' ' 43' ' ' PHE . 8.3 tttm -66.69 -35.85 81.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.184 0.516 . . . . 63.299999999999997 110.21 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.11 -24.25 37.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.84 -0.618 . . . . 65.340000000000003 109.74 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 38' ' ' ALA . 11.8 t -85.28 -40.36 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.64 -0.709 . . . . 74.239999999999995 111.397 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -51.12 -33.16 25.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.062 0.458 . . . . 74.430000000000007 109.788 179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -79.63 -30.32 41.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.695 -0.684 . . . . 75.319999999999993 109.762 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.84 -44.74 84.61 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.774 -0.648 . . . . 54.140000000000001 110.167 179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 t -77.56 -34.67 53.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.757 -0.656 . . . . 61.399999999999999 109.914 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.862 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -59.74 -21.72 61.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.918 -0.583 . . . . 73.510000000000005 110.436 179.309 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.6 mmtt -73.14 -32.15 64.72 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.735 -0.468 . . . . 73.230000000000004 109.735 179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.752 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -111.29 18.33 19.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.753 -0.658 . . . . 74.340000000000003 110.559 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 47' ' ' GLU . 4.3 pp -62.92 -36.38 24.99 Favored Pre-proline 0 N--CA 1.451 -0.408 0 C-N-CA 119.948 -0.701 . . . . 54.530000000000001 110.352 178.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.817 ' HD3' ' HG ' ' A' ' 50' ' ' LEU . 46.5 Cg_endo -77.52 -12.31 16.92 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.745 2.296 . . . . 63.119999999999997 110.033 177.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.888 ' O ' HD11 ' A' ' 56' ' ' ILE . 70.0 t -104.85 -12.32 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 CA-C-N 114.718 -1.128 . . . . 75.049999999999997 110.225 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 49' ' ' ALA . 85.9 t -104.2 -31.45 2.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.631 -0.877 . . . . 70.019999999999996 108.631 178.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.81 HG13 ' O ' ' A' ' 50' ' ' LEU . 20.3 m -82.32 -39.74 16.49 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.51 0 CA-C-N 115.379 -0.828 . . . . 64.530000000000001 110.398 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.705 ' O ' HG23 ' A' ' 59' ' ' ILE . . . -45.83 -29.53 3.18 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.55 -0.834 . . . . 71.239999999999995 112.053 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.888 HD11 ' O ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -84.05 -39.74 15.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.114 0.483 . . . . 73.200000000000003 109.839 178.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.67 -21.84 54.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 63.119999999999997 109.422 178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.623 ' N ' ' O ' ' A' ' 54' ' ' VAL . . . -85.22 -28.13 25.62 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 115.78 -0.645 . . . . 72.010000000000005 110.363 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.743 HD12 ' N ' ' A' ' 60' ' ' GLY . 2.7 pp -90.53 -45.12 14.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 115.967 -0.56 . . . . 73.230000000000004 110.396 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.743 ' N ' HD12 ' A' ' 59' ' ' ILE . . . -87.51 -2.53 82.24 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 111.233 -0.747 . . . . 73.239999999999995 111.233 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.265 -0.874 . . . . 65.319999999999993 110.867 179.937 . . . . . . . . 1 1 . 1 stop_ save_